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Summary 
Many Gram-negative bacteria, among them human enteropathogenic Yersinia enterocolitica, 
use a type III secretion system (T3SS) to directly inject effector molecules into eukaryotic 
cells in order to establish a symbiotic or pathogenic relationship with their host. The export of 
several T3SS proteins requires the assistance of specialized chaperones from the bacterial 
cytosol. The transient interplay of the chaperones with their cognate effector molecules is an 
important aspect in the regulation of the T3SS.  
The translocation of the cytotoxic Y. enterocolitica effector molecule YopT, a cysteine 
protease that removes prenylated Rho GTPases from the host cell membrane, depends on the 
Class I/effector chaperone SycT. In investigating biochemically the complex between YopT 
and SycT, the chaperone-binding domain in the N-terminal part of YopT was specified more 
precisely. The persistent instability of YopT impairing successful crystallization was ad-
dressed using new expression constructs and procedures. Alternatively, the crystal structure of 
the YopT chaperone SycT was solved to high resolution in three independent crystal forms. 
SycT shares the homodimeric, canonical fold as well as the conserved hydrophobic surface 
patches with other T3SS Class I chaperones. In contrast, SycT lacks the dimerization helix 
and possesses an additional β-strand that is capable of undergoing a conformational rear-
rangement. 
Y. enterocolitica Class II chaperone SycD specifically assists the pore-forming translocator 
proteins YopB and YopD. Moreover, SycD is involved in the regulation of virulence factor 
biosynthesis and secretion. The crystal structure of SycD could be determined to 1.95 Å and 
presents the first experimental structure of a T3SS Class II chaperone. SycD exhibits an 
entirely α-helical fold composed of three tetratricopeptide repeats (TPR) as previously 
predicted. Biochemical analysis using site-directed mutagenesis and size exclusion chroma-
tography disclosed the formation of SycD head-to-head homodimers. Structural analysis 
revealed two alternative head-to-head dimer assemblies that share the same interface but 
differ in monomer orientation and overall shape. In the SycD dimer, the two faces of the TPR 
domain are freely accessible for interactions with the cognate translocators YopB and YopD. 
The sycD knockout-like phenotype of a stable but dimerization-defective SycD variant 
corroborated the physiological role of this newly identified SycD interface in vivo. 
The structural and functional investigations of SycT and SycD disclosed intriguing features 
possibly conferring binding specificity and regulatory effect, respectively. The two structures 
thus contribute to the understanding how the T3SS is orchestrated.  
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1 Introduction 
1.1 The pathogenic bacterium Yersinia  
The bacterium Yersinia is a Gram-negative coccobacillus belonging to the family of Entero-
bacteriaceae and comprises three human pathogenic species: Y. pestis is the causative agent of 
plague, Y. pseudotuberculosis and Y. enterocolitica are gastrointestinal pathogens. Plague is a 
devastating acute infectious disease and caused severe pandemics in medieval times. But still 
today, smaller outbreaks of plague are reported throughout the world, recently in the Congo 
(2005/06) (WHO, 2007). Plague is a systemic zoonosis (i.e. transmission from animals to 
humans), which is maintained in a rodent reservoir host through a transmission cycle involv-
ing rat fleas as vector that occasionally bite humans. The bacteria then localize to regional 
lymph nodes. Bubonic plague (bubo=swollen lymph node) is the most common, beside the 
septicemic and pneumonic appearance. Pneumonic plague establishes only in rare cases from 
bubonic plague, or by inhaling respiratory droplets. Compared to 50-60 % mortality of 
bubonic plague, the pulmonary disease is highly contagious and rapidly fatal if left untreated. 
It spreads in an epidemic manner via the respiratory route (Prentice and Rahalison, 2007).  
Unlike Y. pestis, the enteric pathogens Y. enterocolitica and Y. pseudotuberculosis find their 
habitats in the environment (e.g. soil), where they infect animals and are taken up by humans 
with contaminated food or water. The bacteria pass to the small intestine, where the Yersinia 
adhesion molecules invasin and multifunctional YadA promote tight adhesion and invasion 
into epithelial cells. This occurs through either direct (invasin) or indirect, extracellular matrix 
(ECM)-mediated binding (YadA) to β1-integrin, a eukaryotic surface receptor (Leong et al., 
1990; El Tahir and Skurnik, 2001; Isberg and Barnes, 2001). The bacteria cross the intestinal 
barrier inducing the “zipper mechanism” (Pizarro-Cerda and Cossart, 2006) and transcytosis 
of antigen-sampling M-cells embedded in the follicle-associated epithelium of the Peyer’s 
patches (Clark et al., 1998) (Figure 1-1). At the basolateral side, they encounter the cellular 
immune response of the host. After transport into the Peyer’s patches and mesenteric lymph 
nodes, the bacteria proliferate extracellularly, colonize spleen and liver and cause localized 
infections. The clinical symptoms of yersiniosis range from gastroenteritis with mild, self-
limiting diarrhea to acute mesenteric lymphadenitis. In very rare cases the bacteria cause a 
systemic infection with severe sequelae, such as reactive arthritis. As Yersiniae are psychro-
philic, these food-borne germs continue growing at 4 °C and thereby pose a significant 
hygiene challenge especially for pork (~ products). Y. enterocolitica is also of significance in 
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blood transfusion-associated septicemia. The transmission pathways of Yersinia are depicted 
in Figure 1-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1. Transmission and 
dissemination of pathogenic 
Yersiniae in humans. Y. pestis from 
rodent reservoirs is resident in fleas 
and transmitted to other rodents or 
occasionally to humans – causing the 
bubonic plague. Inefficient human-
to-human transmission occurs via 
human fleas. Pneumonic plague is 
transmitted through respiratory 
droplets. Y. enterocolitica and Y. 
pseudotuberculosis are ingested, 
entering the lymphatic system 
through M-cells of the small 
intestine. The inset shows a scanning 
electron-micrograph of Y. enterocoli-
tica proliferating extracellularly 
within the lymphatic follicle tissue of 
a Peyer’s Patch (Clark et al., 1998). 
Adapted from Wren, 2003; Glass 
woman, German Hygiene Museum, 
Dresden.
 
The lymphatic tissue swarms with professional phagocytes such as macrophages and neutro-
philic leucocytes, which are specialized in destroying invading microbes. Yersinia prevents its 
own phagocytosis by the secretion of phagocyte-affecting cytotoxins (see below), and is 
thereby able to survive within the lymphatic tissue. 
 
1.2 Type III secretion - Yersinia’s stratagem 
The three Yersiniae species most likely originate from a common non-pathogenic predeces-
sor, which acquired a virulence plasmid and further elements by lateral gene transfer resulting 
in enteropathogenic Y. enterocolitica and Y. pseudotuberculosis. Population genetics revealed 
that Y. pestis recently (within the last 20’000 years) evolved from the enteropathogen Y. 
pseudotuberculosis by further uptake of genetic determinants and chromosomal degeneration 
(Achtman et al., 1999). Without the virulence plasmid, the bacterium is avirulent as seen for 
Y. enterocolitica biogroup 1A having lost its plasmid.  
Y. pestis is non-motile, whereas other species change their appearance and pathogenicity 
depending on temperature or the concentration of calcium ions. At lower temperatures 
(< 26.7 °C) or in the presence of calcium, Yersinia is non-flagellated and shows a strong 
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tendency to adhere to phagocytic cells with an increased production of invasin at the cell 
surface. During infection, the pathogenic Yersiniae depend on a T3SS that is encoded by the 
~70 kb Yersinia virulence plasmid (pCD/pYV) (Figure 1-2) in order to evade the host 
immune response and to survive extracellularly. After contacting an eukaryotic cell, Yersinia 
boosts the expression and secretion of the plasmid encoded virulence factors comprising 
T3SS effector molecules, chaperones and regulatory proteins (Figure 1-2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2. Genetic map of the virulence plasmid 
pYVe227 from Yersinia enterocolitica strain 
W22703 (serotype 0:9). The genes encoding the 
chaperones (syc) are located close to the cognate 
binding partner (yop). Effector and their cognate 
chaperone loci are colored in red, genes involved 
in intracellular delivery are colored magenta, loci 
required in secretion are colored in green, gene 
loci influencing transcription regulation are 
designated in bright orange (adapted from 
Cornelis et al., 1998). (Loci of virulence factors 
studied in this work are boxed). 
 
 
The term “type III secretion” was first used to describe one of the mechanisms that Gram-
negative bacteria employ in order to export proteins from the cell (Salmond and Reeves, 
1993). Further secretion systems exist ranging from T1S to T6S, including one and two step 
systems (Gerlach and Hensel, 2007). The type III secretion system (T3SS) is widespread 
among Gram-negative animal- and plant-pathogenic bacteria as well as bacterial symbionts. 
Although many components from the molecular machinery, the T3SS apparatus, are structur-
ally and functionally conserved among different species, distinct differences exist regarding 
the genetic basis and the purposes the T3SS is used for by the bacteria. Phylogenetic analysis 
allows the organization of T3SSs into seven groups, among them the Ysc group including the 
plasmid encoded Yersinia T3SS, or the group comprising the chromosomal Salmonella 
pathogenicity islands. It is not uncommon that the same T3SS is employed by different 
bacteria species or that a single species is equipped with T3SSs from different groups 
(Cornelis, 2006). 
The T3SS apparatus spans the inner membrane, the peptidoglycan layer and the outer 
membrane of the bacterium and protrudes in a needle-shaped structure of several nanometers 
in length (Figure 1-3) (reviewed by Galan and Wolf-Watz, 2006). The hollow assembly 
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consists of ~30 proteins and resembles a molecular syringe, therefore also called needle-
complex or injectisome. The actual mechanism of type III secretion is poorly understood. 
Upon sensing host cell contact, the machinery is switched on and effector molecules are 
suggested to be translocated in one step through this hollow conduit directly into the eu-
karyotic cell where they interfere with host cell signaling cascades. However, the inner 
channel diameter of ~2-3 nm does not allow the export of completely folded proteins 
suggesting the proteins to be transported in an at least partially unfolded state (Feldman et al., 
2002). 
Among the different bacteria, a great diversity of the translocated T3SS effectors exists. 
However, certain effector groups show the same biological function and/or biochemical 
activity among different species (for reviews on T3SS see Mota and Cornelis, 2005; Cornelis, 
2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3. The Yersinia Ysc-Yop type III secretion machinery. The T3SS apparatus consists of the basal 
body anchored in the bacterial membranes and a protruding needle-shaped structure. In the absence of host 
cells, the T3SS is down-regulated and cytotoxin secretion is blocked by a multicomponent plug at the gate. 
After sensing contact to the host cell, cytotoxin translation and translocation is induced.  
OM, outer membrane; IM, inner membrane; PG, peptidoglycan. The upper inset shows the needle protruding 
from the microbial cell (Cornelis, 2006), the lower inset depicts the surface rendering of the structure of the 
T3SS needle complex from Salmonella as well as the electron micrograph of isolated needle complexes 
(Marlovits et al., 2004). Modified from Mota and Cornelis, 2005; Desvaux et al., 2006. 
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Interestingly, the virulence- and symbiosis-associated T3SS is closely related to the flagellar 
T3SS and they most likely share a common evolutionary origin and assembly process (Saier, 
2004). This is suggested inter alia by the fact that they both export their own distal compo-
nents. Moreover, both assemblies are ATPase-dependent and include several components, 
especially from the basal body, that are functionally significantly similar (Auvray et al., 2001; 
Young and Young, 2002). 
 
1.3 T3SS translocators and effectors in Yersinia 
Successful translocation of the effector molecules or Yersinia outer proteins (Yops) across 
bacterial and host membranes directly into the host cytosol requires a specialized family of 
proteins, the translocators. Translocator proteins are also transported by the needle-complex 
and form a pore in the eukaryotic cell membrane allowing the effectors to enter the host cell 
(reviewed by Büttner and Bonas, 2002). 
In Yersinia, translocator proteins comprise the hydrophobic pore-forming proteins YopB and 
YopD (Tardy et al., 1999) as well as the hydrophilic channel-size determinant LcrV, the most 
effective immunomodulating yersinial antigen (Holmstrom et al., 2001; Mueller et al., 2005) 
(Figure 1-3). After secreting the components building the T3SS apparatus that were exported 
through the nascent machine, the bacterium switches the secretion specificity toward effector 
secretion. This is triggered by YscP, the proposed “molecular ruler” determining the length of 
the needle (Agrain et al., 2005), communicating with the basal body component YscU 
(Edqvist et al., 2003). In order to ensure its survival and spreading, Yersinia translocates at 
least six Yops into the eukaryotic cell. Here, the effectors modulate host cell processes that 
range from signal transduction to programmed cell death and actin cytoskeletal dynamics 
(Aepfelbacher et al., 2007). The roles of Yops in Yersinia virulence have been investigated in 
detail in cell culture as well as in the mouse infection model. Yersinia accomplishes its 
primary concern, the inhibition of phagocytosis, with four out of six of its Yop effectors 
acting synergistically (YopE/H/O/T). These effectors directly modulate the Rho GTPase cycle 
and focal adhesion complexes normally stimulating actin polymerization required in the 
formation of the phagocytic cup in macrophages, dendritic cells (DC) and neutrophils 
(Figure 1-4). Interference with the adaptive immune responses, the second vitally important 
point in Yop attack, is secured by two further Yops (YopJ/P and YopH). 
Rho GTPases play a central role in regulation of cytoskeletal functions. They are activated by 
guanine nucleotide exchange factors (GEFs) and inactivated by GTPase-activating proteins 
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(GAPs) therefore representing a molecular switch. Activated Rho GTPases recruit further 
proteins that stimulate actin nucleation and polymerization. The Yersinia effector YopE is a 
GTPase-activating protein (GAP) acting on small Rho GTPases promoting actin depolymeri-
zation (Black and Bliska, 2000) and prevents maturation of proinflammatory cytokine IL-1β 
(Schotte et al., 2004).  
The second antiphagocytic effector, the protein tyrosine phosphatase YopH, dephosphorylates 
a number of proteins associated with focal adhesions thus blocking their assembly (Black and 
Bliska, 1997), suppresses the production of reactive oxygen species (Bliska and Black, 1995) 
and the activation of lymphocytes (Yao et al., 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-4. Translocated Yop effectors YopE/H/O/T with an anti-phagocytic effect. Four of the six Yersinia 
effector molecules, YopE, H, O and T, interfere with the actin cytoskeletal dynamics thereby preventing the 
formation of the phagocytic cup. The two other Yersinia effectors, YopP and YopM, which target inflamma-
tory MAPK and NF-κB signaling pathways, are not depicted. Adapted from Cornelis, 2002. 
 
YopO (Yersinia protein kinase A, YpkA, in Y. pestis and Y. pseudotuberculosis), the third 
phagocytosis-antagonist, is a serine/threonine kinase that becomes autophosphorylated upon 
contact to actin (Trasak et al., 2006), inhibits Rho GTPases by its guanine nucleotide disso-
ciation inhibitor (GDI) activity and blocks signaling of trimeric G-proteins by Gαq subunit 
phosphorylation (Navarro et al., 2007).  
YopP (YopJ in Y. pseudotuberculosis and Y. pestis) induces apoptosis in macrophages and 
DCs and was recently discovered to be an acetyltransferase (Mukherjee et al., 2006) forestal-
ling mitogen-activated protein kinase (MAPK) phosphorylation, thereby inhibiting MAPK 
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signaling pathways (Orth et al., 1999) and nuclear-factor (NF)-κB signaling (Ruckdeschel et 
al., 2001). 
YopM is believed to suppress natural killer (NK) cells (Kerschen et al., 2004), however, the 
physiological role of the interaction with two host kinases (McDonald et al., 2003) and the 
YopM localization to the nucleus still remains elusive.  
The sixth Yersinia effector, YopT, has been discovered quite recently (Iriarte and Cornelis, 
1998). YopT is cysteine proteases cleaving small Rho-GTPases and thereby contributes to the 
antiphagocytic effect. YopT is described in more detail below.  
Exported T3SS proteins do not show a secretion signal that is cleaved during transport. The 
nature of the signal is heavily debated. On the one hand, the N-terminal first 17 amino acids 
of the protein are believed to contain the secretion signal (Sory et al., 1995). On the other 
hand, there exists evidence for a 5’ mRNA encoded signal (Anderson and Schneewind, 1997). 
No consensus sequence has yet been found in either the amino terminal part or the 5’ region 
of the mRNA. In addition, the secretion signal was also proposed to reside in the chaperone 
(T3SS chaperones, see below) bound to the effector (Wattiau and Cornelis, 1993). 
The T3SS effectors show an immense structural diversity (reviewed by Johnson et al., 2005). 
Interestingly, several of these bacterial effectors display structural homology to eukaryotic 
proteins (Alto et al., 2006; Xiao et al., 2007) and it is likely that this structural mimicry is 
required for the interference of these effectors with host cell functions. 
 
1.4 The Yersinia effector YopT 
The Yersinia effector molecule YopT is one of the four Yops affecting the dynamics of the 
actin cytoskeleton (Figure 1-4). YopT comprises 322 residues (36.4 kDa, pI 8.9). Addition-
ally, YopT possesses a specific chaperone SycT (Iriarte and Cornelis, 1998). The chaperone-
binding domain in YopT was postulated to comprise at least residues 52-104 (Büttner, 2003).  
Both genes are encoded in the sycT-yopT operon on the Yersinia virulence plasmid 
(Figure 1-2). The sycT-yopT operon is not present in Y. pseudotuberculosis serotype O:3 
strains (Aepfelbacher, 2004). 
Initially, YopT was shown to cause an isoelectric shift of the small Rho GTPase RhoA 
(Zumbihl et al., 1999). In general, YopT targets small, membrane-attached GTPases, prefer-
entially RhoA besides Rac1 and Cdc42 (Iriarte and Cornelis, 1998) that are known to be 
essentially involved in the regulation of the cytoskeleton and phagocytosis (Burridge and 
Wennerberg, 2004). Several small Rho GTPases were shown to be post-translationally 
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modified by a lipid moiety (prenylation) at their C-terminal CaaX box (C, cysteine; a, 
aliphatic residue; X, any residue) (Roskoski, 2003), which allows the GTPase to be anchored 
in the cell membrane. YopT cleaves the GTPase just before the C-terminal cysteine bearing 
the thioether-linked geranylgeranyl isoprenoid moiety and recognizes additionally a polybasic 
sequence N-terminally of the modified cysteine (Shao et al., 2003). Releasing the GTPase 
into the cytosol reduces its effective concentration at the membrane and results in the 
disruption of RhoA-controlled actin stress fibers. The visible effect is the rounding-up of the 
eukaryotic cells (Iriarte and Cornelis, 1998). YopT was identified to be the prototypical 
member of a new family of papain-like cysteine proteases (clan CA) with an invariant 
catalytic Cys/His/Asp triad (Shao et al., 2002). The minimal catalytically active YopT 
fragment was suggested to comprise residues 75 to 318 (Sorg et al., 2003). Moreover, binding 
to the substrate RhoA was proposed to require YopT residues 75-100, though the RhoA-
binding was considerably reduced in an N-terminal 74-amino acid deletion mutant implying 
the involvement of the very YopT N-terminus (Sorg et al., 2003). In general, YopT possesses 
a less distinct anti-phagocytic effect compared to YopE (Viboud et al., 2006), although 
contradicting observations had been made (Grosdent et al., 2002; Adkins et al., 2007). 
Interestingly, YopT co-operates with YopE in attacking the small Rho GTPase Rac1 (Wong 
and Isberg, 2005a), thus contributing to the antiphagocytic activity as activated Rac1 is 
required in invasin-β1 integrin mediated uptake of bacteria (Wong and Isberg, 2005b). 
Interestingly, YopT thereby causes the localization of Rac1 to the nucleus, with a so far 
unknown outcome. Several homologous YopT-like cysteine proteases were found in plant 
pathogenic bacteria such as AvrPphB from Pseudomonas syringae pv. phaseolicola or 
HopPtoCEA in Erwinia amylovora (Shao et al., 2002; Zhao et al., 2005). 
 
1.5 T3SS chaperones 
In general, a chaperone is defined as a protein that is required for the proper folding or 
assembly of proteins or protein complexes without being a component of the final structure 
(Ellis, 2005). 
Effective export of several T3SS proteins depends on specialized proteins from within the 
bacterial cytosol that are not exported themselves. They share a small size (Mr ~12-19 kDa) 
and a predominantly acidic pI (Table 1-1). The gene loci of these so-called T3SS chaperones 
are located adjacently to those of their cognate interaction partners (Figure 1-2) and the 
chaperone and effector genes are co-expressed. The T3SS chaperones specifically bind and 
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assist the secretion of their cognate effector molecules. The absence of ATP hydrolysis and 
protein folding properties distinguishes T3SS chaperones from the "universal" molecular 
chaperones such as many heat shock (Hsp) proteins, DnaK or the chaperonins GroEL/S 
(Houry, 2001; Ellis, 2005). 
 
Table 1-1. Selected representatives of the different classes of T3SS chaperones. 
Species Chaperone Size (aa) pI† Cognate binding partner(s) 
Class IA     
Pseudomonas ssp. Orf1 134 5.9 AvrPphF 
Salmonella ssp. SicP 116 4.2 SptP 
Salmonella ssp. SigE 113 4.2 SigD 
Shigella ssp. IpgA 129 4.8 IcsB 
Yersinia ssp. SycE (YerA) 130 4.8 YopE 
Yersinia ssp. SycN 123 5.3 YscB (heterodimer moiety), YopN 
Yersinia ssp. SycO 155 4.7 YopO/YpkA 
Yersinia ssp. SycT*  130 4.6 YopT 
Yersinia ssp. YscB 137 9.3 SycN (heterodimer moiety), YopN 
Class IB     
EPEC/EHEC CesT 156 4.5 Tir, Map, NleA 
Salmonella ssp. InvB 135 4.7 SipA, SopA, SopE, SopE2 
Shigella ssp. Spa15 133 4.5 IpgB1, IpaA, OspC3, OspD1 
Yersinia ssp. SycH 141 5.1 YopH, LcrQ/YscM1, YscM2 
Xantomonas ssp. HpaB 162 4.3 AvrBs1, AvrBs3 
Class II     
Edwardsiella ssp. EscC 115 7.8 EseB, EseD 
EPEC/EHEC  CesD 151 7.4 EspB, EspD 
Pseudomonas ssp. PcrH 167 4.8 PopB, PopD 
Salmonella ssp. SscA 157 8.0 SscC, SscD 
Shigella ssp. IpgC 155 4.7 IpaB, IpaC 
Yersinia ssp. SycD* /LcrH  168 4.9 YopB, YopD (Ysc-Yop T3SS) 
Yersinia ssp. SycB 169 4.8  YspB, YspC (Ysa T3SS) 
Class III     
Aquifex (flagellum) FliS 124 5.0 FliC (flagellin) 
EPEC CesA 107 9.5 EspA 
Pseudomonas ssp. PscE 67 6.5 PscF 
Yersinia ssp. YscE 66 7.4 YscF 
The list includes chaperones from animal and plant pathogens as well as one flagellar chaperone. Chaperones in 
bold are characterized by crystals structures ( *  this study). †Calculated with Vector NTI (Invitrogen). 
 
1.5.1 Classes of T3SS chaperones 
Although the primary sequence of T3SS chaperones is not conserved, they can be divided in 
at least three major classes according to the function and number of their cognate binding 
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partners (Parsot et al., 2003). This classification corresponds also to the structural differences 
of T3SS chaperones. 
Class I or effector chaperones 
Class I or effector chaperones specifically bind either one (monovalent, Class IA) or more 
(multivalent, Class IB) effector molecules. Class I chaperones represent by far the best 
characterized group. The chaperone-binding domain in their cognate effector is located within 
the first 100-125 residues in the N-terminal region (Sory et al., 1995; Iriarte and Cornelis, 
1998). Although the sequence identity among the effector chaperones is 21 % at most, a 
common C-terminal amphipathic α-helix has been identified in their amino acid sequences 
(Wattiau et al., 1994). Moreover, effector chaperones were found to be organized in dimers, 
an observation that was also supported by several crystal structures, such as that of Yersinia 
SycE (Figure 1-5), the cognate chaperone of the GTPase-activating effector YopE (Wattiau 
and Cornelis, 1993; Birtalan and Ghosh, 2001; Evdokimov et al., 2002; Trame and McKay, 
2003).  
 
 
 
 
 
 
 
 
 
Figure 1-5. Crystal structures of selected T3SS chaperones. Homodimeric Class I chaperone SycE (Protein 
databank (PDB) accession code 1JYA), the cognate chaperone of Rho GTPase-activating protein YopE from 
Yersinia, and Class III members Yersinia YscE (1ZW0) and flagellar chaperone FliS (1ORJ) from Aquifex. No 
crystal structure of a T3SS Class II chaperone has been solved so far.  
 
Class II or translocator chaperones 
Class II chaperones are specific for pore-forming translocators, therefore called translocator 
chaperones. These chaperones are multivalent as they bind both transmembrane translocator 
proteins, and sometimes even further T3SS components. No crystal structure has been solved 
so far for Class II chaperones, though recently, α-helical tetratricopeptide repeat (TPR)-like 
motifs have been predicted from their sequences (Pallen et al., 2003). These degenerated 34-
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residues motifs are often arrayed in tandem (Sikorski et al., 1990). These TPR domains 
usually mediate protein-protein interactions and are found in all biological kingdoms 
(Gregory L. Blatch, 1999). 
Class III chaperones 
A third class of T3SS chaperones assists in secretion of distal components of the needle 
complex that are themselves exported through the nascent secretion apparatus (Creasey et al., 
2003; Quinaud et al., 2005). The chaperones from the related flagellar system are also 
assigned to Class III. In contrast to Class I chaperones, the biological oligomerization state of 
Class III chaperones seems to be the monomer, corroborated by crystal structures such as that 
of the Yersinia needle protein chaperone YscE (Phan et al., 2005) or the flagellar chaperone 
FliS (Evdokimov et al., 2003) (Figure 1-5). As the limited number of crystal structures of 
Class III chaperones reveals a significant structural heterogeneity, a further sub-classification 
might be required. Table 1-1 gives an overview of T3SS chaperones. 
 
1.5.2 Postulated functions of T3SS chaperones 
The role of the T3SS chaperones is still under debate (Feldman and Cornelis, 2003; Letzelter 
et al., 2006; Wilharm et al., 2007). This might be due to the facts that 1) not all secreted 
proteins require a chaperone, 2) some secretion cargoes are stable even in the absence of their 
chaperone and 3) there are possibly different functions according to the classes and some 
chaperones may fulfill more than one function with the different roles not being necessarily 
mutually exclusive (Feldman and Cornelis, 2003; Parsot et al., 2003; Wilharm et al., 2007). 
Selected proposed functions of T3SS chaperone are depicted in Figure 1-6. 
1) Stabilization and secretion competency of the effector molecules 
It has been suggested that T3SS chaperones ensure effector stabilization. They presumably 
prevent unproductive interactions prior to secretion as well as aggregation of hydrophobic 
regions such as the aggregation-prone chaperone-binding domain (CBD) in the effectors or 
the transmembrane regions in the translocators (Figure 1-6, 1). Recently, the CBD was found 
to present a membrane-localization domain (MLD) (Letzelter et al., 2006). Coverage of the 
aggregation prone MLD, thus keeping the protein competent for export, was therefore 
suggested by the authors to be the primary function of T3SS chaperones. 
Additionally, the chaperones are proposed to maintain their binding partners in a secretion-
competent, partially unfolded state in which the secretion signal is accessible to the T3SS 
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apparatus. Remarkably, binding to the chaperone does not necessarily affect the enzymatic 
activity or binding capacity of the bound proteins (Luo et al., 2001; Birtalan et al., 2002; 
Neumayer et al., 2004). This finding indicates that prior to secretion the largest part of the 
polypeptide chain is folded. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-6. Proposed functions of T3SS chaperones. (1) Chaperones are suggested to stabilize their binding 
partner prior to secretion by masking hydrophobic regions and preventing aggregation and premature interac-
tions, which would otherwise lead to degradation. (2) Chaperones might act as secretion pilot toward the 
needle complex. It is unclear whether T3SS chaperones are recycled or degraded after delivering their cognate 
binding partners. (3) The chaperones could establish a hierarchy among the T3SS secretion cargoes. Highest 
priority would possess the chaperone-bound components building the nascent secretion apparatus (1.), 
followed by the chaperone-stabilized pore-forming translocators (2.) and the chaperone-bound effector 
molecules (3.), before proteins without a chaperone (4.) are exported. (4) Some chaperones are involved in the 
regulatory control of gene expression by either an activating or repressing effect. Not all of the proteins 
involved in the regulation are known. OM, outer membrane; PG, peptidoglycan; IM, inner membrane. Figures 
prepared in analogy to Feldman and Cornelis, 2003; Mota et al., 2005. 
 
2) Secretion pilots 
Another suggested role is that of secretion pilots toward the membrane-anchored needle-
complex (Figure 1-6, 2). The effector chaperone CesT from enteropathogenic Escherichia coli 
(E. coli) (EPEC) or the flagellar export chaperone from Salmonella were observed to interact 
with the AAA+ type ATPase of the T3SS (Gauthier and Finlay, 2003; Thomas et al., 2004). 
This is in line with the finding that chaperone release and unfolding of the secretion cargo is 
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an ATP-dependent process, induced by the T3SS ATPase (Akeda and Galan, 2005) and 
possibly facilitated by the T3SS chaperones. In addition, the translocator chaperones CesD 
from EPEC and Edwardsiella EscC were shown to localize to the membrane (Wainwright and 
Kaper, 1998; Zheng et al., 2007). 
Relatedly, the effector-chaperone complex may also present a three-dimensional secretion 
signal. Chaperone-deficient mutants usually fail to export their cognate binding partner 
efficiently (Cheng et al., 1997; Lloyd et al., 2001). Interestingly, in Salmonella, chaperone 
binding defines whether the secretion cargo is transported via the pathogenicity-related T3SS 
or the flagellar T3SS (Lee and Galan, 2004). 
3) Secretion hierarchy 
Furthermore, the T3SS chaperones may uphold a secretion hierarchy among the secretion 
substrates as indicated by Wulff-Strobel et al., 2002 and Thomas et al., 2007. In this model 
(Figure 1-6, 3), components of the nascent machine possess highest secretion priority. After 
the specificity switch, the pore-forming translocators are secreted, followed by the effector 
molecules and further secretion cargoes. 
4) Regulatory control of T3SS gene expression  
Noteworthy, several Class II chaperones and probably also some of the Class I chaperones 
play crucial roles in the regulation of T3SS-associated gene expression (Figure 1-6, 4). SicA, 
the cognate chaperone of the Salmonella translocators SipB and SipC, forms a regulatory 
complex with the AraC-like transcription factor InvF, thereby activating expression of 
Salmonella T3SS pathogenicity island-1 (SPI-1) genes (Darwin and Miller, 2001). T3SS gene 
expression is generally stimulated by transcriptional regulators belonging to the AraC-like 
family (Cornelis et al., 1989). A similar scenario may apply to Shigella flexneri translocator 
chaperone IpgC activating T3SS gene expression by binding to AraC-like MxiE (Mavris et 
al., 2002). In both cases, secretion of the cognate translocator protein is believed to precede 
complex formation between the chaperone and the transcription activator (Figure 1-6). In 
contrast, Yersinia Class II chaperone SycD acts as a negative regulator on yop expression 
together with one of its cognate translocators, YopD, and the negative regulator LcrQ/YscM1 
(Francis et al., 2001; Anderson et al., 2002). The effector chaperone SycH from Yersinia ssp. 
might be the counterpart of SycD inducing yop expression by promoting secretion of 
LcrQ/YscM1 (Cambronne et al., 2004). Possibly, a regulatory function might be also assigned 
to the Yersinia effector chaperone SycO (Dittmann et al., 2007). 
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1.6  The Yersinia T3SS chaperones SycT and SycD 
SycT - the Class I/ effector chaperone for YopT 
Four out of six Yersinia effector molecules are chaperone-assisted, namely YopE, YopH, 
YopO/YpkA and YopT (Wattiau and Cornelis, 1993; Wattiau et al., 1994; Iriarte and 
Cornelis, 1998; Letzelter et al., 2006). In Yersinia, these non-flagellar T3SS-associated 
chaperones are termed specific Yop chaperones (Sycs). The effector protein YopM does not 
possess a specific chaperone, and so far no chaperone has been identified for YopP/J. 
SycT is the specific chaperone for the effector protein YopT. The ~15 kDa chaperone SycT 
exhibits 130 amino acids and an acidic isoelectric point (pI 4.6) that is typical for Class I 
chaperones. SycT presumably shares the mixed α/β-fold of previously determined crystals 
structures of Class I chaperones, such as that of SycE (YerA in Y. pestis and Y. pseudotuber-
culosis) (Figure 1-5) (Birtalan and Ghosh, 2001; Evdokimov et al., 2002; Trame and McKay, 
2003). 
SycD - the Class II/translocator chaperone in Yersinia  
The corresponding representative of Class II chaperones for the Ysc-Yop T3SS in Yersinia 
enterocolitica is SycD (LcrH in Y. pestis and Y. pseudotuberculosis). Like SycT, SycD is a 
small, acidic protein (168 aa, 19 kDa, pI 4.9). SycD specifically chaperones the translocator 
proteins YopB and YopD (Wattiau et al., 1994; Neyt and Cornelis, 1999) and prevents their 
premature, unproductive associations, especially as YopB is cytotoxic in the absence of the 
chaperone (Neyt and Cornelis, 1999). SycD was shown in a yeast two-hybrid system to bind 
to the YopD fragments 53-149 as well as to 278-292 near the C-terminus (Francis et al., 
2000). For YopB, no defined chaperone-binding domain could be detected (Neyt and 
Cornelis, 1999). SycD is furthermore involved in the modulation of the T3SS both via a 
negative regulation of yop gene expression (see above) and Yop secretion control (Day and 
Plano, 2000; Francis et al., 2001; Anderson et al., 2002). Yersinia enterocolitica biovar 1B 
possesses an additional, chromosomally encoded T3SS called Ysa, therefore exhibiting a 
second Class II chaperone, SycB (Foultier et al., 2003). The phylogenetic relationship of Y. 
enterocolitica SycD and other T3SS Class II translocator chaperones indicates Pseudomonas 
aeruginosa PcrH to be the closest relative of SycD, sharing 58 % identical and 76 % similar 
amino acids. The sequence identity to other T3SS translocator chaperones is less than 23 % 
on average. 
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1.7 Aims of the thesis 
At the beginning of this work, only few crystal structures of T3SS Class I chaperones, 
Salmonella SicP and SigE, E. coli CesT, and a single Yersinia effector chaperone, SycE, had 
been determined (Birtalan and Ghosh, 2001; Luo et al., 2001; Stebbins and Galan, 2001; 
Evdokimov et al., 2002; Trame and McKay, 2003). Regarding the effector/chaperone 
complexes, only chaperone-binding domains of the effector molecules but no full-length 
effector protein had been crystallized in complex with the cognate chaperone, such as 
Salmonella SptPCBD/SicP (Stebbins and Galan, 2001) and Yersinia YopECBD/SycE (Birtalan et 
al., 2002). In order to verify the hypothesis of a partial unfolding of the effector upon 
chaperone-binding, the crystal structure of a full-length effector/chaperone complex was of 
enormous interest. 
One aim of this study was therefore to gain further insight into the T3SS effector/chaperone 
interactions by applying X-ray crystallographic and biochemical approaches to the Y. 
enterocolitica YopT/SycT complex. Prior to this work, Prof. Guy Cornelis (University of 
Basel, Switzerland) made the gift of the virulence plasmid pYVe227 of Y. enterocolitica, and 
Dr. Hartmut Niemann (Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig) 
had generated a bicistronic sycT/yopT co-expression vector. The YopT/SycT complex 
produced using this construct and an existing protein production and purification protocol was 
reported to be instable and tended to aggregate (Büttner, 2003). The expression construct and 
the purification protocol was therefore to be optimized in order to obtain stable and homoge-
neous proteins suitable for crystallization trials. 
 
T3SS Class II chaperones are involved in multiple functions and protein-protein interactions 
and represent therefore a highly interesting protein family. As no representative of Class II 
chaperones had been structurally characterized at that time, another aim of this thesis was the 
determination of the crystal structure of SycD, the representative of Class II chaperones in Y. 
enterocolitica. In order to analyze SycD by X-ray crystallography, procedures for the 
recombinant production, purification and crystallization were to be established. 
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2 Results 
2I Characterization of the effector YopT and its cognate 
chaperone SycT 
The full-length effector protein YopT (1-322) was reported to be intrinsically instable and 
significant soluble amounts could only be heterologously produced in E. coli by co-
expression with its cognate chaperone SycT, thereby forming a double band together with a 
truncated YopT species (residues 14-322) (Büttner, 2003). This truncation might be due to 
autocatalytic activity or proteolytic cleavage by a bacterial host endopeptidase. In order to 
overcome degradation as well as the poor stability and expression level of YopT, several new 
approaches were therefore to be tested in this study. This included the generation of new 
expression constructs, expression analysis of a synthetic yopT gene, in vitro translation, 
protein refolding as well as the precise identification of the chaperone-binding domain in 
order to allow co-expression with the chaperone. 
 
2I.1 Strategies to improve the stability of YopT 
2I.1.1 Expression test analysis of new yopT and yopT/sycT constructs 
The generation of new yopT (yopT/sycT) expression constructs is elaborated in Table 2I-1. 
Table 2I-1. Rationale for the generation of new yopT (and yopT/sycT) expression constructs 
 Approach Rationale 
1 yopT S13A Cleavage site mutant, forestalling the double band formation 
2 yopT∆13/∆22/∆40/∆49 Systematic N-terminal YopT deletion mutants, compare also section 2I.1.2, still 
able to bind to the chaperone SycT; forestalling the double band formation 
3 Auto-inducing medium Retarded protein production, promotes correct protein folding 
4 yopT75-318 N-terminal His6- and GST-fusions of the postulated minimal enzymatically active 
core fragment (YopT residues 75-318) (Sorg et al., 2003) 
5 syopT Synthetic yopT effector gene with optimized codon usage for expression in E. coli, 
gene product sYopT has the identical amino acid sequence as YopT 
6 yopT C139S Inactive YopT mutants with the catalytic cysteine replaced with serine (C139S) in 
order to verify whether YopT possesses an autocatalytic protease activity and in 
respect of intended effector/substrate binding studies (see section 2I.2) 
7 GL-syopT /TG1 According to a report describing a promising expression system for YopT using 
E. coli TG1 cells in combination with an N-terminal glycine-rich 12 amino acid 
linker (GL, amino acid sequence SPGISGGGGGSMAGGGRT) (Sorg et al., 2003) 
8 + cpn10/cpn60 Gene expression at low temperatures (10 °C) using archeal chaperonins Cpn10 and 
Cpn60 from Oleispira antarctica (Ferrer et al., 2003) in order to enhance accurate 
folding and solubility of YopT 
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A summary of the expression experiments is provided in the Appendix (Table B1). Without 
simultaneous chaperone expression, no soluble YopT could be obtained. Interestingly, low 
temperatures rather provoked overexpression of one of the cold-adapted chaperonins (Cpn60) 
(not shown). Considerable amounts of soluble protein were only observed for complexes 
YopT∆49 (C139S)/SycT and YopT∆50 (C139S)/SycT. YopT∆49 (C139S)/SycT was 
therefore chosen for large scale protein preparation. In contrast to the study of Locher et al. 
(2005), the inactive YopT mutant did not show a diminished binding to SycT (Figure 2I-1A). 
As expected, N-terminally truncated YopT lacking the internal putative truncation site 
S13/N14 showed only a single effector band in SDS-PAGE analysis (Figure 2I-1A). How-
ever, YopT from the inactive YopT∆49 C139S / SycT complex gradually degraded as seen 
for the effector from the wild-type YopT/SycT complex (Figure 2I-1B). This observation 
excluded an autocatalytic effect. The persistent inhomogeneity still impeded successful 
protein crystallization.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-1. Stability of 
YopT∆49 C139S / SycT and 
YopT∆49 / SycT complexes. (A) 
YopT∆49 C139S/ SycT and 
YopT∆49/ SycT after NiNTA 
agarose affinity chromatography. 
Both complexes were produced 
and purified in comparable 
amounts with a similar apparent 
effector/chaperone ratio. (B) 
Degradation of inactive YopT 
∆49C139S / SycT still occured 
and was not caused by autocata-
lysis. Sample stored over two 
weeks at 4 °C. (15 % SDS-
PAGEs, Coomassie staining). 
 
2I.1.2 In vitro translation of YopT deletion mutants 
As an alternative approach, the folding reporter molecule GFP (Waldo et al., 1999) was 
employed as a protein tag for monitoring the production of soluble (i.e. correctly folded) 
YopT. However, full-length wild-type sYopT C-terminally fused to GFP proved insoluble in 
expression tests. Despite the faint fluorescence in the soluble fractions, SDS-PAGE, N-
terminal sequencing and Western blot analysis using an α-GFP antibody detected only 
insoluble fusion protein (Figure 2I-2A,B). 
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Systematic N-terminal deletion mutants of sYopT (∆16/∆24/∆40/∆49/∆65/∆74) C-terminally 
fused to GFP were tested for in vitro translation using the Rapid Translation System. Only 
insoluble fusion proteins were detected, whereas soluble GFP was readily produced 
(Figure 2I-2 C,D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-2. Expression test of 
pETM-11GFPfus_syopT N-
terminal deletion mutants. (A) 
GFP fluorescence, at 395 nm UV-
excitation, of the uninduced cells 
and of an aliquot taken 8 h after 
induction of the syopT-GFP 
expression at 21 °C. Both samples 
were separated into soluble (s) and 
insoluble (i) fraction. (B) Only 
insoluble sYopT-GFP-fusion 
protein could be detected by SDS-
PAGE (Coomassie staining). (C) 
12 % SDS-PAGE of the insoluble 
in vitro translation samples of 
sYopT∆xx-GFP deletion mutants 
(Coomassie staining). (D) Western 
blot of soluble in vitro fraction of 
sYopT∆16-GFP. Neg., negative 
control (YopT/SycT); Pos., positive 
control (solubilized insoluble 
sYopT∆49-GFP). 
 
2I.1.3 Refolding of YopT 
Using heterologous gene expression in E. coli, only marginal amounts of soluble YopT fusion 
protein were detected. In contrast, insoluble YopT fusion proteins as well as the untagged 
effector could be readily produced in large quantities forming inclusion bodies (Büttner, 2003 
and above). This vast resource of YopT was therefore exploited by refolding experiments in 
order to obtain soluble protein (data not shown). Renaturation of the effector from solubilized 
inclusion bodies did not yield significant amounts of soluble YopT that was stable over time. 
Several methods have been applied including rapid dilution, dialysis and on-column refold-
ing. Addition of stabilizing agents such as L-arginine, polyethylene glycol, detergents or the 
presence of the cognate chaperone SycT did not help either. Most protein precipitated during 
renaturation. In comparison to the amounts of protein solubilized/denatured from inclusion 
bodies used in the refolding experiments, only very little soluble effector was detected after 
refolding with SycT or detergent-assisted renaturation on-column. However, immediate 
degradation of the reconstituted YopT suggested an non-native conformation.  
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2I.1.4 Follow-up investigations of the chaperone-binding site in YopT 
Production of the YopT/SycT complex and preliminary characterization of the chaperone-
binding domain (CBD) in YopT by limited proteolysis of the YopT/SycT complex has been 
described previously (Büttner, 2003). The CBD has been limited at least to a region of 72 
residues (YopT 52-104) extending to residue 140 as determined by fingerprinting of cleavage 
sites. In case of a stable, protease resistant CBD in YopT, this region is supposed to result in a 
distinct fragment of at least 6.2 kDa and of significant amount that should be large enough to 
be visualized by polyacrylamide gel electrophoresis. To characterize the CBD in more detail, 
the YopT/SycT complex was subjected to a second limited proteolysis, this time using 
endopeptidase Lys-C and thermolysin. The fragments were analyzed by 16 % Tris/Tricine 
gels (Figure 2I-3) better suited for separation of oligopeptides than the Tris/Glycine system 
used previously. The most promising fragment accumulating in considerable amounts was 
running at the same level as SycT (Figure 2I-3, box 3, ~10 kDa). Bands of interest were 
analyzed by N-terminal sequencing. 
SycT resisted proteolytic degradation with the exception of eight C-terminal residues as 
previously determined (Büttner, 2003). YopT positions 50 and 51, respectively, as well as 
residue 122 were found to be recurring N-termini of YopT fragments. This gave rise to new 
co-expression constructs coding for the putative YopTCBD and SycT. For this, yopT codons 
encompassing residues 52-104 as previously determined, as well as the codons for residues 
50-121 and 50-139 were cloned into the expression vector pETM-30-IRES_sycT. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-3. Limited proteolysis of YopT/SycT with endopeptidase Lys-C and thermolysin. (A) Aliquots 
were taken during the course of the digest and separated by 16 % Tris/Tricine gels (Coomassie staining). 
Boxed fragments 1-5 were analyzed by N-terminal sequencing. oN, over night. (B) N-terminal sequencing 
detected mixtures of fragments originating from the chaperone and from YopT. 
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However, carrying out co-expression analyses of these three YopTCBD constructs together 
with SycT, the YopTCBD oligopeptide could not be detected using Tris/Tricine gel electropho-
resis (Figure 2I-4). The different constructs for YopTCBD could not be produced as soluble 
oligopeptides even in the presence of SycT. The YopT/SycT complex was therefore digested 
by endopeptidase Lys-C in a preparative scale and the fragments were separated by size 
exclusion chromatography. However, no distinct peak comprising the complex of SycT bound 
to a 6-11 kDa fragment corresponding to the chaperone-binding domain of YopT was 
observed (not shown).  
 
 
 
 
 
 
 
 
Figure 2I-4. 16 % Tris/Tricine gel of the co-expression test for YopTCBD/SycT complexes YopT52-104/SycT, 
YopT50-121/SycT and YopT50-139/SycT. (Coomassie staining). Samples were taken after 3 h, 6 h and over night 
(oN) induction at 20 °C, after 4 h when incubated at 30 °C. M, Marker proteins; C, control of uninduced cells; 
s, soluble; i, insoluble fraction.  
 
2I.1.5 Summary of the attempts to improve the YopT stability  
Overall, the different approaches used in order to increase the long-term stability of YopT and 
the YopT/SycT complex had failed. Furthermore, no isolated stable effector YopT could be 
obtained. As to the YopT/SycT complex, the expression system for the production of 
sufficient amounts of several complex variants such as YopT∆49/SycT and YopT∆50/SycT 
and their inactive variants could be established. Still, the effector in these purified complex 
variants was not stable over time. Attempts aiming at the isolation of a fragment of YopT or 
the YopT/SycT complex for crystallization were finally abandoned. However, this instability 
did not exclude rapid analyses techniques if performed subsequently to the YopT/SycT 
complex purification. Thus, binding studies of freshly prepared YopT/SycT complexes with 
the YopT substrate RhoA using rapid surface plasmon resonance spectrometry were con-
ducted (see below). Additionally, as the crystal structure of YopT, either alone or in complex 
with SycT, was not feasible, three-dimensional modeling was applied in order to obtain an 
estimated structural impression of YopT (section 2I.3).  
 
22   RESULTS - Characterization of the effector YopT and its cognate chaperone SycT 
 
 
2I.2 Binding studies between the YopT/SycT complex and RhoA 
YopT substrates are small Rho GTPases, preferentially RhoA, that are post-translationally 
modified at their C-terminal CaaX box cysteine by a lipid (prenyl) moiety. In vivo, the lipid 
modification requires three steps: Geranylgeranylation, proteolysis and methylation 
(Figure 2I-5A). The last 10 residues in posttranslationally processed RhoA (residues 181-
190), with geranylgeranylated {C20 unit} or farnesylated {C15 unit} Cys190, are sufficient for 
YopT binding and proteolytic activity (Shao et al., 2003). To investigate whether YopT binds 
to a RhoA peptide lacking the carboxy methylester and the lipid modification, different RhoA 
peptides were synthesized (W. Tegge; HZI Braunschweig), which exhibit a biotin tag for use 
in surface plasmon resonance (SPR) spectroscopy. Peptide synthesis proved difficult, 
especially the purification step by HPLC, probably due to the polybasic sequence upstream of 
Cys190 (Figure 2I-5B, blue). Two additional β-alanine residues were therefore inserted 
between the biotin tag and the RhoA sequence (peptide 1, Figure 2I-5B) without much 
success. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-5. YopT substrate RhoA-GTPase. (A) C-terminal RhoA residues 181-193 with the CaaX box (C, 
cysteine; A, aliphatic residue; X any residue). RhoA CaaX box residues: CLVL. Geranylgeranylation of RhoA 
in vivo encompasses the lipid modification at the thiol group of the CaaX box cysteine, proteolytic removal of 
the three C-terminal residues and methylation resulting in a C-terminal carboxy methylester. (B) Synthesized 
RhoA-Peptides with an N-terminal biotin-tag. The C-terminal Cys190 is shaded in yellow. The polybasic 
sequence upstream of the cysteine is highlighted in blue. Two additional β-alanines (βA) served as spacer in 
peptide 1. Facilitated peptide synthesis was achieved by sequence extension (RhoA 174-190 in peptides 2 and 
3). Peptide 3 exhibits low-prenylation (isoprenyl group).  
 
As a geranylgeranylated or farnesylated peptide is insoluble in aqueous solutions and since 
the synthesis of the fully modified peptide was not feasible, the RhoA peptide was provided 
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with one isoprenyl moiety only (low-prenylation, C5 unit) (peptide 3). The extension of the 
RhoA sequence (RhoA174-190) successfully facilitated peptide synthesis and purification. Since 
no soluble YopT was available, (freshly produced and purified) YopT/SycT complex was 
used for SPR binding studies as several effector/chaperone complexes have been reported to 
exhibit full enzymatic activity of the chaperone-bound effector such as YopE/SycE (Birtalan 
et al., 2002) and YopH/SycH (Neumayer et al., 2004). In order to rule out difficulties in 
signal detection due to the cleavage of the RhoA peptide by YopT, the inactive complex 
YopT∆49 C139S /SycT was also tested for binding. Neither YopT/SycT flushed over 
peptide 1 nor YopT∆49 C139S /SycT over peptides 2 and 3 caused a detectable response 
signal even after increasing the protein concentration (8-16 µM). The missing response signal 
indicates that the effector/chaperone complexes did not bind to the synthesized RhoA 
peptides. 
 
 
2I.3 Modeling of the YopT structure 
Several approaches to produce stable, soluble YopT had failed and co-crystallization of YopT 
variants with its chaperone SycT did not yield crystals. Meanwhile, the crystal structure of the 
YopT homolog AvrPphB of the plant pathogen Pseudomonas syringae pv. phaseolicola had 
been solved (Uniprot Q9FE20, PDB entry 1UKF) (Zhu et al., 2004). Although AvrPphB 
shares only low sequence homology with YopT (26 % identity, 56 % similar), both possess 
the invariant catalytic triad C/H/D and are expected to fold in a manner similar to the cysteine 
protease papain as derived from sequence analysis. Therefore, the YopT sequence (residues 
118-316) was modeled onto the crystal structure of AvrPphB (residues 81–267) using the 
program BRAGI (Reichelt et al., 2005). The papain-like fold of the modeled cysteine protease 
YopT in comparison with the crystal structure of papain is visualized in Figure 2I-6. Similar 
to papain, YopT_AvrPphB shares the central antiparallel β-sheet and α-helices. 
Pairwise structure alignment of the YopT model and papain using DALI stated 15 % se-
quence identity with a Z-score of 4.8 for 111 aligned residues. The YopT_AvrPphB model 
exhibits secondary structure elements for a larger part of the protein, and additionally displays 
shorter loops and turns, therefore appearing more compact than loop-rich papain. The 
catalytic triads of the YopT model and papain superpose well for a central α-helix and 
catalytic Cys139 of YopT and Cys25 of papain, as well as for the catalytic histidine 
(His258/His159). Superposition of the third catalytic residue, Asp274 in YopT and the 
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corresponding Asn175 in papain, reveals a larger deviation (Figure 2I-6). The loop involved 
in formation of the S2 substrate-binding site of papain-like proteases comprises 23 residues in 
papain but constitutes only a three-residue turn in the YopT model, thus possibly contributing 
to substrate specificity. 
 
 
 
 
 
 
 
 
 
Figure 2I-6. Structural model of YopT(118-316) (left) and crystal structure of papain* (1PPP) (right). The 
YopT amino acid sequence was modeled based on the crystal structure of AvrPphB from Pseudomonas 
syringae (1UKF). The catalytic triads (YopT Cys139/His258/Asp274, papain Cys25/His159/Asn175) are 
depicted as yellow ball-and-stick models. Structurally conserved helices and β-strands are colored in blue and 
green, respectively. The loop involved in substrate binding via the S2 site is colored red and differs considera-
bly in length. Molecules were aligned based on the superposition of Cα atoms of the catalytic residues and the 
central blue α-helix.  *Note: Compared to YopT_AvrPphB, papain exhibits few secondary structure 
elements. This is an intrinsic feature of papain, as all, even high-resolution structures solved in the recent past 
exhibit the same loop-rich fold (e.g. 1KHQ, 1.6 Å, Janowski et al., 2004). 
 
2I.4 Biochemical characterization of SycT 
As the X-ray crystallographic analysis of the effector YopT was not feasible, the focus of the 
project was therefore shifted to the structure elucidation of the YopT chaperone SycT. One 
aim was to verify the validity of the Class I chaperone fold with regard to different effector 
chaperones from the same species (i.e. in comparison to Yersinia SycE).  
 
2I.4.1 Generation of sycT expression constructs 
Full-length SycT (residues 1-130) was heterologously produced in E. coli BL21(DE3) 
CodonPlus cells as N-terminal GST-fusion protein. Wild-type SycT degraded into a C-
terminally truncated fragment (SycT residues 1-122) during long-term storage at 4 °C as 
noted earlier (Büttner, 2003). A second expression construct encompassing SycT residues 
1-122 was therefore created by cloning the corresponding sycT sequence into the same 
expression vector (pETM-30). 
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2I.4.2 Gene expression and protein purification of SycT 
Fusion proteins GST-SycT and selenomethionine (SeMet)-labeled GST-SycT1-122 were 
produced as soluble proteins in high amounts according to an existing purification protocol 
(Büttner, 2003). Substitution of selenomethionine for the amino acid methionine introduces 
heavy atoms/anomalously scattering atoms that are located at special sites throughout the 
protein and later in the protein crystal. The resulting anomalous portion in the diffraction 
pattern allows the direct determination of the phases of the X-ray reflections (see Materials 
and Methods section 5.14.4), thereby facilitating structure solution.  
Proteins were purified by glutathione sepharose affinity chromatography. The GST tag was 
cleaved on-column with His6-tagged TEV-protease and the protease was removed by NiNTA 
agarose re-chromatography of the cleavage supernatant (Figure 2I-7A, isolation of SeMet 
SycT1-122).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-7. Purification of SeMet SycT1-122. (A) 15 % SDS-PAGE (Coomassie staining) of SeMet GST-
SycT1-122 production and target isolation via glutathione sepharose affinity chromatography and TEV protease 
cleavage (TEV cleav.), followed by NiNTA agarose affinity chromatography. Sup., supernatant. (B) MALDI-
TOF-MS spectrum of purified SeMet SycT1-122. [M+H] indicates the singly-charged species, [M+2H] the 
doubly-charged ion. Minor mass peaks at larger masses are due to matrix adducts. The calculated molecular 
mass of completely selenomethionine-labeled SycT1-122 is 14’625 kDa. 
 
Due to restriction sites used in cloning and the protease cleavage site, TEV cleaved proteins 
exhibit a glycine residue inserted after the start methionine as well as two additional residues 
at the N-terminus (glycine-alanine). The target proteins were further purified by anion 
exchange chromatography. Peak fractions containing pure SycT or SeMet SycT1-122 were 
pooled and applied to size exclusion chromatography (SEC) as a final purification step. Prior 
to crystallization trials, purified protein (yield ~14 mg per liter cell culture) was dialyzed to 
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decrease the salt concentration. MALDI-TOF-MS analysis verified the complete selenome-
thionine incorporation in SeMet SycT1-122 (Figure 2I-7B). Purified SycT as well as SeMet 
SycT1-122 showed a very high grade of purity since no further protein bands could be detected 
in Coomassie-stained SDS polyacrylamide gels. 
 
2I.4.3 SycT forms homodimers in solution 
The formation of full-length SycT homodimers was shown previously by analytical size 
exclusion chromatography (Büttner, 2003). Investigation by dynamic light scattering (DLS) 
confirms the results from chromatography (Table 2I-2). The obtained values for the molecular 
mass correspond to the dimeric species (Mr DLS ~34 kDa, Mr SEC ~30 kDa, Mr theo mono-
mer= 15.3 kDa). As expected, selenomethionine-labeled SycT1-122 (Mr theo = 14.6 kDa), 
behaves as a dimer during size exclusion chromatography (Mr SEC = 28 kDa) (Figure 2I-8). 
 
Table 2I-2. Dynamic light scattering of wild-type SycT.  
Protein rH [nm] Mr DLS [kDa] Polydispersity [%] Base line SOS error 
SycT 2.77 34 19.1 1.002 2.38 
The theoretical molecular mass for full-length SycT is 15.3 kDa. The data represent the best correlation using a 
monomodal analysis model. Protein concentration was ~10 mg/mL. 
 
 
 
 
 
 
 
 
 
 
Figure 2I-8. Analytical size 
exclusion chromatography of 
SeMet SycT1-122. Super-
dex 75 XK 16/60 column, 
running buffer 10 mM Tris pH 
8.0, 200 mM NaCl, 1 mM DTT. 
RT, retention volume. Proteins 
used as calibration standards are 
specified as well as calibration 
function and reliability factor. 
SeMet SycT1-122 (RT= 72.16 mL, 
Mr SEC = 28 kDa, Mr theo= 
14.6 kDa) is indicated as red 
triangle. As observed for wt 
SycT, the truncated variant forms 
dimers in solution.  
 
2I.5 Crystallization of SycT 
2I.5.1 Wild-type SycT 
Purified full-length SycT could easily be concentrated to final concentrations of more than 
10 mg/mL still being monodisperse. Initial screening in 96-well format using sitting drop 
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vapor diffusion at 4 and 20 °C failed to yield crystals. Several initial conditions presumably 
showing microcrystalline/birefringent precipitate or phase separation were chosen for 
optimization (hanging drop vapor diffusion, 24-well format) via altering the precipitant 
concentrations. Finally, one of these optimization attempts resulted in the formation of plate-
like, monoclinic crystals (Figure 2I-9) with a powerful diffraction potential. 
 
 
 
 
 
 
 
 
Figure 2I-9. Crystallization of full-length SycT. (A) Initial screening for crystallization conditions of native 
SycT resulted only in micro-crystalline/birefringent precipitate or phase separation (insets). Optimization of 
these conditions finally yielded monoclinic crystals (B) that could be further increased in size (inset). Scale bar 
= 100 µm. 
 
2I.5.2 Selenomethionine-labeled SycT1-122 
Initial screening for SeMet SycT1-122 crystals at 4 °C produced orthorhombic crystal in a 
single condition that was based on ammonium sulfate (Figure 2I-10A). Since these crystals 
were clustered and resisted optimization, a second crystal form was aimed at. The alteration 
of the crystallization cocktail by changing the buffer system and a salt component resulted in 
single crystals (Figure 2I-10B). Both crystal forms were analyzed by X-ray diffraction. 
 
 
 
 
 
 
 
 
Figure 2I-10. Crystallization of selenomethionine-labeled SycT1-122. (A) Initial screening yielded orthorhom-
bic crystals that where clustered (crystal form 1). (B) Changing only the buffer system of the crystallization 
condition from A yielded single crystals of a second, "sunflower grain"-shaped hexagonal crystal form (crystal 
form 2). Scale bar = 100 µm. 
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2I.6 Structure determination of SycT 
X-ray diffraction analysis disclosed that native SycT crystallized in monoclinic space group 
P21. Selenomethionine-labeled, truncated SycT1-122 crystallized in two unrelated crystal 
forms: Crystal form 1 possessed an orthorhombic space group (P212121), whereas crystal form 
2 exhibited a hexagonal crystal lattice. For crystal form 2, the systematic absence of reflec-
tions with indices ℓ≠3n (n=integer) along the crystallographic ℓ axis indicated a screw axis 
along this axis and limited the possible space groups to the two enantiomorphs P62 or P64. 
Matthews probability analysis (Matthews, 1968; Kantardjieff and Rupp, 2003) suggested for 
the native and the two SeMet crystal forms two molecules per asymmetric unit (VM = 2.1-
2.3 Å3 Da-1). The low solvent content of 41 % for SycT1-122 crystal form 1 indicated further a 
dense packing of the molecules in the crystal. 
Phasing of the native SycT data set by molecular replacement (MR) using the crystal struc-
tures of other T3SS Class I chaperones (compare Introduction Figure 1-5 and Discussion 
Figure 3I-1) as search models and maximum-likelihood as well as Patterson function-based 
algorithms surprisingly failed. In order to phase the SycT data experimentally, heavy atom 
derivatization by crystal soaking was employed. Soaking native SycT crystals with mercury, 
platinum, osmium or bromide caused crystal cracking, loss of diffraction or the crystals did 
not incorporate the heavy atom. In contrast, the anomalous signal of the SeMet-labeled 
SycT1-122 crystals could eventually be exploited in a multiple-wavelength dispersion (MAD) 
experiment. The presence of the anomalously scattering atoms was verified by a selenium 
fluorescence energy scan. In order to maximize the absorption and dispersive effects, three 
data sets were collected at the peak, inflection point and high energy remote wavelengths of 
the absorption curve. As the data sets were collected from the same crystal, the non-
isomorphism was nearly zero. However, the anomalous signal of SeMet SycT1-122 crystal 
form 2 deteriorated upon inclusion of one or two additional wavelengths (inflection or high 
energy remote) of the MAD experiment. Eventually, single-wavelength anomalous dispersion 
(SAD) allowed phasing of the peak data set for SeMet SycT1-122 crystal form 2 using the five 
selenium sites identified by SHELXD (Schneider and Sheldrick, 2002), with six selenium 
sites being possible per asymmetric unit. Density modification finally revealed space group 
P62 to be correct for crystal form 2 and provided excellent initial electron density 
(Figure 2I-11) suitable for automated and manual model building. The anomalous signal-to-
noise ratio of 1.08 for crystal form 1 was considerably lower than the ratio for crystal form 2 
(1.33) and did not suffice for phasing. 
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Figure 2I-11. Selenium-SAD phasing of SycT1-122 crystal form 2. (A) After phasing using the selenium 
substructure found in SHELXD, density modification in SHELXE (Sheldrick, 2002) was carried out for both 
enantiomorph space groups P62 and P64. With increasing cycles of density modification, the large difference in 
the map contrast between the two substructure enantiomorphs together with the high correlation (observed 
heavy atom structure factors compared to the ones calculated for the selenium substructure model) showing a 
Pseudo-free correlation coefficient of 69.2 % indicated a correct solution and the original enantiomorph with 
space group P62 to be correct. (B) The initial electron density map after density modification showed well-
defined density, here for a selenomethionine. Selenium atoms are depicted as green spheres. 
 
 
The complete structural model of SycT1-122 crystal form 2, refined to 1.9 Å, was later used to 
solve the structure of crystal form 1 to 2.0 Å resolution by molecular replacement. Both 
superposed models (from crystal form 1 and 2) were used as MR search ensemble to finally 
solve the structure of native SycT to high resolution (1.8 Å).  
In all three crystal forms, the asymmetric unit harbors two molecules forming a homodimer 
due to non-crystallographic two-fold rotational symmetry. The three crystal structures are 
very similar showing deviations only at the flexible N- and C-terminus and the exceptional 
region 16-28 in one of the monomers of the native SycT structure. The structure of SycT1-122 
crystal form 2 compared to native SycT shows an r.m.s.d. of 0.75 Å for 206 common Cα-
atoms, and SycT1-122 crystal form 1 vs. native SycT differs by 0.85 Å for 195 common Cα-
atoms. SycT1-122 crystal form 1 and 2 are very similar (r.m.s.d. 0.5 Å, 199 Cα-atoms) and the 
two monomers superpose well with an r.m.s.d. of 0.6 Å (crystal form 1) and 0.7 Å (crystal 
form 2), respectively. 
Electron density was visible for SycT1-122 residues 1-113 in monomer A, and 3-122 in 
monomer B of the refined model of crystal form 2. In the model of crystal form 1, the C-
terminal residues 115-122 for both monomers could not be observed in the electron density. 
The model of native SycT comprises residues 3-130 (A), 2-117 and 125-130 (B). The data 
processing and refinement statistics are given in Table 2I-3. 
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2I.7 Structural analysis of SycT 
2I.7.1 Structural overview of SycT 
The SycT monomer exhibits a twisted anti-parallel, six-stranded β-sheet flanked on one side 
by two α-helices (Figure 2I-12, SycT1-122 crystal form 2) sharing most features of the globular 
fold common to other T3SS effector-chaperones (see chapter Discussion Figure 3I-1).  
SycT shows only low sequence identity (9-22 %) to other T3SS effector chaperones, but a 
low r.m.s.d. of <
 
2.7 Å for common Cα-atoms (79 to 109 aligned residues) compared to 
structures of SicP and SigE from Salmonella ssp. (Luo et al., 2001; Stebbins and Galan, 
2001), SycE and SycH from Yersinia ssp. (Birtalan and Ghosh, 2001; Evdokimov et al., 2002; 
Trame and McKay, 2003; Phan et al., 2004), CesT from enterohemorrhagic E. coli EHEC 
(Luo et al., 2001) and AvrPphF Orf1 from plant-pathogenic Pseudomonas syringae pv. 
phaseolicola (Singer et al., 2004). SycT shares the highest sequence identity with the 
structurally uncharacterized Orf1 from Pseudomonas aeruginosa (abbreviated as SpcS) 
believed to be the T3SS chaperone of ExoS (Frithz-Lindsten et al., 1997)(Figure 2I-13). 
Despite the overall similarity of the fold to other T3SS effector chaperones, SycT exhibits 
several unique and distinct characteristics. The depression between the N-terminal α-helices 
α1 and the adjoining loops L4 and L6, typical for other effector chaperones, is less distinct in 
the SycT dimer (Figure 2I-12). In contrast, the groove between both loops L5 on the opposite 
dimer face is more pronounced. Additionally, helices α3 point with their C-terminal ends 
further outwards compared to other effector chaperones where these helices taper resulting in 
a rejuvenating dimer shape (compare Discussion section Figure 3I-1). 
The dimerization interface in SycT encompasses several residues of the region between 
residues 43 and 90, in particular residues from strands β4 and β5, loops L4, L6 as well as the 
extended loop L5 (Figure 2I-12, Figure 2I-13). 
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Figure 2I-12. Crystal structure of the Yersinia enterocolitica SycT homodimer. Stereo view of SycT1-122 
crystal form 2 (monomer A colored in blue, monomer B in red). Front view and top view after turning by 90°. 
The α-helix and β-strand numbering was adapted from earlier T3SS chaperone structures. The SycT monomer 
exhibits a mixed α/β fold comprising an anti-parallel six-stranded β-sheet packing against two α-helices. The 
inset shows the well-defined electron density of the protruding Phe119 side chain (red sticks) of monomer A 
that is involved in a crystal contact (see also Figure 2I-17). 
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Figure 2I-13. Structure-based sequence alignment of SycT with related T3SS effector chaperones. 
Conserved hydrophobic residues in SycT helices α1 (Phe5, Met9, Leu12, Leu16) and α3 (Met97, Leu101, 
Phe104, Ile108) are shaded green. The SycT dimerization interface (red brackets) involves residues Tyr43, 
His44, Trp47, Gln49, Phe51, Asp62, Asn63, Leu64, Phe65, Trp69, Pro70, Ala71, Val73, Gly75, Arg76, 
Leu77, Trp84, Gln87, Val90). The sequence section containing the dimerization mediating residues includes 
also conserved polar residues (blue, Asn63, Gln86) and hydrophobic residues (purple, Val48, Leu50, Leu64, 
Phe65, Val73, Ile82, Trp84). Other conserved residues (Gly17, Leu18, Leu83, Ile105) are highlighted in 
orange. The dimerization mediating residues are located in the loops L4, L5 and L6 and the β-strands β4 and 
β5. Aligned sequences were adjusted by analyzing the SycT structure. Secondary structure elements for SycT 
are indicated above, those for the Yersinia chaperone SycE below the sequences. Aligned sequences com-
prised Yersinia enterocolitica SycT (GenBank entry AAD16809), Y. pseudotuberculosis SycE (NC_006153), 
Pseudomonas syringae pv. phaseolicola AvrPphF ORF1 (AAF67148), E. coli CesT (P58233), Salmonella 
typhimurium SicP (AAC38655), S. enterica SigE (NP455587), Y. pestis SycH (NP052425), putative chaper-
one Orf1 from P. aeruginosa, abbreviated to SpcS (AAA66490). 
 
 
 
 
 
 
34   RESULTS - Characterization of the effector YopT and its cognate chaperone SycT 
 
 
2I.7.2 A closed cavity in the SycT dimerization interface 
The dimerization interface of SycT harbors a cavity of 150 Å3 (Figure 2I-14). Five to six 
(native SycT and SycT1-122 crystal form 2; crystal form 1) water molecules trapped within the 
cavity form hydrogen bonds to polar residues. No charged residue is found in the cavity. 
Symmetrically positioned Ser88 residues from both monomers restrict entry to the cavity and 
are mutually hydrogen-bonded in the native structure and crystal form 1. The cavity in SycT 
is closed and both hydrophobic Val90 residues in loop L6 shield the cavity from the outside 
(Figure 2I-14). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-14. SycT dimerization interface encloses a polar cavity. (Left) SycT harbors a polar, closed cavity 
(SycT1-122 crystal form 1, cavity as pink surface model and side chains of Trp47, Pro70, Ala71, His72, Val73, 
Leu83, Trp84, Ser85, Ser88 as blue stick model, Gln86 in red). (Right) The inset shows the top view along the 
two-fold rotational symmetry axis onto the hydrogen bond network (green dashed lines) of the five water 
molecules within the cavity. Both Val90 residues (green) shield the cavity from the outside. 
 
 
2I.7.3 Hydrophobic surface patches in SycT 
Dimeric SycT exhibits hydrophobic residues that cluster in three hydrophobic patches on the 
surface. Patch 1 and 2, located remote from the two-fold symmetry axis, are symmetrically 
duplicated on the dimer surface (Figure 2I-15). Patch 1, near the dimer interface, comprises 
residues Leu64, Phe65, Gly66, Trp69 of one monomer as well as Val27, Leu39, Ile40, Ala41, 
Tyr43, Trp47, Gln49, Phe51, Gly75, Ile82 of the second. Patch 2 is formed by the amphipa-
thic α-helix involving residues Leu16, Gly17, Leu18, Phe30, Val32 and Ile105. The third 
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hydrophobic patch (patch 3) stretches between both N-terminal helices α1 (residues Met0, 
Leu8, Leu89, Val90, Gly91, Leu92, Ile94) (Figure 2I-15).  
 
 
 
 
 
 
Figure 2I-15. Hydrophobic patches on the SycT dimer 
surface. Two-fold symmetry of hydrophobic patches 1 
and 2 (1, 2) on the surface of SycT (SycT1-122 crystal 
form 1) generates four patches per dimer. In the crystal 
of native SycT, patch 1 mediates hydrophobic interac-
tion to residues 125-130 of the C-terminal peptide 
(violet stick model). Surfaces corresponding to hydro-
phobic side chains are highlighted in green. 
 
 
In five of the six crystallographically independent monomers obtained for SycT, the residues 
connecting α1 and β1 form an additional β−strand β0 anti-parallel to β1. In one monomer of 
the native SycT dimer these connecting residues do not form β0. Instead they form a loop that 
is flipped toward helix α1 thereby opening a shallow groove (Figure 2I-16). The high 
temperature factors of these either loop- or β0−forming residues (not shown) indicate an 
increased flexibility of this protein region. 
 
 
 
 
 
 
 
 
 
 
Figure 2I-16. Rearrangement of secondary structure 
elements in SycT. In native SycT monomer 1 (red), the 
region connecting α1 and β1 exhibits the additional β-
strand β0, while in monomer 2 (blue) β0 has trans-
formed into a loop and moved toward α1 opening a 
shallow groove. 
 
 
 
 
2I.7.4 Interaction of the C-terminal peptide with hydrophobic surface patches 
In full-length SycT, the C-terminal peptide (SPILFI, residues 125-130) of both monomers 
interacts with the hydrophobic patch 1 of the primary dimer as well as of a symmetry-related 
molecule simultaneously, thereby mediating extensive crystal contacts (Figure 2I-15).  
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The C-terminal peptide of truncated SycT1-122 crystal form 2, which is only visible in the 
electron density of one monomer, interacts hydrophobically via the well-defined protruding 
Phe119 (compare Figure 2I-12) with the hydrophobic patch 1 of a symmetry-related mole-
cule. The hydrophobic patch 1 harbors a groove (Phe65 in loop L5 from one monomer, Val27 
from β2, Leu39, Ala41, Tyr43 from β3, Gln49, Phe51 from β4 in the other monomer). In 
crystal form 2 of truncated SycT1-122, this hydrophobic groove of one monomer is occupied by 
Phe119 from the C-terminal peptide of a neighboring monomer in the crystal sustaining an 
important crystal contact (Figure 2II-17A,B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2I-17. Crystal packing of SycT1-122 (crystal form 2) in the hexagonal space group P62. (A) Crystal 
packing of SycT1-122 crystal form 2. Chain A is colored in blue, chain B in red. Symmetry related dimers are 
colored in grey. Phe119 (red spheres) that is visible in the electron density of only one monomer in SycT1-122 
crystal form 2 mediates an important crystal contact by protruding into the hydrophobic patch 1 of symmetry-
related molecules. Unit cell depicted as green rhomboid. View along unit cell axis c. (B) Close-up view of 
Phe119 interacting with hydrophobic patch 1. 
 
 
These C-terminal residues (115-122) are disordered in monomer B (crystal form 2) and in 
both monomers of crystal form 1. Residues 115-122 thus seem to be intrinsically flexible. 
Depending on the crystal packing environment, these C-terminal stretches in SycT are ordered 
by fortuitously binding to patch 1 of a neighboring molecule. 
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2II Type III secretion Class II chaperone SycD 
2II.1  Biochemical characterization of SycD 
2II.1.1 Gene expression, isolation and purification of full-length SycD 
Full-length translocator chaperone SycD (residues 1-168) was recombinantly produced as 
soluble N-terminal GST-fusion protein in high amounts. Fusion protein was purified by 
affinity chromatography using glutathione sepharose and the tag was cleaved on column. Full-
length SycD was initially purified by ceramic hydroxyapatite (CHT) chromatography. CHT 
chromatography separated several high and low molecular weight impurities from SycD, 
though SycD itself did not bind to the column (Figure 2II-1) resulting in negative purification. 
Non-binding behavior of SycD was also observed with a low phosphate concentration and 
calcium chloride in the running buffer implying an unfolded polypeptide chain without 
clustered carboxyl groups. However, circular dichroism measurements of SycD (see 
Figure 2II-23) verified secondary structure elements and thus the native folding of SycD. 
SycD was further purified using size exclusion chromatography. During concentrating of 
purified SycD for crystallization trials, the protein solution exhibited the formation of higher 
oligomers under certain conditions (see section 2II.1.5). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-1. Negative purification of SycD by ceramic hydroxyapatite (CHT) chromatography. (Left) 
CHT chromatogram. SycD did not bind to the column and eluted with the flowthrough (right, lanes 2 and 3 in 
SDS-PAGE). Instead, several high and low molecular weight impurities were retained and eluted with the 
phosphate gradient (right, lane 1). (Right) 15 % SDS-PAGE (Coomassie staining) of the CHT chromatography 
fractions for SycD. Lane 1: phosphate gradient eluate; Lane 2 and 3: concentrated flow through pools I and II 
containing SycD; M, marker proteins.  
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2II.1.2 Limited proteolysis of SycD identifies a stable fragment 
Although purification of full-length SycD yielded very pure protein, extensive crystallization 
trials at room temperature and at 4 °C did not yield crystals. Additionally, SycD stored at 4 °C 
over a long period of time was degraded N-terminally by 20 amino acids as detected by 
MALDI-TOF mass spectrometry (Figure 2II-2A). In order to identify a stable fragment within 
the SycD sequence that was more suitable for crystallization, limited proteolytic digest using 
trypsin was carried out (Figure 2II-2B). The resulting SycD fragment was identical to the one 
obtained by degradation comprising residues 21-168. 
 
 
 
 
 
 
 
 
 
 
Figure 2II-2. Stable fragment of SycD. (A) MALDI-TOF-MS analysis of SycD stored at 4 °C over six weeks 
reveals two protein species. Full-length SycD with residual PreScission protease cleavage oligopeptide 
GPLGS (calculated Mr = 19’406 Da) corresponds to the mass peak on the right. A truncated degradation 
fragment of SycD with 16’590 Da is present in equal amounts. (B) 15 % SDS-PAGE (Coomassie staining) of 
limited proteolysis of full-length SycD. The tryptic digest (at 0 °C on ice, 20 °C and 37 °C) resulted in a stable 
fragment of SycD that is N-terminally truncated by 20 amino acids (Mr theo SycD21-168 = 16’591 Da) corre-
sponding to the degradation fragment in panel A. M, marker proteins.  
 
In contrast to this indicated susceptibility that might possibly be due to disorder, secondary 
structure prediction by the network PROF algorithm (Rost and Sander, 1993) supposed a long 
α-helix in this N-terminal region (Figure 2II-3). With the P1 cleavage site residue lysine 
proceeding three glycines, this region is apparently not entirely helical but accessible to 
proteolytic cleavage. 
 
 
 
 
 
Figure 2II-3. Secondary structure 
prediction of the N-terminal 
region in SycD. PROF output of 
full-length SycD. The cleavage site 
after Lys20 observed during limited 
tryptic digest is indicated by an 
arrow and precedes three succes-
sive glycine residues (green). 
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2II.1.3 New expression construct SycD21-163  
Unsuccessful crystallization trials, the identification of the fragment SycD21-168 by limited 
proteolysis (section 2II.1.2), higher oligomerization of full-length SycD (see section 2II.1.5, 
Figure 2II-7) potentially due to disulfide bond formation of Cys164 close to the C-terminus 
(below) gave rise to the generation of a second expression construct comprising SycD 
residues 21-163. The truncated chaperone was produced in the same way as full-length SycD 
and yielded large amounts of soluble protein (Figure 2II-4A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-4. Purification of SycD21-163. (A) 15 % SDS-PAGE (Coomassie staining) of the SycD21-163 protein 
preparation via glutathione sepharose (GSH Seph) affinity chromatography and PreScission protease cleavage 
(PreSci. Cleav.) on column. Purified SycD21-163 shows a purity level of 99 % (last lane concentrated protein). 
oN, over night; sup, supernatant; M, marker proteins. (B) Anion exchange chromatography AEC (MonoQ HR 
10/10 column, GE Healthcare-Amersham Biosciences). Contaminations C1 and C2 were almost completely 
separated by a flat salt gradient (NaCl) leaving a small window of pure SycD21-163 (Pool) that were combined 
for the next purification step. (C) Size exclusion chromatography (Superdex 200 XK 16/60 column) with AEC 
pool fractions. The elution peak showed slight tailing. Peak fractions were pooled and concentrated for 
crystallization trials. 
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Impurities of higher molecular weight (~30 kDa) were observed during the course of purifica-
tion. Glutathione sepharose re-chromatography did not remove the impurities and reducing 
and non-reducing gels displayed the same band pattern implying that no disulfide bridges 
were involved. Negative purification using ceramic hydroxyapatite chromatography neither 
removed the contaminants. N-terminal sequencing identified one of the impurities as the 
affinity tag GST that has been N-terminally truncated by 99 amino acids. This GST fragment 
(residues 100-226) is defective in binding to glutathione-coupled sepharose. However, the 
size of the GST-fragment observed in SDS-PAGE runs with ~30 kDa, which is double the 
size of the calculated molecular mass for the GST100-226 fragment (Figure 2II-4B). Negative 
purification via ceramic hydroxyapatite chromatography did not remove the contaminants. 
Anion exchange chromatography using a very flat salt gradient (0-15 % of 1 M NaCl-
containing buffer B over 20 column volumes) separated both impurities imperfectly from 
each other, though leaving a small window of almost contaminant-free SycD21-163 in the 
absorption peak of the chromatogram that could be further used for size exclusion chromatog-
raphy (Figure 2II-4B,C). By a second anion exchange chromatography of the remaining 
fractions that resulted in the same chromatogram and band distribution, more pure target 
protein was obtained. SycD21-163 exhibits slight tailing during size exclusion chromatography 
(Figure 2II-4C and Figure 2II-6), a phenomenon also observed for full-length SycD 
(Figure 2II-6). Despite the small fraction of target protein suitable for the final purification 
step and crystallization trials, the yield of SycD21-163 was ~16 mg per liter of bacterial culture 
and purified SycD21-163 showed > 99 % purity (Figure 2II-4A, last lane). 
 
2II.1.4 Surface engineering in SycD 
In order to optimize the surface properties of the chaperone supposed to favor crystallization 
and to overcome oligomerization, the SycD amino acid sequence was scrutinized for critical 
residues (cysteines) and clustered residues of high surface entropy according to the approach 
of surface engineering (Derewenda and Vekilov, 2006). Inspection of the SycD sequence and 
analysis by the surface entropy reduction server (Figure 2II-5, left) assisted by secondary 
structure prediction revealed several regions of clustered lysine and glutamate residues that 
are supposed to lie at the surface and might prevent crystallization due to flexible side chains. 
A further site selected for mutation was the C-terminal cysteine Cys164 that might form 
intermolecular disulfide bonds leading to higher oligomerization observed during purification. 
Selected K/E clusters and Cys164 were eliminated in the corresponding surface mutants of 
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full-length or truncated SycD (Figure 2II-5, right). The physicochemical properties of the 
SycD constructs are listed in Table 2II-1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-5. Surface engineering of SycD. (Left) Analysis of SycD amino acid sequence by the Surface 
Entropy Reduction Server (http://nihserver.mbi.ucla.edu/SER/) reveals several clusters of lysine and glutamate 
residues supposed to be surface-exposed and possibly interfere with protein crystallization due to side chain 
flexibility (score ranking). (Right) Resulting SycD surface mutants used in protein production. 
 
Table 2II-1. Physicochemical properties of SycD and SycD variants. 
 SycD SycD 
C164S 
SycD21-163  SycD21-163 
K117A/K155A 
SycD21-163 
K155S 
Number of residues 173 173 148 148 148 
Mr [Da] 19’404 19’388 16’472 16’128 16’307 
Molecular extinction 
coefficient ε [M-1·cm-1] 
10’720 10’600 9320 9320 9320 
Isoelectric point (pI) 4.9 4.9 5.3 5.0 5.0 
Values generated with Vector NTI (Invitrogen), corresponding to PreScission protease cleaved proteins with an 
extra N-terminal GPLGS peptide. 
 
 
2II.1.5 Oligomerization state of SycD in solution  
During purification, SycD exhibited excellent solubility. The oligomerization state of wild-
type SycD and derived constructs was investigated by dynamic light scattering and analytical 
size exclusion chromatography as well as native PAGEs. Analytical SEC of wild-type SycD 
and SycD21-163 constructs reveals the formation of SycD homodimers in solution 
(Figure 2II-6) that is confirmed by DLS analysis (Table 2II-2, different constructs). 
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Figure 2II-6. Size exclusion chromatography 
of SycD and SycD21-163. Superdex 200 HR 
10/30 (GE Healthcare-Amersham Biosci-
ences), running buffer 20 mM Tris pH 8.0, 
200 mM NaCl, 1 mM DTT. Elution of 
standard molecular weight proteins was used 
for calibration (arrow heads). The observed 
SycD retention times correspond approxi-
mately to the doubled masses expected of a 
SycD monomer (Mr SEC ~40 kDa, 
Mr theo= 19’404 Da) and a SycD21-163 monomer 
(Mobs ~38 kDa, Mr theo = 16’486 Da) suggest-
ing the formation of homodimers.  
 
 
Table 2II-2. Dynamic light scattering results for full-length SycD and truncated constructs.  
Protein c [mg/mL] rH  Mr DLS [kDa] Polydispersity [%] Base line SOS error 
SycD wt  ~6 3.03 42.6 16.2 1.000 2.01 
SycD21-163  22 2.85 37.2 10.4 0.999 0.87 
SycD21-163 K155S  20 2.89 37.9   8.6 0.999 1.04 
The data present the best fit as obtained by regularized radii distribution. 
 
However, aged or concentrated protein batches of full-length SycD tend to aggregate and 
SycD apparently formed higher oligomers in native PAGEs (Figure 2II-7A). Under certain 
conditions, these oligomer bands were even visible in a reducing, denaturing SDS-PAGE. The 
formation of oligomeric inhomogeneities might hamper crystallization, and its elimination is 
therefore essential. 
 
 
 
 
 
 
 
 
 
 
Figure 2II-7. Formation of higher SycD oligomers. (A) 12 % Native PAGE. Concentrated and aged protein 
solutions of full-length SycD with exhausted DTT were prone to form multimers most likely linked by 
disulfide bridges as DTT addition reduces the amount of oligomers (last lane). (B) 12 % Native PAGE of 
truncated SycD21-163 exhibited a homogeneous population, even after concentrating (22 mg/mL). (Coomassie 
staining). 
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This oligomerization might be due to the formation of intermolecular disulfide bonds. 
Analysis of the SycD amino acid sequence (see section Appendix) suggested that one of four 
cysteines in total, Cys164 near the C-terminus, is exposed and could be prone to form 
disulfide bridges. However, investigations of SycD by accurate mass spectrometry (ESI-TOF) 
only detected a species exhibiting exactly the calculated mass of 19’404 Da (not shown) and 
did not indicate the presence of oxidized thiol groups or disulfide bonds. 
The truncated chaperone variant, SycD21-163, lacking the flexible 20 amino acids at the N-
terminus plus the five C-terminal residues including Cys164, as well as its surface-engineered 
derivative K155S, formed homogenous, monodisperse solutions of homodimers even at 
higher concentrations (up to 22 mg/mL) (Figure 2II-7B), conferring suitable properties for 
crystallization.  
 
2II.2  Complex formation studies of SycD with translocator YopD 
2II.2.1 YopD278-300 peptides 
Prior studies on the cognate translocators had identified a C-terminal fragment of YopD 
capable of SycD binding (Francis et al., 2000; Tengel et al., 2002). As a first approach, this 
C-terminal YopD peptide comprising residues 278-300 was recombinantly produced as an N-
terminal GST-fusion protein with a TEV protease cleavage site. Sufficient amounts of the 
soluble GST-fusion could be isolated and purified. TEV protease cleavage was monitored by 
mass-spectrometry and the observed mass difference corresponded to the calculated mass of 
the TEV protease-cleaved YopD278-300_TEV peptide (Mr theo= 3022 Da) (Figure 2II-8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-8. Mass spectrometry of 
GST-YopD278-300 TEV-cleavage. (A) 
Amino acid sequence of the 
YopD278-300_TEV peptide. (B) TEV 
protease cleavage of the GST-fusion 
(31’724 Da) is revealed by the emerging 
mass peak for GST (28’721 Da) during 
MALDI-TOF-MS. The mass difference 
of 3003 Da corresponds to the YopD 
peptide (Mr theo= 3’022 Da).  
44   RESULTS - Type III secretion Class II chaperone SycD 
 
 
However, the attempt to separate the peptide from GST via ultracentrifugation using a 
MWCO of 30’000, which was supposed to retain GST but let pass the peptide, disclosed the 
aggregation of the peptide. As an alternative approach, the chemical synthesis of the 
YopD278-300 peptide was chosen (by Dr. Peter Henklein; Charité Berlin). 
 
2II.2.2 Binding studies and co-crystallization of SycD with YopD278-300 
The complex formation between SycD and the YopD peptide variants was analyzed using 
analytical size exclusion chromatography, native gel shift or an affinity matrix immobilization 
pull-down assay. Analytical SEC of SycD with GST-YopD278-300 and YopD278-300_TEV, 
respectively, did not reveal peak shifting, nor did SycD bind to GST-YopD278-300, which had 
been coupled to glutathione sepharose beads. For the synthetic peptide and the truncated 
chaperone SycD21-163, ambiguous results were obtained during SEC as the common retention 
time error has the magnitude of the peptide mass. Neither was binding observed in the pull-
down assay (Figure 2II-9A). Co-crystallization attempts of wild-type SycD with the synthetic 
peptide YopD278-300 were carried out by adding the solubilized peptide to the concentrated 
protein solution of SycD (c ~20 mg/mL) intending a 1.1 : 1 excess of peptide, followed by 
nanoliter crystallization setups. Strikingly, immediate precipitation during addition of the 
peptide to the SycD solution was observed that occurred independently of the pH value of the 
solubilized peptide, i.e. peptide suspended in water or in 1 M Tris pH 8.0. The supernatant of 
the protein:peptide mixture analyzed with native PAGE disclosed a distinct shift for a small 
fraction of SycD21-163 (Figure 2II-9B), indicating that the chaperone is at least able to bind 
partially to the chaperone. However, the considerable shift in the gel exceeded the expected 
difference that would be induced by the YopD278-300 peptide (23 aa, ~2.8 kDa). Presumably, 
the SycD:YopD278-300 interaction detected in the gel differed from a 1:1 binding ratio and 
might be due to the observed aggregation of the peptide resulting in a SycD:(YopD278-300)n 
complex where n is an unknown integer >1.  
Nonetheless, the SycD:YopD278-300 mixture was used in screening for crystallization condi-
tions – without success. Co-crystallization was repeated with the peptide solubilized in the 
presence of a detergent to prevent the aggregation of the peptide. As detergent, n-dodecyl-β-
D-maltoside (critical micelle concentration 0.1 - 0.6 mM) was used, with a final detergent 
concentration of approximately 0.12 - 0.15 mM in the crystallization drop; still no crystals 
appeared. In previous studies, the peptide was stabilized by trifluorethanol and an acidic 
milieu not applicable for protein crystallization (Tengel et al., 2002). 
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However, under the near-physiological conditions used in this work, apparently no significant 
and useful interaction between SycD and the C-terminal YopD peptide YopD278-300 occurred 
in solution. 
 
 
 
 
 
 
 
 
 
Figure 2II-9. Analysis of the complex formation between SycD and the YopD278-300 peptides. (A) Pull-down-
like assay of GST-YopD278-300 coupled to glutathione sepharose beads and SycD did not disclose binding 
(15 % denaturing SDS-PAGE, Coomassie staining). (B) 12 % native PAGE (Coomassie staining) of the 
supernatant from the SycD:YopD278-300 peptide mixture used for co-crystallization. A distinct shift of a small 
part of SycD is visible indicating the partial binding of the chaperone to the synthetic YopD278-300 peptide, 
though the interaction is different from a 1:1 ratio possibly due to the observed peptide aggregation. M, native 
high molecular weight marker. 
 
 
2II.3  Crystallization of SycD 
2II.3.1 Large, beautiful looking SycD21-163 crystals diffract only poorly 
Extensive nanoliter-scale screening for crystallization conditions of wild-type or reductively 
methylated full-length SycD as well as of the cysteine mutant SycD C164S, with protein 
concentrations between 3 and 20 mg/mL and incubation temperatures varying from 4 to 
20 °C, did not result in crystalline objects. Crystallization setups for the truncated variant 
SycD21-163 using high concentration (20 mg/mL) and low temperature (4 °C) eventually 
yielded tiny needles under a high salt condition (potassium acetate) that could be optimized 
into large, beautiful looking crystals that diffracted very poorly to 3.8 Å (synchrotrons DESY, 
ESRF) at best (Figure 2II-10C; Figure 2II-11A). However, large SycD21-163 crystals grew 
irreproducibly and usually showers of thin rod-shaped crystals appeared in the crystallization 
droplet. Therefore, nucleation had to be slowed down. As setups were already incubated at 
4 °C and SycD21-163 did not respond to (micro-/streak-)seeding, the approach of inserting 
inorganic nucleants with varying pore sizes (Nanonucleant, London, UK) (Chayen et al., 
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2006) was applied that was supposed to provide suitable nucleation surfaces and enforce the 
growth of a few single crystals. Both sitting-drop and hanging drop vapor diffusion tech-
niques were employed (Figure 2II-10). However, SycD21-163 crystals grew independently of 
the nucleant showing the familiar shower. 
 
 
 
 
 
 
Figure 2II-10. Crystallization trials with porous gel glass (Nanonucleant, UK). (A) Innovadyne Innoplate 
SD-2 plate with spotted gel glass in droplet chamber (inset). (B) Hanging drop crystallization trial with applied 
Nano-grain, directly after setting-up. (C) Crystallization setup after seven days. The nucleant had no impact 
onto SycD crystallization. Scale bar = 100 µm. 
 
2II.3.2 Engineering of the tetragonal SycD21-163 crystals using dehydration 
At that time when only the tetragonal crystals of SycD21-163 and SycD21-163K155S 
(Figure 2II-11A,B) were available, which diffracted only poorly at room temperature as well 
as at 100 K (7.5 Å, home source rotating anode), attempts were made to enhance diffraction. 
In order to improve the apparently imperfect crystal packing, the crystals were subjected to 
different techniques of dehydration that were supposed to reduce the water content of the 
crystal and provoke a rearrangement of the molecules resulting in a more regular packing and 
optimized diffraction pattern. Simple cover slip transfer to higher concentrated crystallization 
reservoirs as well as stepwise addition of nanoliter-size droplets and finally the use of an 
humidity control device were tested. Crystals, treated accordingly to the first two methods and 
tested during the course of dehydration, did not reveal an improved diffraction pattern. To 
detect a potentially missed optimum, the crystals were hydrated and dehydrated in an 
automated manner using the free-mounting system for humidity control (FMS, Proteros). For 
both crystal forms the crystallization reservoir solution containing either potassium or lithium 
acetate possesses a very low relative humidity rH (91.2 %) already bearing a dehydrating 
effect. During controlled dehydration (rH
 end = 75.0 %) the diffraction deteriorated and could 
not be rescued by a successive re-hydration gradient, nor did the initial increase of rH up to 
97.0 % have a positive effect on the diffraction potential. In summary, the diffraction potential 
of the tetragonal SycD21-163 crystals could not be improved by dehydration experiments. 
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2II.3.3 Reductive methylation of SycD21-163 yields well-diffracting crystals 
In order to overcome this futile crystal form and to induce an alternative crystal packing, a 
surface-engineered variant SycD21-163 K155S (see section 2II.1.4) was screened for crystalli-
zation conditions. As lysine side chains hamper crystal contacts, this mutant was supposed to 
crystallize more easily, possibly providing different crystal contacts. Indeed, crystals appeared 
in a different condition (Figure 2II-11B, see Materials and Methods section 5.14.1), however, 
they exhibited the same bad diffraction potential and tetragonal crystal lattice parameters as 
the wild-type SycD21-163 crystals, indicating a defective packing of the molecules in the lattice. 
As a second approach, crystallization trials for SycD21-163 were set up utilizing commercial 
and hand-made PEG-based screening solutions to enforce crystallization and possibly a more 
favorable packing from a PEG-based instead of a salt-based cocktail. In a PEG 350 MME as 
well as in a PEG 400-based condition, long, thin needles (<
 
10 µm width) grew, which could 
not be increased in size and that diffracted even worse (resolution 9 Å, synchrotron DESY) 
(Figure 2II-11C). 
As a last resort, the manipulation of the protein itself by reductive methylation of lysine side 
chains was employed, a method that had already been applied to the full-length chaperone in 
vain. In fact, the modified protein SycD21-163 meth produced a different crystal form, this time 
exhibiting a monoclinic packing and diffraction to 1.95 Å (Figure 2II-11D), suitable for 
structure determination. 
 
 
 
 
 
 
 
 
Figure 2II-11. Crystals of SycD variants. (A) Optimized tetragonal SycD21-163 crystals, large and beautiful 
looking but poorly diffracting due to imperfect packing of the huge unit cells with ~34 molecules per asym-
metric unit. (B) Optimized crystals of a quadruple lysine/glutamate surface mutant, SycD21-163 K1555S, grow 
under a different condition, however, they possess the same diffraction properties, crystal lattice and unit cell 
parameters as the wild-type. (C) Crystals of SycD21-163 obtained in a self-made PEG screen. They could not be 
improved in size and diffraction. (D) After reductive methylation of SycD21-163, an alternative (=monoclinic) 
well-diffracting (<2 Å) crystal form was obtained that was used for structure determination. Scale bar = 
100 µm. 
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2II.3.4 Engineering of the SycD21-163meth crystals via heavy atom derivatization 
To accelerate and facilitate structure solution of the monoclinic SycD21-163 meth crystal form, 
heavy atom derivatization was applied that would overcome the phasing problem in case of a 
failure of molecular replacement (further details in Materials and Methods section 5.14.2). 
The Heavy Atom Databank (Islam et al., 1998) listed heavy atom binding sites for mercury, 
platinum and osmium in SycD. Therefore, thimerosal, ethylmercurylphosphate, potassium 
tetracyanoplatinate, potassium tetrachloroplatinate(II) and osmium(III)chloride hydrate were 
selected. Additionally, crystals of SycD21-163 meth were quick-soaked in halogenide solutions 
(potassium and sodium bromide, potassium iodide) following the described method (Dauter et 
al., 2000). Soaking provoked usually crystal cracking and loss of diffraction. Potential 
derivative candidates did not prove as genuine derivatives as examined by fluorescence 
energy scan or diffraction data analysis. Xenon pressurizing as an alternative derivatization 
method was later used successfully to derivatize SycD21-163 meth crystals (section 2II.4.2), 
although the SycD21-163 meth structure eventually could only be solved by molecular replace-
ment (below). 
 
 
2II.4  Structure determination of SycD21-163 
2II.4.1 How to pack 34 SycD21-163 molecules ? 
Preliminary X-ray analysis of the tetragonal SycD21-163 crystals revealed a huge unit cell with 
Matthews’ probability analysis (Matthews, 1968; Kantardjieff and Rupp, 2003) (VM = 2.42 
Å3 Da-1, solvent content 49.2 %) suggesting approximately 34 molecules per asymmetric unit. 
Molecular replacement of wild-type SycD21-163 failed. Neither the use of different search 
algorithms (Patterson function superposition, maximum likelihood) by applying several 
programs such as EPMR (Kissinger et al., 1999), AMORE (Navaza, 1994), MOLREP (Vagin 
and Teplyakov, 1997) or PHASER provided a correct solution, nor did different search 
strategies with tetratricopeptide repeat (TPR)-containing proteins and parts of them such as O-
linked N-acetylglucosamine transferase (OGT), protein phosphatase 5 (PP5) or the homology 
model LcrH/SycD introduced by Pallen et al. (2003). Structure solution of this crystal form 
was finally abandoned and the search for an alternative crystal form enforced that was finally 
obtained by reductive methylation (section 2II.3.3). 
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2II.4.2 Attempts to solve the SycD21-163 meth structure by anomalous phasing 
X-ray analysis of SycD21-163 crystals obtained after reductive methylation assigned them to the 
monoclinic space group C2. The Matthews coefficient VM (VM = 2.16 Å3 Da-1, solvent 
content 43 %) indicated two molecules per asymmetric. With the smaller unit cell parameters, 
these crystal appeared more promising than the tetragonal crystals with respect to successful 
structure determination. The self-rotation function indicated non-crystallographic two-fold 
rotational symmetry (Figure 2II-12) suggesting dimerization of the two molecules per 
asymmetric unit, although actually two two-fold non-crystallographic symmetry (NCS) peaks 
were visible corresponding to two distinct dimeric assemblies. 
 
 
 
 
 
 
 
 
 
 
Figure 2II-12. Self-rotation function for 
SycD21-163meth. In this self-rotation function 
map, the crystallographic two-fold rota-
tional symmetry of the space group C2 is 
present (maxima at the edges of the Y-axis). 
Moreover, the rotational component of a 
non-crystallographic symmetry (NCS) 
operator is visible, which represents the 
local symmetry, i.e. rotational symmetry 
relating the SycD21-163 molecules in the 
asymmetric unit. The maximum peak 1 at 
polar angles θ=120°, ϕ=180°, χ=180° 
indicates a two-fold rotational NCS 
(implied by χ=180°), though a minor peak 2 
is also present (θ~30°). The self-rotation 
function was calculated using the program 
MOLREP. 
 
However, molecular replacement as described above failed again. Therefore, heavy atom 
derivatization was carried out in parallel of which only xenon treatment resulted in a genuine 
derivative. Single-wavelength anomalous dispersion (SAD) data of the xenon-derivatized 
SycD21-163meth crystals were directly input into the beamline version of the automated structure 
determination platform Auto-Rickshaw (Panjikar et al., 2005), although the quality of the 
obtained phases did not suffice to solve the structure. Further attempts to locate the xenon 
atoms by different methods revealed one common, fully-occupied xenon site and several, 
inconsistent sites of minor occupancy. Localization of the xenon positions was also attempted 
in an anomalous difference Patterson map. The relevant Harker section of the Patterson map 
in space group C2 at v= 0 disclosed only one significant peak corresponding to the symmetry 
self-vector of the single xenon site already determined (Figure 2II-13). 
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Figure 2II-13. Harker section 
of the anomalous difference 
Patterson map for the 
SycD21-163 meth xenon deriva-
tive. The anomalous 
Patterson map was calculated 
at 3.5 Å and the relevant 
Harker section u= 0 - 0.5, 
y= 0 w= 0 - 1 is depicted. 
Only one self-vector peak 
(u= 0.1233, w= 0.4953) is 
visible, corresponding to a 
single xenon site. Due to the 
weak anomalous signal, this 
single site did not suffice to 
phase the dataset.  
 
As no further xenon sites were localized and due to the weak anomalous signal, anomalous 
phasing of the SycD21-163 meth data was not feasible. The structure of the xenon derivative was 
later solved by molecular replacement using the refined structural model of SycD21-163 meth as 
search model (see below). In the difference Fourier map (Fo-Fc), four distinct spheres corre-
sponding to xenon sites could be localized (Fehler! Ungültiger Eigenverweis auf 
Textmarke.) of which only one was fully occupied, corresponding to the single solution 
derived from the anomalous Patterson map. 
 
 
Figure 2II-14. Xenon atoms incorporated in the 
crystal packing of SycD21-163meth. Anomalous phasing 
using the single xenon site failed. Later, molecular 
replacement with the SycD21-163meth structure (see 
below) was possible and revealed the positions of four 
xenon atoms (1-4) incorporated in hydrophobic cavities 
within the molecule and in crystal contact voids. Only 
xenon 1 is fully occupied and corresponds to the 
solution identified in the anomalous Patterson and in 
SHELXD. Difference Fourier (Fo-Fc) map (green 
mesh) contoured at 5 σ. View along unit cell axis c. 
 
 
2II.4.3 Molecular replacement of SycD21-163 meth and PHASER sensitivity 
As experimental phasing of the SycD21-163 meth Xe data had failed, enforced attempts were 
made to solve the SycD21-163 meth structure by molecular replacement. These included also the 
modification of the search model. Attempts using one to three TPR motifs of the SycD/LcrH 
homology model were not successful, nor was the trial with a search model that had been 
transformed into a polyalanine chain. Alternatively, searches with TPR domains of structur-
ally related TPR-containing proteins such as Heat shock protein organizing protein (Hop), 
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OGT, PP5 or cyclophilin 40 were carried out. However, independent of searching with a 
single molecule or aligned ensembles, these efforts did not succeed either. Unfortunately, the 
NCS operator of the dimer (i.e. the rotation and translation vectors required to superpose both 
monomers) was not known, which could have been used otherwise for searching the dimer 
directly. Therefore, the program PHASER was extensively used in order to locate one 
monomer after another. The MR search round attempting to find the first monomer comprised 
a rotation function search followed by a translation function search. In the second MR round 
that was supposed to locate the second monomer by running also a rotational and translational 
search, the found solution(s) from the first round were manually re-entered and kept fix. 
However, the two search steps from the first MR round gave only low rotation function Z-
scores (RTZ) and translation function Z-scores (TFZ) that did not indicate a correct solution. 
The scoring did neither improve in the successive round searching for the second molecule. 
However, correct solutions with only low scoring have been reported (Keegan and Winn, 
2007). Therefore, the packing of the potential solutions found by PHASER was visually 
analyzed in order to detect an appropriate dimeric assembly. Still, none of the packing was 
convincing due to severely penetrating, clashing main chains. 
Literature search for help in challenging MR cases came across the importance of an accu-
rately prepared search model and the superior success rate of using so-called mixed models 
that were identified and modified by the Fold and Function Assignment System (FFAS03) 
(Rychlewski et al., 2000; Jaroszewski et al., 2005). With regard to the SycD amino acid 
sequence, FFAS03 returned PDB entry 2FO7, a synthetic 8-repeat consensus TPR protein 
(Kajander et al., 2007), as most suitable MR search model. The FFAS03-aligned sequences 
for SycD (residues 2-137) and 2FO7 (1-136) shared 20 % identical residues. The generated 
model was truncated to three TPR motifs (98 residues) and transformed into a mixed model 
consisting of identical (25.5 %) and otherwise serine residues (Figure 2II-15). This 3-TPR 
mixed model was used with PHASER for a stepwise MR search of SycD21-163 meth. 
 
 
 
 
 
 
 
Figure 2II-15. Ribbon presentation of the mixed 
model successfully applied in the structure solution 
of SycD21-163 meth by molecular replacement. The 
FFAS03 method used in determination of a MR search 
model proposed an artificial TPR repeat protein (PDB 
entry 2FO7) as most suitable model. The final search 
model comprised 98 residues forming three TPR 
motifs (TPR1-3, colored in light green, green, dark 
green) and was additionally prepared as a so-called 
mixed model exhibiting only identical side chains 
(25.5 %) otherwise serine residues (stick model). 
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The first MR round locating monomer 1 resulted in a single solution with low RFZ and TFZ. 
As before, this solution was fixed in the following search round locating the second molecule 
in the asymmetric unit. The RFZ of the second search gave low, dissatisfying Z-score values 
again (PHASER manual guide line for a correct solution: Z>5). However, the translation 
function finally increased significantly (Table 2II-3) indicating the success of the MR search. 
Thus, the correct solution became evident only after placing the second (last) molecule. 
 
Table 2II-3. Summary of the stepwise MR search for SycD21-163 meth in the program PHASER. 
Round Search step Search details Z-score Correct  
    solution ? 
  1 Rotation function  - 3.9 No 
  1 Translation function  - 4.2 No 
  2 Rotation function Solution from 1st round kept fix, 
searching the 2nd molecule 
3.7 No 
  2 Translation function Placing the 2nd molecule 10.0 Yes 
 
 
Both solutions for SycD21-163 meth were improved and completed in several rounds of manual 
model building and refinement. The final, refined model of SycD21-163 meth was used in turn to 
perform a stepwise MR search in PHASER for the tetragonal SycD21-163 crystal form with 
roughly 34 molecules per asymmetric unit. However, attempts to locate one SycD21-163 
monomer after another, similar to the procedure described above in combination with manual 
and subjective (since carried out by eye) selection of the correct solutions only by judging the 
crystal packing, did not exceed six located monomers and was eventually abandoned. 
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2II.5  Structural overview of SycD21-163 
The monoclinic crystal form contains two SycD21-163meth molecules per asymmetric unit. The 
dimethylated amino head groups of lysine side chains were crucial for crystallization as they 
were actually involved in crystal contacts (Figure 2II-16) maintaining the crystal lattice. The 
electron density is well defined for residues 21-154 in monomer A, and for residues 21-160 in 
monomer B. Both monomers differ only in the position of 10 N-terminal residues indicating 
this region to be flexible. The rest of the molecule superposes well with an r.m.s. deviation of 
1.3 Å for 125 common Cα atoms. 
 
 
 
 
 
 
 
 
 
Figure 2II-16. Reductive methylation of SycD21-163 was crucial for crystallization (A) MALDI-TOF mass 
spectrum of reductively methylated SycD21-163. [M+H] indicates the singly-charged species, [M+2H] the 
doubly-charged ion. Molecular mass for SycD21-163meth calculated from amino acid sequence with complete 
dimethylation of 10 lysines and the N-terminus is 16’794 Da. (B) Composite omit map of electron density 
contoured at 1.0 σ for dimethylated residue Lys51 (Mly51, green) involved in a crystal contact, 2Fo - Fc 
Fourier difference map at 1.0 σ for remaining residues. Five out of 10 lysine side chains per monomer, Lys51, 
Lys57, Lys102, Lys117 and Lys137, were well defined in electron density. 
 
 
The SycD monomer consists of eight α-helices (h0, 1A, 1B, 2A, 2B, 3A, 3B, h8) 
(Figure 2II-17). The structure reveals the tetratricopeptide repeat (TPR)-like motifs that had 
been predicted for T3SS Class II chaperones (Pallen et al., 2003). The repeat domain in 
SycD21-163 spans residues 36 to 137 and is composed of six α-helices with the helices 
arranged in an anti-parallel manner. The six helices 1A, 1B, 2A, 2B, 3A and 3B are organized 
in TPR1-3, followed by the C-terminal helix (h8) that is joined also in an antiparallel orienta-
tion resulting in 3.5 repeats overall. In a single TPR motif of SycD, helices A and B pack 
against each other with dihedral packing angles Ω ranging from -152° to -164°, whereas 
packing between helices B and A’ from adjoining TPR motifs show slightly lower angles 
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(-149° to -158°) as calculated by PROMOTIF (Hutchinson and Thornton, 1996). The twist 
per repeat in the overall right-handed superhelical TPR domain of SycD is 43-49° between 
TPR1 and TPR2, 46-47° between TPR2 and TPR3 and 91-95° for the whole domain TPR1-
TPR3 (rotation angles chi as obtained by superposition in LSQKAB, Kabsch, 1976). These 
values are comparable with data from the literature (Main et al., 2003). The twisted arrange-
ment of the TPR motifs results in a concave and convex face of SycD (Figure 2II-17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-17. Ribbon presentation of the crystal structure of SycD21-163. Stereo image of monomeric 
SycD21-163. Front view of the concave side and top view after turning by 90 °, with TPR1 colored in yellow, 
TPR2 in green and TPR3 in blue. 'A' helices are pastel-colored. The C-terminal stabilization helix h8 is 
colored in red.  
 
The integrity of the SycD TPR fold is maintained by a pattern of small and large residues 
consistent with the canonical TPR sequence motif (Trp4-Leu7-Gly8-Tyr11-Ala20-Phe24-
Ala27-Pro32) (Sikorski et al., 1990). The majority of these connecting residues are hydro-
phobic and accumulate at the inner faces between the repeat helices, depicted in a helix wheel 
chart (Figure 2II-18). The long C-terminal α−helix h8 following the TPR motifs exhibits 
numerous charged, hydrophilic amino acids. For that reason, this helix is also termed capping, 
stabilization or solvating helix and is found in almost all currently known structures of TPR-
containing proteins such as PP5 (Das et al., 1998) and Hop (Scheufler et al., 2000). 
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Figure 2II-18. Helix wheel representation of the SycD monomer (top view). Hydrophobic residues are 
depicted as diamonds, according to descending hydrophobicity colored in green to yellow. Hydrophilic 
residues are presented as red to orange circles, accordingly. Negatively charged residues correspond to blue 
triangles, positively charged amino acids to blue pentagons. The wheels were generated by 
http://rzlab.ucr.edu/scripts/wheel/wheel.cgi. 
 
Table 2II-5. The first 20 results of the structural alignment search with DALI (Holm, 1993) for SycD 
residues 21-160 (monomer B). 
Rank Protein PDB ID Z-score Seq.ID [%] Align.res. R.m.s.d.
 
[Å] 
1 Ser/Thr-Protein phosphatase PP5 1A17 16.6 13 128 2.3 
2 CHIP U box E3 ubiquitin ligase 1C2L 16.0 17 106 2.1 
3 Model of a Ca2+ binding protein 2AK6 15.3 8 128 2.9 
4 Peroxisomal targeting signal 1 receptor PEX5p 1FCH 15.3 18 130 3.4 
5 O-linked GlcNAc transferase OGT 1W3B 15.2 17 126 2.4 
6 Model of LcrH (residues 32-165) 1OOL 15.2 87 124 2.4 
7 FK Binding Protein 51 isomerase 1KT0 14.8 14 124 2.3 
8 PilF fimbral pili type 4, lipoprotein 2FI7 14.5 15 126 2.5 
9 PilF fimbral pili type 4, lipoprotein 2HO1 14.2 18 125 2.2 
10 PFL2275c C-terminal domain 2FBN 14.0 14 134 3.3 
11 p67phox Ras-related C3 botulinum toxin  1E96 13.8 16 126 1.9 
12 TOM70 mitochondrial importer 2GW1 13.3 18 133 2.7 
13 Hydrolase prolyl-4-hydroxylase 1TJC 12.7 13 
  85 1.8 
14 NlpI lipoprotein 1XNF 12.5 17 131 2.4 
15 Peroxisomal targeting signal 1 receptor PEX5 1HXI 12.3 15 
  93 2.3 
16 FK Binding Protein 42  2IF4 12.0 17 108 2.5 
17 Sec17 vesicular transport protein 1QQE 11.8 15 138 4.5 
18 transcription factor MalT domain III 1HZ4 11.6 18 139 1.6 
19 14-3-3 protein (signaling) 1IJP 10.9 10 120 2.6 
20 TOM20 mitochondrial importer 1ZU2 10.2 10 109 2.3 
Seq.ID, Sequence identity; Align.res., Number of aligned residues. 
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A DALI search (Holm, 1993) for structural homologs of SycD using the refined structural 
model (monomer B, residues 21-160) returned Ser/Thr protein phosphatase 5, the TPR 
domain of CHIP U box E3 ubiquitin ligase, the peroxisomal targeting signal receptor Pex5p 
and the O-linked N-acetylglucosaminyl transferase OGT as best matches (Z-scores 16.6, 16.0, 
15.3, 15.2; r.m.s.d. 2.3, 2.1, 3.4, 2.4 Å) (Table 2II-5). Taken together, the α-helical fold of 
Class II chaperone SycD reveals genuine TPR repeats. 
 
 
2II.6  Ambiguity of the SycD quaternary structure 
2II.6.1 SycD21-163 meth packing analysis reveals two possible dimer assemblies 
The apparent molecular mass for SycD21-163 determined experimentally by size exclusion 
chromatography and dynamic light scattering gives significantly larger values (Mr ~39 - 
42 kDa) than expected for the monomeric chaperone (~17 kDa) (compare Figure 2II-6 and 
Table 2II-2), suggesting that the SycD dimer in the asymmetric unit is also present in 
solution. However, in the monoclinic crystal packing, different quaternary assemblies of the 
two SycD monomers are possible resulting in two distinct dimers (Figure 2II-19). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-19. Alternative homodimer assemblies of SycD21-163. (A) Monoclinic crystal packing of SycD21-163 
allows two different dimer assemblies. Elongated dimer 1 is composed of the blue and yellow monomer, 
compact dimer 2 of the blue and orange monomer. A tetrameric assembly, which is a dimer-of-dimers, was 
also identified by PISA to be stable comprising the blue, orange and yellow monomer as well as the adjoining 
grey molecule. (B) Ribbon diagram of dimer 1 (upper part) and dimer 2 (lower part) with the monomers 
colored in blue and yellow. View along the two-fold rotation axis in dimer 1 with the monomers tilted by 
~61°. View perpendicular to the imperfect two-fold rotation axis in dimer 2. The interface in dimer 2 is 
asymmetric. Interface sections are indicated by dashed lines.  
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In the elongated dimer 1, both monomers interact head-to-head via TPR1. The second 
assembly (dimer 2) shows the two monomers dimerizing asymmetrically back-to-back via the 
convex face of the TPR repeats involving TPR2 and the turns between the repeats 
(Figure 2II-19B and below). The two dimer assemblies explain also the two peaks present in 
the self-rotation function (Figure 2II-12). The rotational component of the non-
crystallographic symmetry in dimer 1 determined by superposition of both monomers is 
ω= 61°, ϕ= 0°, χ= 179° in polar angles, whereas dimer 2 is related by an imperfect rotational 
symmetry (ω= 29°, ϕ= 178°, χ= 172°) indicated by a χ angle significantly smaller than 180°. 
 
2II.6.2 Characterization of dimer assembly alternatives 1 and 2 
To obtain a qualitative characterization of the assemblies, the structure and crystal packing 
were analyzed by the PISA server (Krissinel and Henrick, 2007) as well as the protein-protein 
interaction server (Laskowski, 1995). Both analyses suggested the assemblies in dimer 1 and 
in dimer 2 to be stable. Interestingly, the PISA analysis detected a tetrameric/dimer-of-dimers 
assembly in the crystal packing that is suggested to be stable as well (Figure 2II-19A). 
 
Table 2II-6. Comparison of dimer interface characteristics for potential SycD21-163 dimer 1 and dimer 2.  
Interface statistics Dimer 1 - elongated Dimer 2 - compact 
Monomer buried SA [Å2] 924 655 
% Monomer SA 11.4 7.8 
Number of residues 25 18 
% Non-polar atoms a 72.6 78.7 
% Polar atoms a 27.6 22.8 
Planarity a 2.3 1.9 
Hydrogen bonds c  2 
  symmetric 
  Q60_O···E30_NE2 
3 
    AY68_OH··· BS94_OG 
    BH91_O   ···  AH67_NE2 
   
BS94_O   ···  AY95-OH 
Salt-bridges 0 0 
Gap volume index a 2.03 4.07 
Shape correlation statistics b 0.617 0.699 
Interfacing residues symmetric 
I31, T35, Q38, L39, L42, D54, Mly57, 
V58, Q60, A61, V64, L65 
asymmetric 
V64, H67, Y68, F73, H91,Y95, I101 
A : V64, H67, Y68, F73, H91, Y95, 
       M99, I101 
B : V64, H67, Y68, F73, H91, S94, 
      Y95, V98, I101 
Data were obtained with PISA. SA, surface area; a Calculated using the Protein-Protein Interaction server; 
b calculated by SC (Lawrence and Colman, 1993); c hydrogen bond donor and acceptor atoms/groups are listed. 
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However, as SycD behaved as a dimer in solution, the crystallographic dimer-of-dimers was 
excluded from further examination. The dimerization interfaces in the potential dimer 
assemblies 1 and 2 are both centered at the corresponding local rotation axis and mediated by 
hydrophobic interactions supported by hydrogen bonds (Figure 2II-21). Dimethylated lysine 
Mly57 at the edge of the dimerization interface of dimer 1 supports the dimerization only via 
its aliphatic side chain whereas the dimethylamino head group is not involved. The structural 
and statistical analyses (summarized in Table 2II-6) favor dimer 1, however, alternative 
dimer 2 could not be excluded with certainty.  
 
 
2II.6.3 SycD forms head-to-head dimers in solution 
To verify which dimer assembly SycD adopts in solution, key residues involved in the 
potential interfaces were chosen for site-directed mutagenesis in order to disrupt the interac-
tion, followed by an analysis of the mutants in solution. A structure-based multiple sequence 
alignment of SycD with other T3SS translocator chaperones (Figure 2II-20) highlights the 
canonical and conserved residues characteristic for tetratricopeptide repeats that were 
excluded from mutagenesis. Several further residues are conserved, however, not predomi-
nantly in the dimerization interface.  
Concerning elongated dimer 1, Ala61 and Leu65 were selected for the mutation into large, 
charged glutamates (single substitutions A61E, L65E and double mutant A61E/L65E). Both 
residues are centrally buried in the interface and occur twice due to the two-fold symmetry 
thereby facing each other (Figure 2II-21A). The introduction of two or four negatively 
charged residues was expected to cause steric hindrance as well as electrostatic repulsion and, 
therefore, the disruption of the dimer interface. In the interface of compact dimer 2, Ser94 as 
well as Tyr95 were selected. Tyr95 is a key residue located at the convex surface mediating 
hydrophobic and hydrogen-bonded interactions between both monomers (Figure 2II-21B). 
Replacement of large Tyr95 with small, polar serine instead of alanine was chosen to prevent 
aggregation. Equivalently to the glutamate double mutant A61E/L65E for the interface in 
dimer 1, the double mutant S94E/Y95E for potential interface 2 was generated. 
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Figure 2II-20. Structure-based sequence alignment of SycD and homologous T3SS chaperones, adjusted 
with ESPript. Y. enterocolitica SycD (GenBank accession number AAD16814), P. aeruginosa PcrH 
(NP250398), E. coli CesD (AAC38376), Salmonella typhimurium SicA (AAB06794), Shigella flexneri IpgC 
(P0A2U4), Chlamydia trachomatis LcrH-1 (NP220091), Burkholderia pseudomallei BicA (YP335732), Y. 
enterocolitica SycB (AAM47500), S. typhimurium SscB (NP460368) and SscA (NP460364). – TPR1; 
≡ TPR2; = TPR3. () Canonical residues at TPR positions 8, 20, 27; () conserved residues at positions 4, 7, 
11, 24, 32. Interfacing residues in dimer 1 are shaded blue, those common in both monomers in dimer 2 are 
shaded light blue. For purposes of clarity only the first five sequences are depicted. Conserved surface 
residues, as derived from ProtSkin by analysis of the complete alignment, are highlighted in orange. 
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Figure 2II-21. Stereo 
views of the potential 
dimerization inter-
faces in dimer 1 (A) 
and dimer 2 (B). 
Residues chosen for 
mutational analysis are 
highlighted in red. 
Hydrogen bonds are 
depicted as green 
dashed lines. The 
residues mediating 
dimerization are 
mainly hydrophobic. 
The potential dimer 1 
possesses a more 
planar interface with a 
smaller gap volume 
compared to the 
potential interface in 
dimer 2 (see 
Table 2II-6). 
 
 
 
All five SycD21-163 mutant proteins, single site mutants A61E, L65E and Y95S as well as the 
double mutants A61E/L65E and S94E/Y95E, were highly soluble and could be purified in 
wild-type-like quantities using the same protocol as for SycD21-163. Their physicochemical 
properties are listed in Table 2II-7. 
 
 
Table 2II-7. Physicochemical properties of SycD21-163 and the dimer interface mutants. 
 SycD21-163 
wt 
Interface 1 
A61E 
 
L65E 
 
A61E/L65E 
Interface 2 
Y95S 
 
S94E/Y95E 
Number of residues 148      
Mr  [Da] 16'472 16'531 16'488 16'546 16'396 16'481 
Mol ext. coeff. ε 9320 9320 9320 9320 8040 8040 
Isoelectric point (pI) 5.3 5.2 5.2 5.1 5.3 5.1 
Values generated with Vector NTI (Invitrogen). Mr , molecular mass; Mol. ext. coeff., molecular extinction 
coefficient, dimensions [M-1·cm-1]. Due to PreScission protease cleavage, the proteins contain an extra N-
terminal GPLGS peptide. 
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Analytical size exclusion chromatography and dynamic light scattering measurements were 
applied to investigate the oligomerization state of wild-type and mutant SycD21-163. In size 
exclusion chromatography, wild-type SycD21-163 as well as both dimer interface 2 mutants 
Y95S and S94E/Y95E eluted with an apparent molecular mass of 40 - 43 kDa, whereas the 
single and double interface 1 mutants, A61E, L65E and A61E/L65E, eluted with an apparent 
molecular mass of ~25 kDa suggesting a monomeric species (Figure 2II-22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-22. Analytical size exclusion chromatography for SycD21-163 and interface mutants. Superdex 
200 HR 10/30 column (GE Healthcare-Amersham Biosciences). Running buffer 10 mM Tris pH 8.0, 150 mM 
NaCl, 1 mM DTT. Elution of calibration standard proteins are indicated by arrows. Interface mutants of 
putative elongated dimer 1 (interface 1) and compact dimer 2 (interface 2) are termed by mutations. Mutations 
introduced in the potential interface 1 resulted in a significant shift of retention time, thus indicating the 
monomeric species. Mutations applied to the potential interface 2 had no effect and the proteins behaved like a 
wild-type dimer. In conclusion, SycD21-163 forms head-to-head dimers (dimer 1) in solution. 
 
 
Dynamic light scattering measurements of the peak fractions gave ~38 kDa for wild-type 
SycD21-163, ~40 kDa for the potential interface 2 mutant Y95S and ~41 kDa for S95E/Y95E, 
but only ~21 kDa for interface 1 mutants A61E, L65E and A61E/L65E (Table 2II-8). This is 
in line with the results derived from chromatography.  
To ensure that the monomeric behavior of SycD21-163 A61E, L65E and A61E/L65E was not 
caused by destroying the integrity of the TPR fold, wild-type SycD21-163 and the mutants were 
analyzed by native PAGE (Figure 2II-23A). Wild-type SycD21-163 and the monomeric 
A61E/L65E mutant were additionally examined by circular dichroism (CD) (Figure 2II-23B). 
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Table 2II-8. Dynamic light scattering results for the SycD interface mutants. 
Protein c  
[mg/mL] 
rH  
[nm] 
Mr  DLS 
[kDa] 
Polydispersity 
[%] 
Base line SOS error 
SycD21-163 wt  22 2.85 37.2 10.4 0.999 0.87 
SycD21-163 A61E 1.75 2.26 21.0 13 1.000 3.62 
SycD21-163 L65E 1.4 2.26 20.7 11 0.999 4.95 
SycD21-163 A61E/L65E 3.95 2.24 20.5  8.3 1.000 2.93 
SycD21-163 Y95S 3.7 2.88 37.5 11.0 0.999 0.71 
SycD21-163 S94E/Y95E 3.5 2.95 39.8  8 1.000 0.79 
rH, hydrodynamic radius. Best fits for regularized radii distribution are listed. The calculated molecular mass of 
monomeric wild-type and mutant SycD21-163 is ~16.5 kDa. 
 
 
In the native gel, SycD21-163 wild-type and the interface mutants migrated as focused single 
bands consistent with folded proteins. Wild-type SycD21-163 and the mutant Y95S (pI 5.3) 
migrated on the same level, whereas the single glutamate mutants A65E, L65E (pI 5.2), and 
more significantly the double mutants A61E/L65E and S94E/Y95E (pI 5.1) migrated faster 
due to the additional surface-exposed negative charges accelerating migration in the electric 
field (Figure 2II-23A). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-23. Native PAGE and circular dichroism analysis of SycD and derivatives verify the native 
fold. (A) All mutants ran as focused bands corresponding to correctly folded proteins. The extra-charge 
mutants A61E, L65E and more obvious the double-mutants A61E/L65E and S94E/Y95E ran faster. M, native 
high molecular weight marker. (B) Circular dichroism spectra. SycD21-163 wt and interface mutants exhibit 
virtually identical CD spectra corresponding to α-helical secondary structure elements. Measurements were 
carried out in 10-20 mM potassium sodium phosphate pH 7.5. Protein concentration was ~6-9 mM.  
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The CD spectra of the wild-type and the mutant proteins were virtually identical displaying 
two minima at 208 and 222 nm (Figure 2II-23B). This results are characteristic for α-helical 
secondary structure elements indicating that the mutants were correctly folded. Further, CD 
spectra analysis via least square fitting (Bolotina et al., 1980) calculated an α-helical content 
of 68 % for wild-type SycD and 67 % for SycD21-163. In comparison, the content of α-helical 
secondary structure elements derived from the crystal structure of SycD21-163 is 78 % with 111 
residues out of 143 being located in α-helices (see section 2II.5). The CD spectra of both 
interface mutants A61E/L65E and Y95S were apparently identical with the CD spectra of 
SycD21-163 and full-length, wild-type SycD suggesting that all SycD species possessed the 
intact secondary structure elements and the native fold. 
 
2II.6.4 A third dimer assembly indicates flexible SycD dimerization 
In addition to wild-type SycD21-163 meth, crystals were obtained for dimethylated mutants 
SycD21-163 S94E/Y95E meth (dimeric) and SycD21-163 L65E meth (monomeric) as well as for non-
methylated SycD21-163 A61E/L65E (monomeric) (section 2II.6.3).  
Intriguingly, the monomeric interface 1 mutant A61E/L65E crystallized by chance in the 
same condition as wild-type SycD21-163 meth, however, exhibiting inferior diffraction and an 
orthorhombic space group (I222) with only one molecule per asymmetric unit (Table 2II-4). 
The structure was solved by MR using one monomer of the refined SycD21-163 structural 
model from the monoclinic crystal form as search model. No stable oligomeric assembly 
within the crystal packing was detected, which is consistent with the mutant’s monomeric 
behavior observed in solution. The refined structural model of SycD21-163 A61E/L65E 
comprises SycD residues 29 - 163. 
 
 
 
 
 
 
Figure 2II-24. Crystals of SycD21-163 interface mutants. (A) and (B) Trigonal crystals of SycD21-163 
S94E/Y95E
 
meth
 (space group P3221). The varying morphology is due to different ratios of two PEG precipi-
tants. (C) By chance, the unmethylated monomeric interface mutant SycD21-163 A61E/L65E crystallized under 
the same condition as SycD21-163 meth, although in an orthorhombic space group (I222). (D) Monomeric 
SycD21-163 L65E meth yielded bizarre book-like clusters with very thin plate-leaves, which could not be im-
proved in thickness. Scale bar = 100 µm. 
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As to the well-diffracting crystals of SycD21-163 meth S94E/Y95E, the PHENIX program 
XTRIAGE used for a twinning analysis of the diffraction data, initially indexed as P3, 
suggested a higher point group symmetry, P321. Systematic absences along the reciprocal ℓ 
axis indicated the presence of either a 31 or 32 screw axis along the three-fold rotation axis. 
Matthews coefficient calculation did not clearly indicate a probability maximum at an integer 
number of molecules per asymmetric unit, rather ranged between one or two molecules and a 
solvent content of 68 % and 37 %, respectively (Figure 2II-25B). However, as SycD21-163 meth 
S94E/Y95E behaved as a dimer in solution, two molecules in the asymmetric unit related by 
non-crystallographic symmetry were also conceivable. Molecular replacement for 
SycD21-163 meth S94E/Y95E provided the correct solution for the first molecule without 
difficulties. Attempts to place the second monomer of the assumed SycD21-163 meth S94E/Y95E 
homodimer in the asymmetric unit during a further MR search run was not successful. 
Inspection of the packing revealed sufficient crystal contacts between the symmetry related 
monomers, principally via the long C-terminal helix h8 (Figure 2II-25C). The asymmetric 
unit thus harbors only one molecule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-25. SycD monomer overlay and crystal packing for SycD21-163 meth S94E/Y95E. (A) Stereo image 
of the superposed monomer structures of wild-type SycD21-163 and the interface mutants. All monomers show 
the intact TPR domain fold and a higher flexibility of the terminal regions. (B) Corresponding to Matthews’ 
probability calculation two molecules per asymmetric unit seemed more probable, though only one molecule 
is actually present in the asymmetric unit with a high solvent content of 68 %. (C) Crystal packing. View 
perpendicular to the three-fold rotational screw axis and along the crystallographic two-fold rotational symme-
try axis parallel to unit cell axis b. The blue monomer is symmetry-related to the yellow monomer by the 
crystallographic symmetry operation (-x, -x+y, -z + 2/3) forming dimer 3. Main crystal contacts are mediated 
by the C-terminal helix h8 (designated by asterisks). 
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Well-defined electron density was observed for SycD residues 29-160. Furthermore, the 
packing disclosed the assembly of homodimers as well, with the two SycD21-163 S94E/Y95E 
monomers sitting at the two-fold crystallographic rotational symmetry axis (Figure 2II-25C). 
The SycD21-163 S94E/Y95E dimer is again a head-to-head dimer. Strikingly, the monomers in 
this new dimer are orientated differently, with both monomers rotated more heavily with 
respect to each other (crossing angle 90° vs. 61° in dimer 1), resulting in a kinked assembly 
(Figure 2II-26, compare dimer 1 in Figure 2II-19).  
 
 
 
 
 
 
 
 
 
 
Figure 2II-26. Front and top view of a third dimer assembly of SycD21-163. Ribbon and surface presentations 
of the crystal structure of homodimeric SycD21-163 S94E/Y95E, one of the mutants used to determine the real 
dimerization interface of SycD. One monomer colored in yellow, the other in blue. Basically, the same 
residues as in dimer 1 are involved in dimerization. However, the monomers in the third dimer are skewed 
more heavily with respect to each other (90° instead of 61°as in dimer 1), thus forming a kinked dimer 
(dimer 3). 
 
 
Interfacing residues in this new dimer (dimer 3) are basically the same as for dimer 1, forming 
a predominantly hydrophobic surface (Figure 2II-27). The interface is stabilized exclusively 
by non-polar contacts, lacking hydrogen bonds or salt-bridges between the monomers. 
However the buried interface area per monomer is considerably smaller in the kinked 
SycD21-163 S94E/Y95E dimer (607 Å2) than in dimer 1 (924 Å2) (Table 2II-9). 
Taken together, the results from the mutational analysis and the additional mutant structure 
strongly suggest that the SycD dimer in solution corresponds to a head-to-head dimer and that 
dimerization is disrupted in the A61E, L65E and A61E/L65E mutants.  
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Table 2II-9. Comparison of the dimer interface 
characteristics for SycD21-163 dimer 1 and dimer 3 
Interface statistics Dimer 1 - 
elongated 
    Dimer 3 - 
kinked 
Monomer buried SA 
[Å2] 
924 607 
% Monomer SA 11.4 7.5 
Number of residues 25 21 
% Non-polar atoms a 72.6 68.7 
% Polar atoms a 27.6 31.3 
Planarity a 2.3 2.9 
Hydrogen bonds 2 0 
Salt-bridges 0 0 
Gap volume index a 2.03 3.84 
Shape correlation 
statistics b 
0.617 0.548 
Interfacing residues 
(buried SA>40 %, both 
protomers) 
I31, T35, 
Q38, L39, 
L42, D54, 
Mly57, V58, 
Q60, A61, 
V64, L65 
E30, T35, 
L39, L42, 
Q46, D54, 
Mly57, 
V58, Q60, 
A61, V64, 
L65 
Data were obtained with PISA; a calculated by 
Protein-Protein Interaction server; b calculated by SC 
(Lawrence and Colman, 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-27. The dimerization interfaces of the 
head-to-head SycD21-163 dimers 1 and 3. Dimeriza-
tion in both cases utilized roughly the same residues 
of TPR1. View onto the interfaces opened up.  
 
2II.7  Relevance of the SycD dimerization interface in vivo 
In order to investigate the physiological role of SycD dimerization, in vivo experiments with 
Yersinia were carried out comparing a wild-type strain, a sycD null mutant and the sycD null 
mutant reexpressing either wild-type sycD or the sycD double mutant A61E/L65E. Culture 
supernatants were analyzed by SDS-PAGE to assay for Yop secretion. Total cell fractions and 
supernatants were analyzed by Western blot for production and secretion of YopE and of the 
SycD binding partners YopB and YopD. Experiments were performed in the absence and 
presence of calcium ions in order to monitor the calcium dependence of Yop production, as in 
vitro, the activation of the T3SS machinery can be achieved by a temperature shift to 37 °C 
and the depletion of calcium ions by chelating agents (calcium dependent (CD) growth 
phenotype (Forsberg et al., 1987)), also termed Low calcium response (LCR).  
The SycD A61E/L65E mutant shows typical characteristics of a sycD null mutant 
(Figure 2II-28, Table 2II-10). These include the lack of YopB and YopD secretion in the 
absence of calcium, deregulated Yop production in the presence of calcium (calcium inde-
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pendent phenotype) and an increased LcrV secretion independent of the calcium concentra-
tion. Mutations in the SycD dimerization interface obviously abrogate the functionality of 
SycD. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-28. In vivo relevance of the SycD dimerization interface. Expression and secretion of Yersinia 
Yops in the absence and presence of calcium, detected by (A) Coomassie-stained SDS-PAGE of the culture 
supernatant and (B) Western blot of total cell and supernatant fractions (sample application pattern as in (A). 
Yersinia wild-type, a sycD knockout ∆sycD, and ∆sycD reexpressing either wild-type sycD or the monomeric 
A61E/L65E mutant (sycD*) were examined. The A61E/L65E mutant showed a null mutant-like phenotype. 
Note: The polyclonal antibody against SycD cross-reacts with a band (marked with a cross, +) running directly 
below SycD. (Experiments carried out by I. Sorg; Biozentrum of the University of Basel, Switzerland). 
 
Table 2II-10. Quantification of the Western blot results assaying Yop secretion and expression. 
No calcium 
Sample TC (YopB) SN (YopB) TC (YopD) SN (YopD) TC (YopE) SN (YopE) 
Wild-type +++ +++ +++ +++ ++++ ++++ 
∆sycD – – + + ++++ ++++ 
∆sycD + 
sycD ++ + ++ +++ +++ ++++ 
∆sycD + 
sycD* – – + + ++++ ++++ 
+ 5 mM calcium 
Sample TC (YopB) SN (YopB) TC (YopD) SN (YopD) TC (YopE) SN (YopE) 
Wild-type – – + – +++ – 
∆sycD ++ – +++ – ++++ + 
∆sycD + 
sycD + – + – +++ – 
∆sycD + 
sycD* ++ – + – ++++ + 
sycD*, monomeric A61E/L65E mutant; (TC), total cell fraction; (SN), supernatant fraction; (++++/ +++/ 
++/ +), intensity of the signal; (–), no signal. 
 
RESULTS - Type III secretion Class II chaperone SycD 69 
 
 
2II.8  Determination of further interaction surfaces in SycD 
To identify potential interfaces in SycD involved in protein-protein interactions, the electro-
static surface potential, conserved sequence features and predicted binding sites in SycD were 
examined.  
The electrostatic surface potential of the elongated dimer 1 of SycD21-163 is shown in 
Figure 2II-29. The flat top/bottom face of the dimer displays an extended negative charge that 
additionally encompasses the upper part of the concave groove, whereas the lower part of the 
concave face on the dimer front exposes a predominantly hydrophobic area interspersed with 
positively charged patches. The side chain of Arg71 in the crystal structure is bent toward 
Glu37 forming a salt-bridge (compare Figure 3II-1) and does not create a positively charged 
patch on the concave face together with Arg105 contrary to the predictions derived from the 
homology model (Pallen et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2II-29. Electrostatic surface potential of the elongated SycD21-163 dimer 1. The electrostatic surface 
potential was calculated using the APBS (Baker et al., 2001) plug-in of PyMOL. The dimer surface exposing 
both concave TPR faces harbors positively charged patches (blue). A negatively charged patch (red) is located 
on the flat dimer top/bottom face (after a 90° turn upwards). Neutrally charged regions are colored white. 
 
 
In addition to the region within the concave face that has been previously identified as binding 
groove (Edqvist et al., 2006), the prediction program ProMate (Neuvirth et al., 2004) 
suggested a large continuous patch for protein-protein-interactions comprising additionally 
residues from the top of the monomer, reaching further to the upper part of the opposite, 
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convex face, comprising residues Tyr40, Phe44, Gln48, Tyr59, His67, Tyr68, Asp69, Ser70, 
Arg71, Phe73, Leu74, Gly75, Ser92, Ser94, Tyr95 (not shown). In order to visualize the 
conservation of surface residues in SycD and other T3SS Class II chaperones and thus 
putative conserved interaction sites, the structure-based multiple alignment of Figure 2II-20  
was converted into a property file via ProtSkin (http://www.mcgnmr.ca/ProtSkin/). The 
concave surface of SycD exhibits numerous conserved amino acids, whereas the convex side 
of the chaperone shows little sequence conservation (Figure 2II-30).  
 
 
 
 
 
 
 
 
 
 
Figure 2II-30. Sequence conservation of T3SS Class II chaperones. Sequence conservation drawing for the 
SycD21-163 monomer as obtained by ProtSkin (http://www.mcgnmr.ca/ProtSkin/). Orange denotes conserved 
regions. Tyrosines are highly conserved and line the inner groove. In comparison to the concave face (left), the 
convex side (right) shows only minimal conservation. 
 
 
Most of the protein’s tyrosine residues on the concave face are conserved throughout the 
majority of the T3SS Class II chaperones. Additionally conserved, surface exposed residues 
comprise an acidic and a heterocyclic/aromatic side chain (Glu37, His109), as well as two 
leucine residues at TPR consensus positions (Leu39, Leu76) (Figure 2II-30). All of these 
residues line the concave face/binding groove of the chaperone with exception of Leu39 in the 
dimer interface, Leu76 pointing toward the convex outside and the protruding Tyr68.  
In summary, SycD exhibits several distinct surface areas possessing favorable properties for 
protein-protein interactions. 
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3 Discussion
3I SycT – a typical and special T3SS effector chaperone ? 
3I.1 SycT lacks the dimerization helix 
SycT shares the global mixed α/β-fold fold with other homodimeric effector chaperones 
(Figure 3I-1). All crystal structures of T3SS effector chaperones determined before and after 
SycT display three α-helices arranged around the anti-parallel β-sheet, with helix α2 being 
considerably involved in dimerization (Parsot et al., 2003) (Figure 3I-1). Strikingly, α-helix 
α2 is consistently absent in all three crystals forms of SycT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3I-1. Ribbon representations of homodimeric SycT1-122 and of all T3SS effector chaperones 
structurally characterized so far. SycT shares the global mixed α/β-fold of other effector chaperones. 
However, SycT lacks α-helix α2, designated as dimerization helix in other effector chaperones. Y. enterocoli-
tica SycT, Y. pseudotuberculosis SycE (PDB identifier 1L2W) (Birtalan and Ghosh, 2001), Salmonella 
typhimurium SicP (1JYO) (Stebbins and Galan, 2001), Salmonella enterica SigE (1K3S) and E. coli CesT 
(1K3E) (Luo et al., 2001), Y. pestis SycH (1TTW) (Phan et al., 2004), Pseudomonas syringae pv. phaseolicola 
AvrPphF ORF1 (1S28) Singer et al., 2004, and multivalent Shigella flexneri Spa15 (1R9Y) (Van Eerde et al., 
2004) and S. typhimurium InvB (2FM8) (Lilic et al., 2006) as well as Y. pestis heterodimeric SycN/YscB 
(1XKP) (Schubot et al., 2005). The monomers in a homodimer are colored in blue and red, respectively. The 
helices α2 are highlighted in orange and turquoise. 
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Instead, dimerization involves hydrophobic and polar residues exclusively located in loops 
and β-strands (Figure 2I-13). The accessible surface area buried per monomer comprises 
1100 Å2, corresponding to ~15 % of the total surface area value that lies within the range of 
buried surfaces found for other T3SS effector chaperones (900 to 1200 Å2). 
The missing α-helix α2 in SycT, confirmed by the SycT structure solved by a second group at 
the same time (Locher et al., 2005), might well be the cause of the failure of molecular 
replacement attempts for SycT. SycT lacking α-helix α2 can be regarded as a dimerization 
helix-free variant of effector chaperones with helices α2 varying from absent (SycT) to short 
(e.g. SycH) and long (e.g. SicP) (Figure 3I-1). 
In conclusion, dimerization in effector chaperones depends predominantly on the hydrophobic 
nature of the involved residues and is independent of an α-helical conformation. 
 
3I.2 The hydrophobic surface patches in SycT are spatially 
conserved  
In the crystal structures of other effector chaperone structures, the hydrophobic patches 1 and 
2 seen in SycT are present at approximately the same position (Figure 3I-2), whereas patch 3 
is not observed. The interaction of the C-terminal peptide of SycT with one of the hydropho-
bic patches resembles the situation in one of the SycE structures where the flexible C-
terminus similarly binds to the hydrophobic patch 1 of an adjacent dimer (Trame and McKay, 
2003).  
The conserved position of patches 1 and 2 in SycT suggests a similar mode of effector 
binding. In the recent past, several T3SS effector chaperones have been structurally character-
ized in complex with their cognate effector such as Salmonella SicA/SicP (Stebbins and 
Galan, 2001) and InvB/SipA (Lilic et al., 2006) as well as Yersinia YopE/SycE (Birtalan et 
al., 2002) (Figure 3I-2) and YscM2/SycH (Phan et al., 2004). In theses complex structures, 
the N-terminal region of the effector wraps around the chaperones displaying only secondary 
but no tertiary structure. In the YopE/SycE complex, both patches 1 bind α-helices while both 
patches 2 bind β-strands of the YopE chaperone-binding domain (Figure 3I-2). Strikingly, 
only one monomer in the Salmonella InvB dimer contacts the effector SipA, which might 
confer the binding specificity of this multivalent chaperone. 
Despite the spatially conserved hydrophobic patches 1 and 2 representing the postulated 
effector-binding sites, the details of the YopT/SycT interaction could differ from those of 
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other effector/chaperone pairs. The third hydrophobic patch of SycT may indicate an enlarged 
contact area and the effector YopT may follow a different path wrapping around SycT. 
 
 
 
 
 
 
 
 
 
Figure 3I-2. Hydrophobic patches on the SycT dimer surface. Patches 1 and 2 in SycT correspond to those of 
a SycE dimer where these patches are involved in effector binding (right, SycE in complex with the CBD of 
YopE, YopE23-78, red). SycT possesses an additional hydrophobic patch (3) not present in SycE. Surfaces 
corresponding to hydrophobic side chains are highlighted in green. 
 
3I.3 Does effector binding require conformational 
rearrangements of SycT? 
The vicinity of hydrophobic patch 2 in SycT exhibits significant differences compared to 
other T3SS effector chaperones (except probably Spa15). In most chaperones structurally 
characterized to date, patch 2 comprises also a pocket, formed by conserved hydrophobic 
residues from α-helices α1 and α3, as well as a shallow groove between β−strand β1 and the 
loop connecting the N-terminal α-helix α1 with β1. In SycT, the residues connecting α1 and 
β1 form an additional β−strand β0 anti-parallel to β1 that occupies this shallow groove 
(Figure 3I-3, left) and results in a more compact shape compared to the heart-shaped outline 
of other effector chaperones such as SycE (Figure 3I-2). 
In one SycT monomer, the additional β-strand is transformed into a loop and flipped toward 
helix α1, thereby opening up the abovementioned groove (Figure 3I-3, left). This strongly 
resembles the situation in Spa15 (Van Eerde et al., 2004) (Figure 3I-3, left). Effector proteins 
that had been co-crystallized with their cognate chaperone such as the complexes YopE/SycE, 
SptP/SicP, SipA/InvB and YopN/SycN-YscB (Schubot et al., 2005) bind to the chaperone’s 
patch 2 filling this shallow groove and extending the chaperone β-sheet by an additional 
strand along side strand β1 (Figure 3I-3, right). This effector β-strand is a common feature of 
effector CBDs, therefore called β-motif, and is strictly required for effective binding to the 
wedge-shaped groove of the cognate chaperone (Lilic et al., 2006). 
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Figure 3I-3. Effector binding and rearrangement of secondary structure elements in SycT. The shallow 
groove near hydrophobic patch 2 is involved in effector binding such as in the SptP/SicA complex. In SycT 
and Spa15, this groove is filled by the additional β-strand that is formed by the region connecting α-helix α1 
and β-strand β1. Superposed native SycT monomers 1 (red) and 2 (blue) are depicted in both overlays. (Left) 
Superposition of both SycT monomers onto Shigella flexneri Spa15 (grey). Despite the longer loop (+4 
residues) connecting α1 and β1 in Spa15, the structural organization is similar to the red SycT monomer. 
(Right) In the SicP/SptP complex (SicP in grey, SptP in yellow) superposed on SycT monomer 1 (red), the 
effector strand β2 occupies the groove and extends the chaperone β-sheet. If YopT binds in the same manner 
to SycT as SptP to SicA, it would partially overlap with β0 in the red monomer, but not with the conforma-
tionally rearranged blue monomer. 
 
 
The chaperone residues involved in forming the corresponding β-motif-binding pocket 
comprise conserved hydrophobic residues that are located in α-helices α1 and α3 and β-
strand β1 (compare Figure 3I-4A). Structural overlay revealed also their spatial conservation 
(Lilic et al., 2006). The work of Lilic et al. based on the SipA/InvB complex did not address 
the YopT/SycT complex. Therefore the SycT structure and the YopT sequence were analyzed 
in order to identify the corresponding pocket and β-motif. A structure-based alignment and 
the structural overlay of InvB with rearranged native SycT monomer 1 (lacking β0) disclosed 
hydrophobic residues in SycT (Leu16, Tyr28, Phe30, Val32, Leu101, Ile105) that match with 
the β-motif-binding pocket in InvB (Figure 3I-4A,B). 
The structure-based sequence alignment of the YopT sequence with effectors that had been 
co-crystallized with their cognate chaperone allowed the assignment of two similar β-motif 
triplets to the YopT sequence, comprising residues Leu65, Leu69, Asp72 as well as Leu95, 
Val99, Val102 (Figure 3I-4C). Secondary structure prediction does not consistently assign 
any secondary structure to these YopT regions. Apart from insufficient prediction, the 
proposed β-motifs in YopT, which are very likely required in binding to SycT, might be 
formed during the binding process. Although no conformational changes have been observed 
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upon effector binding in the chaperone SycE (Birtalan et al., 2002), the conformational 
rearrangement of SycT β0 is thus likely to be additionally required for binding to YopT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3I-4. β-motif binding pocket in SycT. (A) Structure-based sequence alignment of native SycT 
(monomer 1 = chain A) and InvB. InvB residues located in the shallow groove near hydrophobic patch 2 that 
are involved in binding to the β-motif of effector SptP are shaded orange and superpose well with hydrophobic 
residues in SycT. Identical and homologous residues are boxed in blue. (B) In the structural overlay (ribbon 
and stick model), these hydrophobic residues of Salmonella enterica InvB (GenBank, PDB-ID 2FM8) (yellow, 
Leu14, Ile33, Leu35, Leu37, Leu119, Tyr123) (Lilic et al., 2006) superpose well with the corresponding 
residues in rearranged monomer 1 of native SycT (blue, Leu14, Tyr28, Phe30, Val32, Leu101, Ile105), thus 
these SycT residues are most likely involved in binding to YopT. (C) Structure-based sequence comparison of 
YopT with T3SS effectors co-crystallized with their cognate chaperones (in parentheses). The β-motif 
identified in the SipA sequence in the first place by Lilic et al. (2006) is also found twice in the YopT chaper-
one-binding domain (YopT 51-121, see section 2I.1.4). Y. enterocolitica YopT (GeneBank entry AAD16808), 
Salmonella enterica SipA (AAA86618), Y. pseudotuberculosis YopE (P08008), S. typhimurium (P74873), Y. 
pseudotuberculosis YopN (YP068474). 
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3I.4 The cavity in the SycT dimerization interface is closed and 
uncharged 
A polar cavity located at the dimerization interface of T3SS effector chaperones was first 
described for SycE (Evdokimov et al., 2002). Fully enclosed cavities as in SycT are also 
present in Spa15 and AvrPphF Orf1 dimers (Singer et al., 2004; Van Eerde et al., 2004). The 
dimerization interfaces of other T3SS effector chaperones, e.g. SycE, SycN/YscB (Schubot et 
al., 2005) or SycH (Phan et al., 2004), reveal similar yet open, solvent accessible cavities 
(Figure 3I-5). Compared to other solvated intersubunit cavities (Hubbard and Argos, 1994) 
that of SycT is quite large with ~100 Å2 or 9 % of the dimerization interface per monomer not 
being involved in direct protein-protein interactions.  
 
 
 
 
 
 
 
 
Figure 3I-5. SycT dimerization interface encloses a polar cavity. In contrast to the closed cavity in SycT 
(left), the cavity in the dimerization interface of SycH (right) is accessible and dotted by the positive charges 
of Arg80 (red stick model) at the position where in SycT an uncharged residues is found (Gln86, red stick 
model). 
 
Conservation of the cavity, open or closed, among T3SS effector-binding chaperones is 
strongly suggestive of a biological role. In SycE, SycH and SycN/YscB, the three chaperones 
from Y. pestis for which structural information is available, two arginines create a positively 
charged patch inside the cavity (Evdokimov et al., 2002; Phan et al., 2004; Schubot et al., 
2005). These arginines are conserved among many of the effector chaperones and were 
therefore proposed to be functionally relevant, possibly for interaction with the type III 
secretion machinery (Phan et al., 2004; Schubot et al., 2005). The lack of charged residues in 
the cavity of SycT means that they are unlikely to be a general point of interaction between 
T3SS effector chaperones and the secretion machinery.  
Overall, SycT shares the common characteristics of other Class I chaperones, at the same time 
exhibiting unique features that may be required for the special interaction with the cognate 
effector YopT. 
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3I.5 YopT structural model and chaperone-binding domain 
Apart from the close sequence relationship among YopT from the three pathogenic Yersinia 
species showing 94-96 % identical residues, the BLAST homology search for further YopT 
family members returned the T3SS effector LopT from animal pathogenic Photorhabdus 
luminescence (51 % identity, 67 % similarity). The following proteins also share considerable 
sequence identity with YopT: Pasteurella multocida filamentous hemagglutinin PfhB1 and 
the putative immunoglobulin binding protein (37 %/56 %), Haemophilus influenza large 
supernatant protein (31 %/52 %) as well as the putative YopT-like cysteine protease from 
marine microbe Hahella chejuensis (28 %/47 %). Other family members are found in plant 
pathogens such as Pseudomonas syringae pv. phaseolicola AvrP3 (=AvrPphB, 26 %/56 %) 
and Erwinia amylovora HopPtoC (19 % identical), but also in symbionts such as Bradyrhizo-
bium japonicum ID797 (17 %). Secondary structure prediction for YopT provides only a very 
rough estimation concerning the location of structural elements. The prediction was partially 
corroborated by the crystal structure of the C-terminal, catalytic part of the cysteine protease 
AvrPphB (Zhu et al., 2004), which was therefore used in this study to model the YopT 
structure for residues 118 to 316 (see Results section 2I.3). The YopT model presented here 
lacks the N-terminal part comprising the complete CBD that is postulated to be located 
between residues 51 and 121 and to contain the β-motifs (see above). In view of the compact 
fold of the C-terminal part of AvrPphB, binding of SycT to an N-terminal, flexible CBD of 
YopT missing tertiary structure seems possible. However, the N-terminal region of YopT, in 
particular residues 75-100, were suggested to be involved in binding to substrate RhoA (Sorg 
et al., 2003). Thus, a YopT/SycT complex might be incapable of interacting with the substrate 
or accomplishing the enzymatic reaction. This eventuality might account for the negative 
findings during SPR analysis, apart from the possibility that the RhoA peptides used in the 
experiments may not be suitable for YopT binding. 
Recently, a chaperone was also identified for the fourth Yersinia effector YopO/YpkA 
(Letzelter et al., 2006), for which additionally a GDI activity for membrane–anchored Rho-
GTPases was found. Intriguingly, all four chaperone-assisted effectors YopT, YopE, YopH 
and YopO target the host cell membrane, and the CBD was therefore suggested to present the 
hydrophobic membrane localization domain (Letzelter et al., 2006). In contrast to YopT, the 
membrane–localizing homolog AvrPphB does not possess a cognate chaperone, rather the 
autocatalytic cleavage at the N-terminus reveals a myristoylation site that promotes the 
membrane targeting of AvrPphB (Nimchuk et al., 2000). 
78   DISCUSSION - SycD – a multi-faceted Class II chaperone with multiple faces 
 
 
3II SycD – a multi-faceted Class II chaperone with 
multiple faces 
3II.1 Comparison with the LcrH/SycD homology model 
The crystal structure of SycD presents the first experimental structure of a T3SS Class II 
chaperone specific for translocators. Moreover, it shows that a structural model of the SycD 
monomer based on the structure of serine/threonine phosphatase 5 (Pallen et al., 2003, 1OOL) 
is in good overall agreement with the crystal structure of the SycD monomer. It confirms the 
prediction that T3SS Class II chaperones contain TPR-like repeats despite their low sequence 
similarity. The monomers A and B of SycD21-163 superpose with the LcrH/SycD32-165 model 
showing an r.m.s. deviation of ~1.0 Å for the repeats TPR1-3 (103 equivalent Cα atoms). 
However, superposition of all common residues between SycD and the model (32-160, 129 
Cα atoms) increases the r.m.s. deviation to 3.6 Å, due to a completely different orientation of 
the C-terminal helix h8 (Figure 3II-1A). Additional striking differences between the model 
and the crystal structure were observed for the side chains of Tyr93, Phe106 and Arg71 
(Figure 3II-1B).  
 
 
 
 
 
 
 
Figure 3II-1. Superposition of the SycD21-163 structure and the LcrH homology model. (A) SycD residues 
32-160 (dark grey, blue) superposed onto the LcrH/SycD homology model (light grey, orange) (Pallen et al., 
2003) exhibit different orientations of helix h8. (B) Stereo close-up view of SycD (blue, side chains as yellow 
sticks) and the LcrH model (light grey, brown), revealing side chain deviations for Tyr93, Phe106 and Arg71. 
Tyr93 in the crystal structure points toward the concave face, maintaining the TPR fold. Its hydroxyl group 
might represent a hydrogen donor/acceptor in translocator binding, explaining a Y93A non-functional mutant. 
 
In the model the side chains of Tyr93 and Phe106 point outwards to the convex surface, 
whereas in the crystal structure both side chains are flipped by 180° and deeply buried in the 
interstice between TPR2 and TPR3, stabilizing the TPR fold by hydrophobic interactions. 
Moreover, in the crystal structure the hydroxyl group of Tyr93 points into the concave groove 
(Figure 3II-1) where it may serve as hydrogen bond donor/acceptor in translocator binding. 
The dual function of Tyr93 might explain the unexpected null mutant phenotype observed for  
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LcrH Y93A (Edqvist et al., 2006). Interestingly, in the crystal structure, the side chain of 
Arg71 in helix A of TPR2 does not freely project into the concave groove, rather it is bent 
toward Glu37 from TPR1 forming an intramolecular salt-bridge that neutralizes its positive 
charge. To summarize, the crystal structure of SycD is similar to the LcrH homology model 
but discloses several differences that might help to explain observations of previous 
mutagenesis studies (see section 3II.4).  
 
3II.2 Alternative dimerization of SycD  
Under physiological conditions, SycD forms dimers in solution (this study and Schmid et al., 
2006) similar to the homodimeric Class I chaperones. Oligomerization of other T3SS Class II 
chaperones has not been examined so far by standard biophysical methods except for SycD 
(this work and Schmid et al., 2006). The closest SycD homolog is Pseudomonas aeruginosa 
PcrH that shares 76 % sequence similarity and 58 % identity. SycD and PcrH are functionally 
partially interchangeable since they reciprocally bind to YopD and the homolog PopD, 
respectively (Broms et al., 2006), although not to YopB/PopB (Allmond et al., 2003). 
Therefore, PcrH might very likely form head-to-head dimers in the absence of the transloca-
tors as well. Interestingly, PopD/PcrH complexes were reported to exhibit a 1:1 ratio only 
(Schoehn et al., 2003; Faudry et al., 2007). 
TPR-containing proteins usually dimerize via the convex outer side formed by TPR motifs in 
the middle of the repeat domain as observed in the crystal structures of human OGT (Jinek et 
al., 2004), P. aeruginosa type 4 pilus protein PilF (Kim et al., 2006) or for the mitochondrial 
outer membrane transporter Tom70p (Wu and Sha, 2006) (Figure 3II-2). The monomers in 
these dimers are tilted (in the PilF dimer by approximately 20°). 
 
 
 
 
 
 
 
 
Figure 3II-2. Homodimerization of TPR proteins. The predominant dimerization mode is via the convex back 
faces of the TPR domain involving the middle TPR repeats. O-linked GlcNac transferase OGT (PDB acces-
sion code 1W3B); mitochondrial transporter protein Tom70 (2GW1); type IV pilus assembly protein PilF 
(2FI7). The arrow head designates the concave face of the TPR domain. 
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A minimal region for dimerization of the TPR domain of Hsp90 co-chaperone Sti1 has been 
recently identified to be located in helix A of the second TPR motif (Flom et al., 2007).  
Based on the packing in the monoclinic crystals, two different assemblies of the monomers 
into a dimer seemed possible for SycD. The compact dimer 2 shows a back-to-back dimeriza-
tion via the convex outer side, as described for other TPR-containing proteins above, 
exhibiting an asymmetric interface – very unusual but not unprecedented for homodimers 
(Cha et al., 2002; Deo et al., 2002). The back-to-back dimer 2 was finally excluded by 
mutagenesis studies. In contrast, SycD dimerization involves mainly helices A and B of the 
first TPR motif generating a head-to-head assembly of either a rather elongated shape with the 
monomers tilted by a larger angle (dimer 1, ~61°) or a kinked arrangement (dimer 3, 90°). 
The latter might still also be due to a crystallization artifact. 
The comparison of the head-to-head dimers 1 and 3 of SycD21-163 disclosed that both the 
concave and convex faces of the monomer are freely accessible in the dimer assemblies 
(Figure 3II-3). In contrast to the elongated dimer 1, where equal faces are located on the same 
dimer front, in the kinked dimer 3 each front exhibits both a concave and a convex face. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3II-3. Accessibility of the concave and convex TPR faces in the different SycD dimer assemblies. 
Front view (left) and top view (right) of SycD21-163 dimer 1 and dimer 3. Aligned front view with respect to the 
blue monomer. In both assemblies the concave and convex face of each monomer are freely accessible for 
protein interactions. In dimer 1, both the concave () as well as the convex () surfaces are located on 
opposite dimer faces, whereas in dimer 3, convex and concave surfaces are found together on the same face. 
 
The formation of alternative dimers is extremely unusual. Up to now, this is the first example 
of a homodimer exhibiting two alternative dimer assemblies sharing the same interface. SycD 
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dimerization is almost exclusively mediated by hydrophobic contacts. There is only one 
hydrogen bond in the interface of dimer 1 linking the side chain of Gln60 with the backbone 
oxygen of Glu30. No polar interaction at all is found in dimer 3 (compare Results section, 
Table 2II-9). While the hydrophobic contacts confer considerable affinity to the SycD dimer 
in vitro, the specificity may be limited, as also suggested by the two different dimer arrange-
ments. In contrast to Class I chaperones, dimerization of SycD is obviously non-obligate. 
Moreover, the SEC profile tailing observed for the SycD wt and SycD21-163 elution peaks 
indicates a monomer-dimer equilibrium with a fast kinetic and the dimer being the predomi-
nant species (see also below). However, it still remains unclear if the "specifically hydrogen-
bonded", elongated dimer 1 can transform to the “unspecific", non-hydrogen-bonded kinked 
dimer 3 and vice versa without dissociation into monomers by simply pivoting around the 
interface (Figure 3II-4). Further, the question arises as to what extent both dimer assemblies 
are present in solution and whether even more conformational states exist.  
 
 
 
 
 
 
 
 
 
 
Figure 3II-4. Dimer-monomer equilibrium of SycD in solution. The predominant species of SycD in solution 
is the dimer. It remains unclear, if the elongated dimer (dimer 1, left) can transform to the kinked dimer (dimer 
3, right) or to what extend both dimer species coexist in solution or if there exist even more conformations. 
 
3II.3 Affinity of the SycD homodimer 
With respect to the flexible, alternative dimer formation of SycD, it would be interesting to 
know the affinity of the chaperone homodimer. Handling of wild-type SycD during purifica-
tion suggests a stable dimer and the explicit stability of monomeric SycD21-163 mutants 
strongly suggests that SycD dimerization is non-obligate. The SEC elution profiles of wild-
type SycD and SycD21-163 display slight tailing, thus indicating a dimer-monomer equilibrium 
(Stevens, 1989; Yu et al., 2006) (compare Figure 3II-4). This is in line with the finding that 
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SycD can form two structurally different head-to-head homodimers with distinct arrange-
ments of the monomers utilizing the same interface. In the past, simulated and experimental 
SEC elution profiles of protein complexes and homodimers have been examined (Stevens, 
1989; Yu et al., 2006). According to these, dimerization of wild-type SycD most likely 
possesses a fast association and dissociation kinetic with a medium to high equilibrium 
dissociation constant (affinity) of KD ~10-5 M or less. The introduction of equally-charged 
glutamate side chains in the dimer interface mutants SycD21-163 A61E, L65E and A61E/L65E 
leads to electrostatic repulsion. Here, this most likely decreases the association rate constant 
kon, and consequently KD via the valid relation ship KD=kon/koff, whereas the dissociation rate 
koff is almost unaffected (also described by Selzer et al., 2000), accompanied by the fronting 
elution profile that corresponds to slow association and medium/fast dissociation rates (Yu et 
al., 2006). The experimental determination of KD of the SycD dimer has not been carried out 
but should in principle be possible using sedimentation equilibrium analytical ultra centrifu-
gation, isothermal titration calorimetry  or fluorescence anisotropy approaches. 
 
3II.4 Mapping of mutagenesis results onto the SycD structure 
Extensive random and subsequent site-directed mutational analyses complemented by 
investigations of mutant stability had been carried out for the binding groove, the canonical 
sequence motif and additional surface-exposed residues in SycD (Francis et al., 2000; Francis 
et al., 2001; Edqvist et al., 2006; Edqvist et al., 2007), covering also most of the conserved 
residues mentioned above (summarized in Table 3II-11). These studies had identified surface-
located residues that are indispensable in binding to the translocators. Residues whose alanine 
mutants are defective in YopB but not in YopD binding (Phe59, Arg71, Phe72, Leu74, Gly75, 
His109) (Francis et al., 2000) point into the concave groove and are primarily located in 
TPR2 helix A (surface-located residues Arg71 and His109 depicted in Figure 3II-5). Of these, 
Arg71 contributes to the TPR stability via a salt-bridge to conserved Glu37 (Figure 3II-1, 
Figure 2II-30). Conserved His109 opposite in the concave groove is probably involved in 
YopB binding as well, since mutation to alanine weakens the interaction (Edqvist et al., 
2006)(Figure 3II-5). Thus, the concave face of SycD is most likely involved in YopB binding. 
YopD binding and secretion strictly depends on His67 (Francis et al., 2000; Edqvist et al., 
2006), located in the turn separating TPR1 from TPR2, and Leu76, both accessible only from 
the convex TPR face. YopD binding requires further Leu42 at the edge of the dimerization 
interface (Figure 3II-5 and Figure 2II-27). 
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Table 3II-11. Correlation of previous mutagenesis results (Francis et al., 2000; Edqvist et al., 2006) with the 
SycD crystal structure. 
Residue/Mutation Binding/Secretion/Stability Structure 
H67*A – / D↓ / WT Turn, convex face 
L42*A – / D↓ / WT Dimerization interface 
L76*A – / D↓ / ↓ Accessible from convex face, fold (?) 
E30G, I31V, L42*F, H91Y, D136G Suppressor mutations D↑ Loops, convex face, dimeriz. interface 
I101*M, K102R D↓ / n.d./ n.d. Turn, convex face 
R71A D B↓ / B↓ / ↓ Salt-bridge to Glu37 
H109A (as double mutant F108A) D B↓ / B↓ / ↓ Concave face 
E37 n.d. / n.d. / n.d. Concave, salt-bridge to Arg71 
Y52A WT / WT / WT  Concave face 
Y86 n.d. / n.d. / n.d. Concave face 
L39A  n.d./ WT/ ↓ Dimerization interface 
Y40C/A, Y47A B↓ D↓ / B↓ D↓ / ↓ Concave face, fold 
L74A B↓ / B↓ / ↓ Buried, fold 
Y93A  B↓ D↓  / B↓ D↓ / ↓ 
Buried, fold, hydroxyl group points into 
concave face, hydrogen bond donor / 
acceptor 
F72L/S/A, F73L/S, C79Y, F108S, 
I134T B↓ D↓ / ~ / ~ Buried, fold 
(B): YopB; (D): YopD; (↓) Binding abolished/reduced; (↑) re-established; (-) neither YopB nor YopD; (WT) 
wild-type; (n.d.) not determined; (~), differing. Asterisks designate residues at TPR consensus positions 
4/7/11/24/32. Conserved sequence residues are underlined. 
 
 
Screening for suppressor mutations in the chaperone that re-established the binding to YopD 
mutants unable to bind wild-type LcrH disclosed additional, surface located sites involved in 
YopD binding, e.g. Glu30, Ile31, Leu42, His91, Asn136 (Francis et al., 2000). Together with 
two additional sites associated with YopD binding that had been identified in multiple 
mutants (Ile101, Lys102) (Francis et al., 2000), these residues are located on the convex face 
of the chaperone (Figure 3II-5). 
Substitution of the surface exposed, conserved Tyr52 in the lower part of the concave groove 
has no effect albeit hydrophobic residues are preferred at this position (Edqvist et al., 2006). 
Tyr86 and the Glu37 represent so far uninvestigated residues near the groove (mentioned 
above), although the aromatic side chain and the negative charge are well conserved at these 
positions, suggesting that these two residues may be involved in the interaction with binding 
partners.  
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Figure 3II-5. Mutations abrogating YopB or YopD binding mapped onto the SycD surface. Mutational 
analyses of SycD/LcrH previously carried out by Francis et al., 2000; Edqvist et al., 2006. Key residues 
located at the surface of SycD21-163 that are involved in YopD secretion (dark blue, single mutations; light blue, 
likely involved, multiple mutations) and YopB binding and secretion (red). Residues accompanied by a non-
binding and non-secreting phenotype (Tyr40, Tyr47, Tyr93) are colored green. 
 
Alanine substitutions of conserved Tyr40 and Tyr47, exposed on the concave face, resulted in 
a less stable chaperone, abrogated the binding and secretion of YopB and YopD and impaired 
the regulatory function on Yop synthesis and secretion (Edqvist et al., 2006), indicating that 
these amino acids are also necessary for maintaining the TPR integrity (Figure 3II-5, green). 
As already mentioned, conserved, buried Tyr93 with its hydroxyl group pointing into the 
concave groove most likely stabilizes the TPR fold, simultaneously enabling hydrogen bonds 
potentially required in translocator binding (Figure 3II-1, Figure 3II-5). Residues Phe72, 
Phe73, Leu74, Cys79, Phe108 and Ile134 are buried and their mutation will most likely affect 
the TPR fold. Overall, surface-exposed residues affecting YopB binding map to the concave 
face of the structure, whereas those required for YopD binding are located on the convex 
surface (Figure 3II-5, red and blue). This strongly supports the idea that YopB binds to the 
concave face and YopD to the convex face of SycD. This hypothesis is corroborated by a 
recent crystal structure of the yeast mitochondrial fission assembly protein Fis1 in complex 
with its binding partners (Zhang and Chan, 2007). The N-terminal arm of Fis1 preceding the 
TPR domain was recently reported to adopt an α-helical structure (Suzuki et al., 2005), and 
this helical conformation is also present in SycD. In contrast to SycD, the Fis1 helix binds to a 
part of the concave groove. It remains there packed even after binding to the adapter proteins 
Caf4 or Mdv1 where it stabilizes the interaction partners (Figure 3II-6). 
The N-terminal helix h0 comprising residues 22-29 in the SycD21-163 structure might extend 
even further into the N-terminus according to secondary structure predictions of full-length 
wild-type SycD. It is conceivable that this N-terminal helix that is flexibly attached to the 
TPR domain might stabilize the translocator upon binding either in a manner similar to Fis1 
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or by embracing the translocator. Recent findings on the Pseudomonas YopD homolog PopD 
indicate a molten globule conformation of the translocator that is independent from binding to 
the chaperone (Faudry et al., 2007), whereas the Shigella translocator IpaC apparently 
undergoes significant conformational changes upon chaperone binding (Birket et al., 2007). 
Obviously, the hydrophobic translocators have to be kept in a state between folded and 
unfolded that is both non-cytotoxic for the bacterium and at the same time secretion-
competent. This delicate balance might require the assistance of the chaperone. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3II-6. TPR domain interaction involving both faces. 
Fis1 (blue) binds to Caf4 (red) by using both its concave and 
convex face of the TPR domain. The N-terminal helical 
region (orange, residues 9-14) is embedded in the concave 
groove stabilizing the binding partner (Zhang and Chan, 
2007). 
 
Most intriguingly, Fis1 binds different parts of the adapter Caf4 simultaneously via its 
concave and convex TPR face (Figure 3II-6). Fis1 presents therefore the first TPR-containing 
protein for which the structural evidence exists that both faces of the TPR domain are actually 
involved in protein-protein interactions. These findings substantiate the conclusions on 
translocator binding in SycD with YopB binding to the concave and YopD to the convex face 
of the TPR domain. 
 
 
3II.5 Implications for further interaction surfaces in SycD 
In contrast to T3SS Class I chaperones, where distinct features such as hydrophobic surface 
patches and a so-called β-motif (Lilic et al., 2006, see Discussion section 3I.3) have been 
identified that are essential for the interaction with the specific secretion target, Class II 
chaperones interact with multiple binding partners of different fold and function and conse-
quentially had to develop a panoply of binding sites. TPR-containing proteins predominantly 
interact with their binding partners via both the concave groove (the prevalent binding site) 
and the convex outer side (compare Figure 3II-6), but basically use all possible faces of the 
TPR domain for ligand and interdomain contacts (for a review see D'Andrea and Regan, 
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2003). So far, only limited information on binding sites in Class II chaperones is available, 
and the prediction of further interaction sites in these multivalent T3SS regulators is therefore 
challenging. 
SycD is also involved in the control of effector biosynthesis by establishing a negative 
regulatory network on yop gene expression together with YopD and LcrQ (YscM1 and 
YscM2 in Y. enterocolitica) (Francis et al., 2001; Anderson et al., 2002). Additionally, SycD 
was reported to have a regulatory effect on Yop secretion via an YscY-YscX loop (Iriarte and 
Cornelis, 1999). Regions in SycD required for YscY binding and the regulatory effect were 
mapped to TPR1 and a so-called NEISS region, comprising residues 29-33, that is located 
between helix h0 and TPR1 with Glu30 as key regulatory residue (Francis et al., 2001; Broms 
et al., 2005). In the crystal structure of SycD, the NEISS element is freely accessible due to its 
linear, exposed structure (compare Results section Figure 2II-17, NEISS sequence colored in 
magenta). Thus, experimental results on its regulatory role appear plausible. 
Additionally, SycD exhibits striking conserved sequence features such as tyrosines residues 
located mainly on the concave chaperone face predicted to be a protein-protein interaction 
surface (Results section Figure 2II-30). Tyrosine, an amino acid with a polar hydroxyl group, 
displays a high propensity to occur in protein-protein interfaces, acting as binding energy 
hotspot (Bogan and Thorn, 1998), and to protrude from the surface to offer suitable interac-
tion sites (Jones and Thornton, 1995). Protruding tyrosines were identified to be the 
functional residues of a TPR domain required in binding to a proline-rich ligand (Pekkala et 
al., 2004). YopB possesses five proline residues within a short N-terminal fragment (residues 
24-55). However, systematic sequence deletions in YopB did not unravel a clearly defined 
chaperone-binding domain. Rather several parts of the YopB sequence seem to be required 
for SycD binding (Neyt and Cornelis, 1999). And although both the convex as well as the 
concave side of the TPR in the SycD head-to-head dimers are freely accessible (compare 
Figure 3II-3) and SycD therefore could theoretically bind to two YopB and two YopD 
molecules simultaneously, the stoichiometry and affinity of the SycD/YopD/YopB interac-
tions remain to be determined. 
The tetrameric SycD21-163 assembly (dimer-of-dimers), suggested by PISA due to the crystal 
contacts in the monoclinic packing, might present an appealing transient solution state of the 
chaperone. This would explain the occasional formation of higher oligomers of SycD (Results 
section Figure 2II-7, also observed by Tengel et al., 2002; Schmid et al., 2006), utilizing so 
far unknown surfaces in SycD. The effector chaperone SycH was also reported to form a 
dimer-of-dimers (Neumayer et al., 2004). Although the interaction of these polymerized 
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chaperone structures with their cognate binding partners has still to be confirmed, this 
presents a compelling possibility of a bandoleer of chaperones preloaded with their cognate 
Yops and ready to release them at the injectisome. Only a very short period of time has been 
observed between the bacterial attachment and a visible cytotoxic effect due to effector 
activity. This short time frame is in the range of < 600 s for injection of all Salmonella SipA 
effector molecules (Schlumberger et al., 2005) and 241 s for the depletion halftime of 
Shigella flexneri translocators (Enninga et al., 2005). This fast phenomenon cannot be 
explained by biosynthesis on demand, rather the virulence factors must be stored within the 
bacterial cytosol prior to cell contact and translocation. In summary, there exist at least two 
potential interaction surfaces that could be employed in the protein-protein interactions of 
multi-functional SycD. 
 
 
3II.6 The dimerization interface in SycD – a new interaction 
surface? 
The apparent lack of specificity in the SycD dimerization interface implies that in vivo this 
interface could be involved in interactions other than homodimerization, e.g. localization to 
the membrane or the T3SS apparatus, potentially via binding to so far unknown interaction 
partners.  
Until now, only few SycD mutations had been described that localize to the dimerization 
interface and show an effect on translocator binding (Leu39, Leu42) (Francis et al., 2000; 
Edqvist et al., 2006). However, the in vivo phenotype of the monomeric SycD mutant 
A61E/L65E clearly indicates that this dimerization interface is functionally relevant. This 
SycD mutant is stable and folded under physiological conditions in vitro and both the concave 
and convex binding faces are intact. The null mutant-like behavior, however, suggests that 
either dimerization is indispensable for appropriate SycD function or that the mutation has 
eliminated so far undetected interactions of the chaperone with the translocators or other 
interaction partners. 
Apart from the cognate translocators YopB and YopD, SycD has been recently shown to 
interact with other T3SS proteins. Further known SycD/LcrH binding partners include 
additional regulatory T3SS components such as TyeA and YscE (Iriarte et al., 1998; Swiet-
nicki et al., 2004). SycD could possibly bind YscE via TPR motif 1 in a manner similar to 
that observed for the Pseudomonas YscE homolog PscE in complex with the TPR-like protein 
PscG (Quinaud et al., 2007). 
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Figure 3II-7. Stereo view of a potential interaction of SycD (blue) with YscE (red), modeled onto hetero-
dimeric PscG/PscE from P. aeruginosa (yellow/grey) (Quinaud et al., 2007, PDB entry 2UWJ). Due to three 
TPR-reminiscent motifs, chaperone PscG superposes with SycD (r.m.s.d. 3.5 Å, 113 aligned residues). Surface 
plasmon resonance and native mass spectrometry experiments have recently elucidated the interaction of SycD 
with YscE (Swietnicki et al., 2004), though its physiological role needs exploration. The model illustrates how 
SycD - via its TPR1 - might bind to YscE in a manner similar to the PscG/PscE interaction. 
 
Interestingly, PscG exhibits a TPR-like fold that was not predicted from its amino acid 
sequence. PscG binds to PscE via its first two (TPR motif-like) helices. Superposition of the 
SycD monomer onto PscG and the crystal structure of YscE (Phan et al., 2005) onto PscE 
might therefore demonstrate how the interaction of SycD with YscE could involve TPR1 
(Figure 3II-7).  
 
3III   Concluding remarks  
Despite their low sequence homology, Class I chaperone structures proved to be well 
conserved and structure prediction for Class II chaperones approaches surprisingly well the 
experimental, atomic structure. As to Class III chaperones, the identification and characteriza-
tion of further members will clarify whether this group actually encloses a heterogeneous set 
of structures or whether the structurally deviant flagellar chaperones should be grouped 
separately. On first sight, a single, representative structure of Class I or Class II chaperones 
virtually holds all the characteristics of these small accessory proteins. However, with the 
growing collection of chaperone structures it became evident that, in contrast to their assumed 
static nature, several of these chaperones, such as of SycT, InvB or SycD, disclose intriguing, 
deviant structural and functional details. These variations provide insight into the fine-tuning 
of type III secretion. Therefore, future chaperone structures will contribute to filling the gaps 
in understanding the complex process of type III secretion and its regulation that is far from 
being complete. 
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4 Outlook 
4I SycT and its cognate effector YopT 
Several Yops other than YopT have been previously reported to be aggregation-prone 
(Michiels et al., 1990; Birtalan et al., 2002; Letzelter et al., 2006). Moreover, the two 
effector/chaperone complexes that have been solved in the recent past could take advantage of 
stable protease digestion products of the effector (YopN32-277/YscB-SycN, SipA48-264/InvB) 
(Schubot et al., 2005; Lilic et al., 2006). This approach is not applicable to the YopT/SycT 
complex as the effector is intrinsically instable even in the complex with the chaperone (this 
work). Thus, a crystal structure of (near) full-length YopT represents a challenging target that 
might be well out of reach. Potentially, the co-expression of an inactive YopT variant 
(C139S) together with the substrate RhoA in eukaryotic cells ensuring the proper RhoA 
geranylgeranylation might result in a stable effector/substrate complex suitable for isolation 
and crystallization. 
Many effector/chaperone complexes have been reported to be still enzymatically active or 
capable of binding to the target protein (Luo et al., 2001; Birtalan et al., 2002; Neumayer et 
al., 2004) due to the separation of the CBD from the catalytically active protein part and only 
partial unfolding during binding to the chaperone. However, YopT has been shown to bind to 
its cognate substrate RhoA using residues within the N-terminal part of the protein that 
partially overlaps with the CBD. It would be interesting to clarify whether SycT-complexed 
YopT is actually capable of interacting with RhoA. To achieve this end, the binding studies 
from this work will have to be continued and extended. Possible approaches are further SPR 
binding experiments either with full-length geranylgeranylated RhoA or the physiologically 
adequate C-terminal RhoA-peptide. This would also help to determine the binding affinity of 
the complex.  
In order to verify the suggested conformational change in SycT upon effector binding, the 
crystal structure of the (possibly synthesized) chaperone-binding domain of YopT with SycT 
would be the most convincing evidence. However, if a soluble YopTCBD can be obtained or 
the aggregation of full-length YopT minimized, nuclear magnetic resonance investigations 
could constitute an alternative approach to unravel rearranging SycT residues. 
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4II Translocator chaperone SycD 
The crystal structure of SycD solved in this thesis presents the first experimental structure of a 
T3SS Class II chaperone specific for translocators. The crystal structure of SycD and the 
identification of a new interaction surface in the translocator chaperone contribute to the 
understanding of its versatile functionality. Certainly, a crystal structure of SycD in complex 
with one of its cognate binding partners YopB or YopD would answer many remaining 
questions. However, since the translocators are hydrophobic transmembrane proteins and can 
apparently bind to the chaperone in a molten globule conformation (Faudry et al., 2007), such 
a complex structure represents a major challenge or might not be feasible at all. Under near-
physiological conditions, as used in this study, a C-terminal YopD peptide, YopD278-300, did 
not show any significant or useful interaction with SycD in solution. A more promising 
approach would therefore be the co-expression of SycD together with one of the pore formers, 
either in the form of the full-length protein or of a covalently linked peptide. 
The alternative dimerization properties of SycD premise an appropriate, yet unknown affinity 
of the dimer. The determination of the affinity in self-associating systems is far from routine, 
and eligible methods such as dilution ITC, fluorescence anisotropy and SE-AUC might not 
exhibit a suitable sensitivity range for detecting the affinity in SycD. The intrinsic protein 
fluorescence by tryptophan constitutes an elegant way to follow protein dissociation. How-
ever, as SycD does not possess any tryptophan residue, site-directed mutagenesis would have 
to be used to introduce a single tryptophan residue in a suitable position. 
The in vivo experiments with Yersinia performed in this study investigating the behavior of 
the monomeric SycD21-163 mutant A61E/L65E should be completed by in vitro analyses using 
pull-down or co-immunoprecipitation methods in order to probe the binding of the mutant to 
the translocators YopB and YopD. In the courses of these experiments, investigations 
concerning the behavior of a specifically covalently cross-linked SycD dimer would be of 
particular interest. Moreover, the stoichiometric ratio of the SycD/YopB/YopD interactions 
still needs to be unraveled. The molecular and structural examination of the interaction with 
further binding partners such as YscE or YscY etc. would be of further interest and might 
elucidate the concrete in vivo function of the dimerization interface. 
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5 Materials and Methods 
Methods in molecular biology were derived from standard procedures (Sambrook and 
Russell, 2001; Coligan et al., 2007) and are not described in detail unless essential modifica-
tions were made. 
 
5.1 Chemicals and material  
If not stated otherwise, chemicals were purchased from Aldrich, J.T. Baker, DIFCO, Emerald 
Biostructures, Fluka, GE-Healthcare-Amersham Biosciences, GIBCO-BRL, Hampton 
Research, Invitrogen, Merck, Millipore, New England BioLabs, Qiagen-Nextal, Riedel-de-
Haën, Roche, Roth, Sigma, Stratagene. The standard quality was pro analysis (p.a.). 
 
5.2 Molecular weight standards 
Table 5-1. Molecular weight standards used in protein biochemistry. 
Name Source Type 
BenchMark Invitrogen SDS-PAGE protein marker 
Low molecular weight Fermentas SDS-PAGE protein marker 
Precision Plus Protein All Blue Standards BIO-RAD SDS-PAGE protein marker 
Broad range protein/peptide standard (unstained)  BIO-RAD SDS-PAGE protein marker 
High molecular weight (native) GE-Healthcare-
Amersham Biosciences 
Native PAGE Protein marker 
HMW und LMW Gel Filtration Calibration  GE-Healthcare-
Amersham Biosciences 
Protein marker for SEC 
 
5.3 Enzymes 
Table 5-2. Enzymes used in protein production and limited proteolysis. 
Enzyme EC  Source Sepecification 
Endoproteinase LysC EC 3.4.21.50 Promega Serine endopeptidase 
Lysozyme EC 3.2.1.17 Fluka Glucoside hydrolase 
PreScission protease EC 3.4.22.28 GE Healthcare Cysteine endopeptidase 
TEV protease EC 3.4.22.44 Lab prepared Cysteine endopeptidase 
Thermolysin EC 3.4.24.27 Boeringer M./Roche Metallo-endopeptidase 
Trypsin EC 3.4.21.4 Promega Serine endopeptidase, modified, 
sequencing grade 
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5.4 Special chemicals 
Table 5-3. Additional chemicals used in this study. 
Chemical Source 
Complete - protease inhibitor cocktail tablets Roche 
Complete, EDTA free Roche 
BugBuster Protein Extraction Reagent Novagen 
Pefablock - Serine protease inhibitor Roche 
 
5.5 Oligonucleotides 
5.5.1 Primers used in polymerase chain reactions 
Table 5-4. Sequences of primers used in PCR and ligation. Forward orientation (FW) and reverse (RV, 
5’→3’ complement). Restriction sites are included in the primer name and underlined in the sequence. 
Oligonucleotide Sequence 5’→3’ Source 
yopT_104_Stop3_ RV_NotI AAGCGGCCGCTTAGTTAGTTACTCTCTCACCGCG this work 
yopT_NcoI_FW AGGAGCCATGGACAGTATTCACGGACACTACCATA
TCC 
this work 
yopT_RV_SalI AAGTCGACAACCTCCTTGGAGTCAAATG this work 
yopT_RV_XhoI AACTCGAGAACCTCCTTGGAGTCAAATG this work 
yopT1-74_Stop_NotI_RV AAGCGGCCGCTTATTTGCCGTCGCTGGTCAAC this work 
yopT318_Stop_NotI_RV AAGCGGCCGCTTAGTCAAATGTTAACACG this work 
yopTdel22_NcoI_FW AGGAGCCATGGGGTCAGCTACACTCACCGAAGGG this work 
yopTdel49_NcoI_FW  AAGAGCCATGGGGAAGTTATCAGCTACC this work 
yopTdel49_NdeI_FW AGGAGCATATGAAGTTATCAGCTACCATAAAAC this work 
yopTdel50_NcoI_FW AGGAGCCATGGGGTTATCAGCTACCATAAAAC this work 
yopTdel50_NdeI_FW AGGAGCATATGTTATCAGCTACCATAAAAC this work 
yopTdel52_NdeI_FW AACATATGTCAGCTACCATAAAACATAACCAGTCA
AGCCG 
this work 
yopTdel74_NcoI_FW AACCATGGCTAACCAACGAAGCAGCTTTACCTTC this work 
yopTdel74_NdeI_FW AACATATGGCTAACCAACGAAGCAGCTTTACC this work 
syopT_BamHI_FW AGGAGGGATCCATGATAGCATCCACGGCC this work 
syopT_EcoRI_RV AGGAGGAATTCTTACACTTCTTTGCTATCG this work 
syopT_NcoI_FW AGGAGCCATGGATAGCATCCACGGCCATTATC this work 
syopT_Stop_NotI_RV AGGAGGCGGCCGCTCACACTTCTTTGCTATCGAAG
GTCAGCAC 
this work 
syopT_XhoI_RV AGGAGCTCGAGCACTTCTTTGCTATCGAAGGTCAG
CAC 
this work 
syopTdel16_NcoI_FW AACCATGGCGGGTGAAAACTTGCAGAGC this work 
syopTdel24_NcoI_FW AACCATGGGGACCCTGACCGAAGGTGTTATTG this work 
syopTdel40_NcoI_FW AACCATGGGGACCGCGCTGAGCCATAGC this work 
syopTdel49_NcoI_FW AACCATGGGGAAACTGAGCGCGACCATC this work 
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Oligonucleotide Sequence 5’→3’ Source 
syopTdel49_NdeI_FW AGGAGCATATGAAACTGAGCGCGACCATC this work 
syopTdel50_NcoI_FW AGGAGCCATGGGGCTGAGCGCGACCATCAAAC this work 
syopTdel50_NdeI_FW AGGAGCATATGCTGAGCGCGACCATCAAAC this work 
syopTdel65_NcoI_FW AACCATGGATCGTAAACTGACCAGCGATGG this work 
syopTdel74_BamHI_FW AGGAGGGATCCATGGCGAATCAGCGTAGC this work 
syopTdel74_NcoI_FW AACCATGGCGAATCAGCGTAGCAGCTTTAC this work 
syopTdel181_PstI_RV AACTGCAGCTGTTTAATGCTGTACAGGGTATC this work 
sycT_NcoI_FW AACCATGGGACAGACAACCTTGACAGAAC H. Niemann; 
HZI, Braun-
schweig 
sycT_RV_Stop_NotI AAGCGGCCGCTCAGATGAATAATATAGGTG H. Niemann; 
HZI, Braun-
schweig 
sycT122_Stop_NotI_RV AAGCGGCCGCTCAGTTGGGCTGAAACTTAGTATTTT
GCGG 
this work 
sycD_BamHI_FW AGGAGGGATCCATGCAACAAGAGACGACAGACACT
CAAG 
this work 
sycD_Pos21_BamHI_FW AGGAGGGATCCGGAGGGGGAACTATCGCCATGCTC
AACG 
this work 
sycD_Stop_EcoRI_RV AGGAGGAATTCTCATGGGTTATCAACGCACTCATG
TTTCATCTCC 
this work 
sycD163_Stop_EcoRI_RV AGGAGGAATTCCTCACTCATGTTTCATCTCCTTTTT
C 
this work 
yopD278-300_NcoINotI_FW CATGGATAACTTTATGAAAGATGTCCTGCGCTTGAT
TGAACAATATGTTAGCAGTCATACTCACGCCATGA
AATAAGC 
this work 
yopD278-300_NcoINotI_RV GGCCGCTTATTTCATGGCGTGAGTATGACTGCTAAC
ATATTGTTCAATCAAGCGCAGGACATCTTTCATAAA
GTTATC 
this work 
Gly-Linker_BamHINcoINotI 
_BamHIEcoRI_FW 
GATCTCCGGGAATTTCCGGTGGTGGTGGTGGATCC
ATGGCAGGCGGCGGCCGCACTGG 
this work 
Gly-Linker_BamHINcoINotI 
_BamHIEcoRI_RV 
AATTCCAGTGCGGCCGCCGCCTGCCATGGATCCAC
CACCACCACCGGAAATTCCCGGA 
this work 
 
 
5.5.2 Site-directed mutagenesis 
The following cycling parameters were applied for site-directed mutagenesis using a thermo-
cycler (Biometra, Whatman) and 18 cycles comprising steps 1 to 3. Oligonucleotides used for 
site-directed mutagenesis are listed in Table 5-5.  
 
Step  0.)   4 min 95 °C, denaturation 
 1.)   45 s 95 °C, denaturation 
 2.)   1 min 55 °C, primer binding 
 3.)   2 min/1 kb plasmid length 68 °C, extension 
 4.)   7 min 68 °C 
 5.)   Hold, 4 °C 
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Table 5-5. Sequences of oligonucleotides used in site-directed mutagenesis. Reverse primer sequences 
correspond to complement sequences of the listed forward (FW) primers. Mutation sites are highlighted. 
Oligonucleotide Mutation Sequence 
yopTS13A_FW S13A 5’ CGGACACTACCATATCCAACTAGCGAATTATTCTG
CCGGTG 3’ 
yopT_140stop_FW E140Stop 5’ GACACCGCTAGCGGTGTCTGTTAAGCTTTATGTGC
ACATTGG 3’ 
yopT_C139S_FW C139S 5’ CCGCTAGCGGTGTCTCAGAGGCTTTATGTGCACAT
TGG 3’ 
syopT_C139S_FW C139S 5’ CCGCGAGCGGTGTTAGCGAAGCGCTGTGCGCGCA
TTGG 3’ 
yopT121stop_FW K121Stop 5’ CAATTTCAAGTTTGCTCAGACCTAAGGGGCTTTTC
TTCATC 3’ 
sycD_K155-159A_FW K155A/K157A/ 
K158A/E159A 
5’ TCCACCCGAGTTAGCTCAATGTTAGAAGCAATTGC
ATTGGCAGCGGCGATGAAACATGAG 3’ 
sycD_K117-119A_FW K117A/E119A 5’ GCCGAATGTTTACTGCAAGCGGGAGCGCTTGCTG
AAGCAGAAAGTGGC 3’ 
sycD_K155S_FW K155S/K157S/ 
K158S/E159S 
5’ TCCACCCGAGTTAGCTCAATGTTAGAAGCAATTAG
CTTGAGCTCGTCGATGAAACATGAG 3’ 
sycD_C164S_FW C164S 5’ GGAGATGAAACATGAGAGCGTTGATAACCCATGA
GAATTCCCGGGTC 3’ 
sycD_Y95S_FW Y95S 5’ GCGATTCATAGCTACAGCTCTGGCGCCGTAATGG
ATATAAAAGAACCTCG 3’ 
sycD_S94E/Y95E_FW S94E/Y95E 5’ GCGATTCATAGCTACGAGGAAGGCGCCGTAATGG
ATATAAAAGAACCTCG 3’ 
sycD_AL6165EE_FW A61E/L65E 5’ GATGCTCACAAGGTCTTTCAAGAACTCTGTGTGGA
AGACCACTATGATTCACG 3’ 
sycD_A61E_FW A61E 5’ GATGCTCACAAGGTCTTTCAAGAACTCTGTGTGCT
AGACCACTATGATTCACG 3’ 
sycD_L65E_FW L65E 5’ GATGCTCACAAGGTCTTTCAAGCTCTCTGTGTGGA
AGACCACTATGATTCACG 3’ 
 
5.6 Plasmids 
Table 5-6. Virulence plasmid used as PCR template. 
Plasmid Organism GenBank entry Source 
pYVe227 Yersinia enterocolitica  
strain W22703, serotype 0:9 
AF102990 G.R. Cornelis; Biozentrum, 
University of Basel, Switzer-
land 
 
Table 5-7. Synthesized yopT gene, cloned into a transport vector. 
Plasmid Original gene Optimized gene Source 
pPCRscript_syopT yopT from Yersinia enterocolitica 
strain W22703, serotype 0:9 
syopT † 
(No. 04691, E.coli codon usage, 
removal of internal EcoRI site) 
GENEART; 
Regensburg 
†
 Nucleotide sequence in the Appendix. 
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Table 5-8. Plasmids used. 
Plasmid Tag Protease cleavage site Selection Source 
pETM-11 N-terminal, His6 TEV protease KanR G. Stier; EMBL, 
Heidelberg 
pETM-30 N-terminal, His6 
N-terminal, GST 
TEV protease KanR G. Stier; EMBL, 
Heidelberg 
pETM-41 N-terminal, MBP TEV protease KanR G. Stier; EMBL, 
Heidelberg 
pETM-60 N-terminal, NusA TEV protease KanR G. Stier; EMBL, 
Heidelberg 
pET-28c+ N/C-terminal, His6 Thrombin KanR Novagen 
pGEX-2T N-terminal, GST Thrombin AmpR GE Healthcare-
Amersham Biosciences 
pGEX-6P-1 N-terminal, GST PreScission protease AmpR GE Healthcare-
Amersham Biosciences 
pETM-11GFPfus N/C-terminal, His6,  
C-terminal, GFP  
- KanR Joop van den Heuvel; 
HZI, Braunschweig 
 
Table 5-9. Recombinant plasmids used. 
Plasmid Features Size Source 
pETM-30-IRES_sycT_yopT 976 bp NdeI/NotI-yopT fragment and 398 bp NcoI/AscI 
sycT fragment from Y. enterocolitica into pETM-30-
IRES (1. NcoI/AscI, 2. NdeI/NotI) 
6.4 kb H. Niemann; 
HZI, 
Braunschweig 
pETM-30-IRES_sycT 
_∆49yopT 
828 bp NdeI/NotI yopT fragment in pETM-30-
IRES_sycT_yopT (NcoI/NotI) 
6.2 kb this work 
pETM-30-IRES_sycT 
_∆49yopT C139S 
Site-directed mutagenesis of 
pETM-30-IRES_sycT_∆49yopT 
6.2 kb this work 
pETM-30-IRES_sycT 
_∆50yopT 
825 bp NdeI/NotI yopT fragment in pETM-30-
IRES_sycT_yopT (NcoI/NotI) 
6.2 kb this work 
pETM-30-IRES_sycT 
_∆49yopTC139S 
Site-directed mutagenesis of 
pETM-30-IRES_sycT_∆50yopT 
6.2 kb this work 
pETM-30-IRES_sycT 
_∆13yopT 
938 bp NdeI/NotI yopT fragment in pETM-30-
IRES_sycT_yopT (NdeI/NotI) 
6.3 kb this work 
pETM-30-IRES_sycT 
_yopTS13A 
Site-directed mutagenesis of pETM-30-
IRES_sycT_yopT 
6.4 this work 
pETM-30-IRES_sycT 
_yopTC139S 
Site-directed mutagenesis of pETM-30-
IRES_sycT_yopT 
6.4 this work 
pETM-30-IRES_sycT 
_yopT52-104 
168 bp NdeI/NotI yopT fragment in pETM-30-
IRES_sycT_yopT (NdeI/NotI) 
5.6 kb this work 
pETM-30-IRES_sycT 
_yopT50-139 
Site directed mutagenesis (E139Stop) of 
pETM-30-IRES_sycT_∆49yopT 
6.4 kb this work 
pETM-30-IRES_sycT 
_yopT50-121 
Site directed mutagenesis (K121Stop) of 
pETM-30-IRES_sycT_∆49yopT 
6.4 kb this work 
pETM-11GFPfus6His 
_syopT 
974 bp NcoI/BamHI syopT fragment cut from 
pCRscript_syopT into pETM11GFPfus (NcoI/BamHI) 
7.1 kb this work 
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Plasmid Features Size Source 
pETM-11GFPfus6His 
_∆16yopT 
498 bp NcoI/PstI syopT fragment into pETM11GFPfus 
(1. NcoI/BamHI, 2. NcoI/PstI) 
7.0 kb this work 
pETM-11GFPfus6His 
_∆24yopT 
477 bp NcoI/PstI syopT fragment into pETM11GFPfus 
(1. NcoI/BamHI, 2. NcoI/PstI) 
7.0 kb this work 
pETM-11GFPfus6His 
_∆40yopT 
432 bp NcoI/PstI syopT fragment into pETM11GFPfus 
(1. NcoI/BamHI, 2. NcoI/PstI) 
7.0 kb this work 
pETM-11GFPfus6His 
_∆49yopT 
402 bp NcoI/PstI syopT fragment into pETM11GFPfus 
(1. NcoI/BamHI, 2. NcoI/PstI) 
7.0 kb this work 
pETM-11GFPfus6His 
_∆65yopT 
351 bp NcoI/PstI syopT fragment into pETM11GFPfus 
(1. NcoI/BamHI, 2. NcoI/PstI) 
7.0 kb this work 
pETM-11GFPfus6His 
_∆74yopT 
324 bp NcoI/PstI syopT fragment into pETM11GFPfus 
(1. NcoI/BamHI, 2. NcoI/PstI) 
7.0 kb this work 
pETM-11-yopT 976 bp NcoI/NotI yopT fragment in pETM-11 
(NcoI/NotI) 
6.3 kb H. Niemann; 
HZI, 
Braunschweig 
pETM-30-yopT 976 bp NcoI/NotI yopT fragment in pETM-30 
(NcoI/NotI) 
7.0 kb H. Niemann; 
HZI, 
Braunschweig 
pETM-41-yopT 976 bp NcoI/NotI yopT fragment in pETM-41 
(NcoI/NotI) 
6.3 kb H. Niemann; 
HZI, 
Braunschweig 
pETM-60-yopT 976 bp NcoI/NotI yopT fragment in pETM-60 
(NcoI/NotI) 
7.8 kb H. Niemann; 
HZI, 
Braunschweig 
pETM-30-yopTC139S Site directed mutagenesis of pETM-30-yopT 7.0 kb this work 
pETM-11_yopT75-318 741 bp NcoI/NotI yopT fragment in pETM-11 
(NcoI/NotI) 
5.0 kb this work 
pETM-30_yopT75-318 741 bp NcoI/NotI yopT fragment in pETM-30 
(NcoI/NotI) 
5.7 kb this work 
pETM-11_syopT 976 bp NcoI/NotI syopT fragment in pETM-11 
(NcoI/NotI) 
6.3 kb this work 
pETM-30_syopT 976 bp NcoI/NotI syopT fragment in pETM-30 
(NcoI/NotI) 
7.0 kb this work 
pGEX-2TGL_syopT 58 bp BamHI/EcoRI Glycine linker fragment and 972 
NcoI/NotI syopT fragment in pGEX-2T 
(1. BamHI/EcoRI, 2. NcoI/NotI) 
6.0 kb this work 
pET-28c+_syopT 6His 969 bp NcoI/XhoI syopT fragment in pET-28c+ 
(NcoI/XhoI) 
6.2 kb this work 
pET-28c+_syopT 976 bp NcoI/NotI syopT fragment in pET-28c+ 
(NcoI/NotI) 
6.2 kb this work 
pETM-30_sycT 399 bp NcoI/NotI sycT fragment in pETM-30 
(NcoI/NotI) 
6.4 kb C. Büttner, 
(dipl. thesis) 
pETM-30_sycT1-122 375 bp NcoI/NotI sycT fragment in pETM-30 
(NcoI/NotI) 
6.4 kb this work 
pGEX-6P-1_sycD 513 bp BamHI/EcoRI fragment of sycD in pGEX-6P-1 
(BamHI/EcoRI) 
5.5 kb this work 
pGEX-6P-1_ 
sycDC164S 
Site directed mutagenesis of pGEX-6P-1_sycD 5.5 kb this work 
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Plasmid Features Size Source 
pGEX-6P-1_ 
sycD21-163  
438 bp BamHI/EcoRI fragment of sycD in pGEX-6P-1 
(BamHI/EcoRI) 
5.4 kb this work 
pGEX-6P-1_ 
sycD21-163K155A 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.5 kb this work 
pGEX-6P-1_sycD21-163 
K155A/K117A 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
pGEX-6P-1_sycD21-163 
K155S 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
pGEX-6P-1_sycD21-163 
Y95SS 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
pGEX-6P-1_sycD21-163 
S94E/Y95E 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
pGEX-6P-1_sycD21-163 
A61E/L65E 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
pGEX-6P-1_sycD21-163 
A61E 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
pGEX-6P-1_sycD21-163 
L65E 
Site directed mutagenesis of pGEX-6P-1_sycD21-163 5.4 kb this work 
 
5.7 Oligopeptides 
Table 5-10. Synthetic peptides used in surface plasmon resonance or co-crystallization.  
 Peptide  Length Sequence Source 
1 RhoA181-190_1C 17 aa Biotin - ATRAALQARRGKKKSGC 
 
W. Tegge; HZI, 
Braunschweig 
2 RhoA181-190_2  17 aa Biotin - ATRAALQARRGKKKSGCIsoprenyl 
 
W. Tegge; HZI, 
Braunschweig 
3 YopD278-300 23 aa DNFMKDVLRLIEQYVSSHTHAMK 
 
P. Henklein; 
Charité, Berlin 
The isoprenylated cysteine is underlined. 
 
5.8 Bacterial strains 
Table 5-11. Bacterial strains used for gene expression. 
Strain Genotype Selection marker Source 
ArcticExpress 
(DE3)-RIL 
E. coli B, F– ompT hsdS (rB– mB–) dcm+ TetR 
galλ(DE3) endA Hte [argU, ileY, leuW, StrR] 
CmR Stratagene, 
Amsterdam 
BL21 CodonPlus 
(DE3)-RIL 
F- ompT hsdSB(rB– mB–) dcm+ dam+ TetR galλ 
(DE3) endA Hte [argU, ileY, leuW, CmR] 
CmR Stratagene, 
Amsterdam 
Rosetta(DE3) F- ompT hsdS(rB– mB–) dcm+ gal lacY1 (DE3) 
pRARE [argU, argW, glyT, _mmu, leuW, metT, 
proL, thrT, tyrU, _mmu, CmR] 
CmR Novagen 
TG1 supE thi-1 ∆(lac-proAB) ∆(mcrB-hsdSM)5 (rK– 
mK
–) [F´ traD36 proAB, lacIq, ∆M15] 
- Stratagene, 
Amsterdam 
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5.9 Antibodies 
Table 5-12. Primary antibodies used in Western blotting. 
Name Antibody 
species 
Antigen Source 
α-YopT Rabbit YopT G.R. Cornelis, University of Basel, 
Switzerland 
α-GFP Mouse Green fluorescent protein 
(GFP) 
Molecular probes 
Penta·His HRP 
Conjugate 
Mouse Penta-His Qiagen 
 
Table 5-13. Secondary antibodies used in Western blotting. 
Name AB  
species 
A/R 
species 
A/R name Conjugate Source 
Goat Anti-Rabbit IgG HR 
conjugate † 
Goat Rabbit IgG Horse radish peroxidase Dianova 
Goat Anti-Mouse IgG 
(H+L) AP Conjugate 
Goat Mouse IgG (H+L) Alcaline phosphatase Promega 
† Internal laboratory labeling B4c. 
 
5.10 Protein biochemistry 
5.10.1 Solutions and buffers 
Table 5-14. Buffers and solutions used in protein biochemistry. 
Solution/Buffer Composition 
Anion exchange buffer A1 (SycT) 20 mM Tris pH 8.0, 50 mM NaCl, 1 mM DTT 
Anion exchange buffer A2 (SycD) 50 mM Tris pH 8.0, 4 mM DTT 
Anion exchange buffer B1 (SycT) 20 mM Tris pH 8.0, 1 M NaCl, 1 mM DTT 
Anion exchange buffer B2 (SycD) 50 mM Tris pH 8.0, 1 M NaCl, 4 mM DTT 
BIAcore buffer 20 mM Tris pH 8.0, 200 mM NaCl, 2 mM DTT 
BugBuster lysis buffer 1 mL BugBuster reagent, 1000 U lysozyme, 25 U benzonase, 5 mM 
Pefablock 
CD buffer 1 20 mM Sodium/potassium phosphate pH 7.5,  
CD buffer 2 10 mM Sodium/potassium phosphate pH 8.0, 150 mM NaCl 
CHT buffer A 10 mM Sodium/potassium phosphate pH 7.0, 2 mM DTT 
CHT buffer B 10 mM Sodium/potassium phosphate pH 7.0, 1 M NaCl, 2 mM DTT 
CHT buffer C 400 mM Sodium/potassium phosphate pH 7.0, 2 mM DTT 
Dialysis buffer 1 (SycT)  10 mM Tris pH 8.0, 10 mM NaCl, 1 mM DTT 
GPC running buffer 1 (SycT, YopT) 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT 
GPC running buffer 2 (SycD) 10 mM Tris pH 8.0, 50 mM NaCl, 1 mM DTT 
GSH-SepH wash buffer 1 (SycT, YopT) 50 mM Tris pH 7.0, 150 mM NaCl, 5 mM DTT 
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Solution/Buffer Composition 
GSH-SepH wash buffer 2 (SycD) 50 mM Tris pH 7.5, 150 mM NaCl, 10 mM β-mercaptoethanol 
Lysis buffer 1 (SycT, YopT) 50 mM Sodium phosphate pH 8.0, 150 mM NaCl, 10 mM β-
mercaptoethanol, 1 tablet protease inhibitor cocktail (Complete, 
Roche), 125 U DNase (Benzonase, Merck) 
Lysis buffer 2 (SycD) 1xPBS, 10 mM β-mercaptoethanol, 1 tablet protease inhibitor 
cocktail (Complete, Roche), 125 U DNase (Benzonase, Merck) 
Master mix for in vitro translation RTS 12 µL E. coli cell lysate, 10 µL reaction mix, 12 µL amino acids, 
1 µL methionine, 35 µL restoration buffer  
5x Native sample buffer 0.31 M Tris/HCl, pH 6.8, 50 % glycerol, 0.1 % bromophenol blue 
10x Native PAGE running buffer 0.4 M Tris, 1.92 M glycine, adjust pH 8.3 
NiNTA binding buffer 10 mM Imidazole, 50 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT 
NiNTA elution buffer 250 mM Imidazole, 50 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT 
NiNTA wash buffer 25 mM Imidazole, 50 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT 
1x PBS 137 mM NaCl, 3 mM KCl, 12 mM Na2HPO4, 2 mM K2HPO4, pH 7.4 
PreScission protease cleavage buffer 50 mM Tris pH 7.4, 200 mM NaCl, 1 mM EDTA, 10 mM β-
mercaptoethanol 
Protease inhibitor mix 40 µM Pefablock, 0.3 µM aprotinin, 10 µM E-64, 1 mM EDTA 
Selenomethionine salt solution 0.3 % w/v MgSO4, 20 % w/v glucose, 100 mg/L Fe(SO4)3, 100 mg/L 
thiamine 
20x TEV protease cleavage buffer 1 M Tris pH 8.0, 10 mM EDTA, 20 mM DTT 
Trace metal mixture (1000x) 50 mM FeCl3·6 H2O, 20 mM CaCl2, 10 mM MnCl2·4 H2O, 10 mM 
ZnSO4·7 H2O, 2 mM CoCl2·6 H2O, 2 mM NiCl2·6H2O, 2 mM 
Na2MoO4·2 H2O, 2 mM Na2SeO3, 2 mM H3BO·, 60 mM HCl 
Transfer buffer for Western blotting 20 mM Tris pH 8.0, 192 mM glycine, 15 % methanol 
Tris-Tricine gel electrophoresis cathode 
buffer 
0.1 M Tris, 0.1 M Tricine, and 0.1% SDS 
Tris-Tricine gel electrophoresis anode 
buffer 
0.2 M Tris/HCl, pH 8.9 
2x Tris/Tricine sample buffer 1 mL 1 M Tris/HCl pH 6.8, 2.4 mM (3 g) glycerol, 0.8 g SDS, 2 mg 
Coomassie blue G-250, 0.31 g DTT, add H2O to 10 mL 
Tris-Tricine stacking gel 2.43 mL Polyacrylamide solution (Rotiphorese Gel 30, Roth), 6.2 mL 
Tris/HCl/SDS buffer pH 8.45, 16.38 mL H2O, 50 µL TEMED, 30 µL 
APS 
Tris-Tricine resolving gel 10.86 mL Polyacrylamide solution, 10 mL Tris/HCl SDS buffer 
pH 8.45, 5.97 mL H2O, 2.17 mL glycerol 50 µL TEMED, 15 µL APS 
Tris/HCl/SDS buffer 3 M Tris/HCl, 0.3 % SDS, pH 8.45 
 
5.10.2 Media 
Media were subjected to autoclave sterilization (121 °C, 2 bar, 20 min, Top7000PST, Sauter, 
Sulgen, Switzerland). Antibiotics were added after media cooling below 50 °C. Depending on 
plasmid and bacteria strain following end concentrations of antibiotics were used: Ampicillin 
(Amp) 100 µg/mL, kanamycin (Kan) 30 µg/mL, chloramphenicol (Cm) 34 µg/mL. 
 
100   MATERIALS AND METHODS 
 
 
Table 5-15. Media used in bacteria cultivation for protein production. 
Medium Composition 
Luria Bertani (LB) 10 g/L Tryptone, 7 g/L, NaCl, 5 g/L yeast extract 
MDG (non-inducing) 25 mM Na2HPO4, 25 mM KH2PO4, 50 mM NH4Cl, 5 mM Na2SO4, 2 mM 
MgSO4·7 H2O, 1x trace metal mixture, 0.5% glucose, 0.25 % aspartate 
ZYM502 (auto-inducing) 1% Tryptone, 0.5 % yeast extract, 25 mM Na2HPO4, 25 mM KH2PO4, 50 mM 
NH4Cl, 5 mM Na2SO4, 2 mM MgSO4·7 H2O, 1x trace metal mixture, 0.5% 
glycerol, 0.05% glucose, 0.2 % lactose 
2x YT 16 g/L Tryptone, 5 g/L NaCl, 10 g/L yeast extract 
Selenomethionine basis 1 g/L NH4Cl, 3 g/L KH4PO4, 4 g/L NaHPO4·2H2O 
 
5.10.3 Absorption coefficients of proteins used for concentration determination 
Table 5-16. Calculated absorption coefficients of selected proteins.  
Protein Molar extinction coeffi-
cient ε [M-1·cm-1] 
1 OD280 ≡ x mg/ml 1 mg/ml ≡ y OD280 
YopT 44’290  0.82 1.22 
YopT75-318 41’730 0.67 1.49 
YopT/SycT 95’170  0.70 1.43 
YopT∆49(C139S)/SycT 92’610 0.67 1.5 
SycT 25’440  0.60 1.67 
SycT1-122 25’440 0.57 1.76 
SycD 10’720 0.55 1.81 
SycD21-163    9320 0.57 1.77 
SycD21-163 K155S    9320 0.57 1.75 
SycD21-163 Y95S    8040 0.49 2.04 
SycD21-163 S94E/Y95E    8040 0.51 2.05 
SycD21-163 A61E/L65E    9320 0.56 1.77 
SycD21-163 A61E    9320 0.56 1.77 
SycD21-163 L65E    9320 0.56 1.77 
   The OD280-concentration relation for a 1 cm cuvette are listed additionally. 
 
5.11 Protein production 
5.11.1 YopT/SycT and SycT  
Gene expression and protein production  
Expression host bacteria were freshly transformed with the expression vector. Target proteins 
expressed in large scale were expressed as GST-fusion proteins. Precultures of 50 mL 
medium with corresponding antibiotics were inoculated with a single colony, incubated for 
16 h and served as inoculum for 2 L medium-antibiotic mix in cultivation flasks. Cells were 
grown at 37 °C till an OD600 ~0.45, shifted to the expression temperature and incubated 
further till an OD600 ~0.6. Gene expression was induced with 1 mM IPTG and extended for 
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15 h at 20 °C, if not mentioned otherwise. Cells were harvested by centrifugation for 15 min 
at 7100xg (Sorvall Thermo RC6 centrifuge, SLA-3000 rotor). The supernatant was discarded 
and the pellet suspended in ice-cold lysis buffer. The cell suspension (~40 mL) was lysed 
using a French Press (SLM Aminco). Soluble and insoluble fractions were separated by 
centrifugation (37’000xg, 60 min, 4 °C). 
 
Purification of YopT/SycT complex variants 
Soluble fusion protein from the centrifugation supernatant was coupled to ~10 mL glutathione 
sepharose 4B beads (GE-Healthcare) (1 h, 4 °C, shaking) that had been equilibrated with lysis 
buffer 1. The beads were washed with GSH-Seph wash buffer 1 till the OD280 absorption 
reached a stable, low value. The tag was cleaved on column in 1-3 column volumes of 
corresponding cleavage buffer with 500 mg TEV protease added and incubated at 16 °C for 
16 h. The supernatant containing tag-free target protein as well as the His6-tagged TEV 
protease was applied to 2 mL NiNTA agarose (QIAGEN) in order to remove the protease. 
The NiNTA agarose affinity chromatography supernatant containing the YopT/SycT complex 
was directly subjected to size exclusion chromatography. SEC columns were used with FPLC 
devices (ÄKTA, GE Healthcare). Prior to this, the affinity chromatography supernatant 
containing the purified complex was concentrated to 2-3 mL using Vivaspin 20 (Sartorius, 
MWCO 3500 - 5000) ultrafiltration units. The complex was purified by SEC using a Super-
dex 75 XK 16/60 column (GE-Healthcare-Amersham Biosciences). Peak fractions were 
pooled. Purified protein was subjected to dynamic light scattering and MADLI-TOF-MS 
measurements (Ultraflex Bruker, Dr. Manfred Nimtz and Anja Meier; HZI, Braunschweig) to 
investigate protein monodispersity and integrity, respectively. Aliquots were frozen at -70 °C 
until further use. 
 
Purification of SycT 
Production as GST-fusion and protein purification ill affinity chromatography was carried out 
as described above. The supernatant from affinity chromatography was dialyzed against 
buffer A 1 (2 L, one buffer exchange with 2 L) of the following anion exchange chromatogra-
phy. Anion exchange material (MonoQ HR 10/10, GE Healthcare) was used with FPLC 
devices (ÄKTA, GE Healthcare). SycT was purified by anion exchange chromatography 
(AEC) using a linear NaCl gradient. The AEC peak fractions containing the purified SycT 
were concentrated to 2-3 mL using Vivaspin 20 (Sartorius, MWCO 3500) ultrafiltration units. 
SycT was further purified by SEC using a Superdex 75 XK 16/60 column (GE-Healthcare-
Amersham Biosciences). Peak fractions were pooled and dialyzed. Purified SycT was 
concentrated for crystallization trials (see section 5.14.1) and subjected to dynamic light 
scattering and MADLI-TOF-MS measurements to check protein monodispersity and integrity, 
respectively. Aliquots were frozen at -70 °C until further use. 
 
5.11.2 SycD  
Gene expression of sycD and variants 
Expression host bacteria were freshly transformed with the expression vector. SycD produced 
in large scale was expressed as a GST-fusion protein. The preculture of 50 mL medium with 
corresponding antibiotics was inoculated with a single colony, incubated for 6 h and served as 
inoculum for 2 L medium-antibiotic mix in cultivation flasks. Cells were grown at 37 °C until 
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an OD600 ~0.6 and shifted to 20 °C. Gene expression was induced at an OD600 ~0.9 with 
0.25 mM IPTG and extended to 15 h at 20 °C. Cell harvest was carried out by centrifugation 
for 15 min at 7100xg (Sorvall Thermo RC6 centrifuge, SLA-3000 rotor). The supernatant was 
discarded and the pellet suspended in ice-cold lysis buffer 2. The cell suspension (~50 mL) 
was lysed using a homogenizer (Constant Cell Disruption Systems). Soluble and insoluble 
fractions were separated by centrifugation (37’000xg, 75 min, 4 °C). 
Purification of SycD and variants 
Soluble fusion protein from the centrifugation supernatant was coupled to ~10 mL glutathione 
sepharose 4B beads (GE-Healthcare) (1 h, 4 °C, shaking) that had been equilibrated with lysis 
buffer 2. The beads were washed with GSH-Seph wash buffer 2 till the OD280 absorption 
reached a stable, low value, and further washed with 3 column volumes of PreScission 
protease cleavage buffer supplied with the protease inhibitor mix. The tag was cleaved on 
column in 2-3 column volumes of PreScission protease cleavage buffer/inhibitor mix. 
Proteolytic cleavage required 500 U PreScission protease and 48-60 h at 4 °C. The super-
natant containing the tag-free target protein was dialyzed against buffer A 2 (2.5 L, one buffer 
exchange with 2.5 L) of the following anion exchange or ceramic hydroxyapatite (CHT) 
chromatography. CHT, a sintered material turned from crystalline to ceramic, possesses 
different functional groups such as Ca2+, PO43- and OH groups. Negatively charged carboxyl 
groups of the protein can interact with hydroxyapatite calcium ions and are competed out by a 
phosphate gradient. Here, CHT chromatography was used as a negative purification step with 
the protein rescued from the flowthrough. Anion exchange material (MonoQ HR 10/10, GE 
Healthcare), ceramic hydroxyapatite (Bio-Rad) and SEC columns were used with FPLC 
devices (ÄKTA, GE Healthcare). SycD purification by AEC was carried out using a linear 
NaCl gradient. The AEC peak fractions or the CHT flowthrough containing the purified target 
protein were concentrated to 2-3 mL using Vivaspin 20 (Sartorius, MWCO 5000) ultrafiltra-
tion units. SycD was further purified by SEC using a Superdex 200 XK 16/60 column (GE-
Healthcare-Amersham Biosciences). Peak fractions were pooled. Purified protein was 
concentrated for crystallization trials (see section 5.14.1) and subjected to dynamic light 
scattering and MADLI-TOF-MS to check protein monodispersity and integrity, respectively. 
Aliquots were frozen at -70 °C until further use. 
 
5.11.3 Production of selenomethionine-labeled substituted SycT 
The media were prepared as described (Guerrero et al., 2001). An 1 L over night culture of 
pETM-30_sycT1-122/ methionine-auxotroph E. coli BL21 CodonPlus(DE3)-RIL in LB-
medium was pelleted (15 min, 4000xg), and washed twice via suspension in sterilized H2O. 
After the second wash and centrifugation step, the pellet was suspended in the selenomethion-
ine basis medium/salt (10:1) mixture. The cell suspension was diluted in 2 L of prewarmed 
selenomethionine basis medium/salt mixture to yield a final OD600 of ~0.6 and incubated at 
20 °C for 20 min and 140 rpm to use up all residual methionine in the bacterial cells. Gene 
expression was induced with 1 mM IPTG (14 h, 20 °C, 140 rpm). Cell harvest, lysis and 
protein purification of selenomethionine (SeMet)-labeled GST-SycT1-122 were performed as 
described above. 
 
5.11.4 Gene expression using auto-inducing medium 
Expression host containing the expression vector was grown over night at 30 °C in non-
inducing (MDG) medium (Studier, 2005) with corresponding antibiotics. The desired volume 
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of auto-inducing medium (Studier, 2005) was inoculated with the over-night culture (ratio 
1:100) and incubated at 20 °C for 24-36 h.  
In case of glucose and lactose being in the culture medium simultaneously, the bacteria first 
use glucose as carbon source and later activate the catabolit activator protein (CAP)-
dependent lactose operon (catabolit repression). Lactose serves as an inducer for expression of 
the target genes that are controlled by the LacI repressor. The lactose induced gene expression 
is less strong and slower compared to IPTG induction. As a result, the nascent target protein 
chain has more time to fold correctly and the bacterium produces in total more biomass and 
therefore more soluble target protein. 
 
5.11.5 Expression test 
Expression constructs were transformed into suitable bacterial expression hosts. Precultures of 
a single colony picked into 3 mL medium with appropriate antibiotics were grown over night 
at 30 °C. Expression test cultures of 50 mL medium/antibiotics were inoculated with the pre-
culture (ratio 1:100) and incubated at 37 °C to an OD600 ~0.45, shifted to the expression 
temperature and induced at OD600 ~0.6 with IPTG (1 mM end concentration). Samples were 
taken during expression progress (3-5 h, over night induction) and their OD600 determined. 
Samples were centrifuged (21’000xg, 1 min) and BugBuster lysis buffer was used to suspend 
the cell pellet (100 µL lysis buffer to 1 mL cell culture with an OD600 = 1). After 20 min 
incubation at room temperature the tubes were centrifuged (21’000xg, 10 min), the super-
natant containing soluble protein fraction was pipetted off and the pellet suspend in the same 
volume of 8 M urea (50 mM Tris-buffered, pH 8). Aliquots of soluble and insoluble fractions 
were analyzed by denaturing polyacrylamide gel electrophoresis. 
 
5.11.6 In vitro translation  
GFP-fusion proteins were produced in vitro using the pETM-11GFPfus expression constructs 
(requirements: T7 promoter, ribosomal binding site and T7 terminator) with the Rapid 
Translation System (RTS 100 E. coli HY Kit and ProteoMaster, Roche) according to the 
manufacturer’s instructions. One reaction tube was filled with 10 µL containing 0.5 µg DNA, 
mixed with 40 µL of in vitro translation master mix and incubated (6 h, 30 °C, 150 rpm).  
 
5.11.7 Reductive methylation of lysines 
The target protein purified by anion exchange chromatography was subjected to ultrafiltration 
(Vivaspin, Sartorius, MWCO 5000) for buffer exchange with 50 mM sodium potassium 
phosphate/150 mM NaCl, pH 7.5. The protein was concentrated to ~10 mg/mL in a total 
volume of 2x 1 mL and methylated as described (Rypniewski et al., 1993). All reagents were 
freshly prepared. 1 mL protein solution was gently mixed with 20 µL of 1 M dimethylamine-
borane complex (ABC) immediately followed by the addition of 40 µL 1 M formaldehyde 
and incubated on ice and in the dark for 2 h. The reaction step was repeated twice with only 
half of the volumes added in the third round followed by incubation for 36 h. Quenching of 
the reaction was achieved by the addition of 100 µL 1 M ammonium sulfate and incubation 
for 24 h. The methylated protein was mixed with 50 mM DTT to a final concentration of 
5 mM and separated from reaction residue by size exclusion chromatography as described 
above. Peak fractions were concentrated for crystallization trials. 
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5.12 Protein analytical methods 
5.12.1 Gel electrophoresis 
Discontinuous polyacrylamide gel electrophoresis (PAGE) was carried out using a gel 
electrophoresis device (Mini Protean III, Bio-Rad). Gels for native PAGE were prepared in 
the same way as described for denaturing sodium dodecyl sulfate (SDS) discontinuous gel 
electrophoresis (Laemmli, 1970) with the exception of using for both gel parts Tris/HCl 
buffer pH 8.8 and leaving out SDS. Samples were mixed with an equal volume of native 
sample buffer, and with half the volume of SDS sample buffer, respectively. The native 
PAGE was run at 30 mA until the tracking dye was 1 cm away from the gel edge. 16 % Tris 
Tricine gels were prepared as described (Schägger and Jagow, 1987) using the appropriate 
solutions listed above and run at constant voltage (110 V). 
 
5.12.2 Limited proteolysis 
Purified protein was mixed with 1x protease cleavage buffer to yield a final protein concentra-
tion of ~1-2 mg/mL in 200 µL reaction volume. Proteases were added resulting in a 
protein:protease ratio of 70:1 or 100:1, respectively. The reaction tubes were kept on different 
temperatures (on ice, 20 °C, 37 °C). Aliquots were taken at different time points during the 
reaction progress and immediately mixed with 2 µL protease inhibitor mix, incubated for 
5 min, mixed with 10 µL sample buffer and denaturated (5 min, 95 °C) for further analysis by 
denaturing gel electrophoresis. 
 
5.12.3 Western blotting 
Transfer of proteins separated by molecular size via gel electrophoresis to polyvinyl di-
fluoride (PVDF) membranes was carried out according to the described method (Towbin and 
Staehelin, 1979). The membrane was activated by treatment with methanol for 1 min, 
followed by washing in transfer buffer. The gel was incubated in transfer buffer as well 
(15 min). The anode of the semi-dry blot chamber (TransBlot semi-dry transfer cell, Bio-Rad) 
was covered with two stacked tissue papers (Whatman) of slightly larger size than the gel that 
had been soaked in transfer buffer, followed by the membrane, the gel and two additional 
soaked tissue papers on top. The transfer was carried out for 40 min at 15 V. Unspecific 
binding-sites on the membrane were blocked (5 % non-fat dry milk in PBS, 1 h) and the 
membrane was washed with PBS (10 min). The primary antibody was diluted (α-YopT 1:100, 
others 1:2000) in 0.3 - 5 % non-fat dry milk/PBS and incubated with the membrane for 1 h at 
room temperature and gentle shaking. After washing with PBS (3x 5 min) the membrane was 
incubated for 2 h with the secondary antibody (1:5000-1:10’000 in PBS) and finally washed 
with PBS (3x 10 min). The protein on the blot was detected by chloronaphthol staining or 
Enhanced Chemiluminescence (ECL) (LumiLight, Roche). 
 
5.12.4 N-terminal sequencing 
Protein bands separated by SDS-PAGE, blotted onto PVDF membrane (see section 5.12.3) 
and visualized by Coomassie staining were sequenced by automated Edman degradation 
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(Edman and Begg, 1967) performed by Rita Getzlaff (HZI, Braunschweig) using an 494A HT 
Protein Sequenzer (Applied Biosystems). 
 
5.12.5 Dynamic light scattering 
In order to determine the particle size distribution of a protein solution, dynamic light 
scattering (also quasi-elastic light scattering) experiments were carried out on a DynaPro 
801TC instrument (ProteinSolutions/Wyatt Technologies). The protein sample, approximately 
15 µL of a prior centrifuged (15 min, 21’000xg) protein solution, was introduced in the cell 
and the scattering intensity fluctuations were recorded at room temperature until the signal 
stabilized (approx. 30 data points). The data were analyzed assuming a globular shape of the 
particles using the instrument software. As a rule of thumb, a polydispersity of the sample of 
< 20 % was used as an indicator for a monodisperse protein solution suitable for crystalliza-
tion trials. 
 
5.12.6 Surface plasmon resonance spectroscopy 
Surface plasmon resonance (SPR) is a biosensing technique that allows the detection of 
biomolecular interactions. One of the molecules of interest is immobilized onto one side of a 
metallic film. Light coming from the opposite side of the film excites surface plasmons 
(oscillation of free electrons on the film surface) and is refracted with a certain refractive 
index. Binding of a ligand to the immobilized molecule on the opposite side results in an 
alteration in surface plasmons. The subsequent change of refractive index measured is 
proportional to the amount of bound ligand. Binding studies between analyte (protein) and 
ligand (peptide) were carried out using the BIACORE 2000 (BIACORE AB) device and 
BIAcore buffer (flow rate 10 µL/min, 25 °C). Dilutions of biotinylated RhoA peptides were 
coupled to a streptavidin coated sensor chip (SA, GE Healthcare) until sufficient response 
units (RU) were coated. The analyte, protein complexes YopT/SycT and YopT∆49 
C139S/ SycT with a concentration of 8-16 µM, respectively, were directed over the immobi-
lized RhoA peptides for binding studies. 
 
5.12.7 Circular dichroism 
Protein solutions were subjected to dialysis or buffer exchange via ultrafiltration against CD 
buffer 1 or 2, respectively, diluted to an end concentration of ~0.1 mg/mL (6-9 mM) and 
analyzed with a spectropolarimeter (JASCO J-810). Typically, 10 spectra in the 180-250 nm 
range were collected at room temperature, averaged and converted to molar ellipticity. Data 
were evaluated in DICROPROT (Deleage and Geourjon, 1993) using a least square fitting 
algorithm by Bolotina et al., 1980. 
 
5.13 Bioinformatics 
Sequences of genes and gene products were analyzed and archived in Vector NTI version 6. 
Amino acid sequences were analyzed for potential surface entropy reduction of residues 
suitable for site-directed mutagenesis (Derewenda and Vekilov, 2006) using the surface 
entropy reduction server http://nihserver.mbi.ucla.edu/SER/. 
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Pairwise and multiple sequence alignments were performed using CLUSTALW (Thompson, 
1994) and EMBOSS (Pearson et al., 1997).  
Modeling the YopT amino acid sequence onto the crystal structure of AvrPphB (PDB 
accession code 1UKF) was carried out using the program BRAGI (Reichelt et al., 2005) and 
Joachim Reichelt’s (HZI, Braunschweig) assistance. 
The identification and generation of the SycD mixed model used in molecular replacement 
was carried out using the Fold & Function Assignment System (http://ffas.ljcrf.edu/ffas-
cgi/cgi/ffas.pl, FFAS03) (Jaroszewski et al., 2005). 
 
5.14 X-ray structural analysis 
5.14.1 Crystallization experiments 
Initial screening for crystallization conditions was carried out in 96-well format using several 
commercially available screens (Nextal/Qiagen, Emerald Biostructures, Hampton Research) 
and sitting drop vapor diffusion at 20 °C and 4 °C, partially supported by nano-drop pipetting 
(Mosquito, Molecular Dimensions). Tests were further carried out with porous gel-glass, a 
universal nucleant, spotted onto Innovaplate SD-2 drop chambers or in the form of small 
grains (Nano-Grain) (cooperation with Jason Maroothynaden from Nanonucleant, London, 
UK), which was supposed to provide suitable nucleation surfaces and enforce crystallization. 
Optimization of crystallization conditions (buffer system, pH, precipitant concentrations) was 
carried out using hanging drop (24-well plate) and sitting drop vapor diffusion at 4 °C. An 
overview of the different crystallization conditions is given in Table 5-17.  
 
Table 5-17. Crystallization conditions of target proteins crystallized in this study. Initial and optimized 
conditions as well as specifications on the crystallization droplet are given. 
Protein Initial condition Optimized reservoir condition Droplet/Incubation 
SycT    
SycT Birefringent spheru-
lites 
CrystalScreen1 No.40 
5 % 2-Propanol, 0.1 M trisodium 
citrate pH 5.6, 21 % PEG 4000 
11.2 mg/mL, 1 µL 
protein + 1 µL 
reservoir, hanging 
drop, over night 
SeMet SycT1-122  
(crystal form 1) 
Emerald Biostructures 
Wizard I No.33 
1.6 M Ammonium sulfate, 0.1 M 
CAPS pH 10.5, 0.15 M lithium 
sulfate  
12.3 mg/mL, 0.5µL 
+ 0.5 µL, hanging 
drop, over night 
SeMet SycT1-122  
(crystal form 2) 
- 1.8 M Ammonium sulfate, 0.1 M 
sodium bicarbonate pH 10.5, 
0.05 M magnesium chloride  
 
12.3 mg/mL, 0.5 µL 
+ 0.2 µL, hanging 
drop, over night 
SycD    
SycD21-163 Nextal Cations No.92 1.9-2.2 M Potassium acetate, 
0.1 M Tris pH 8.2 
23 mg/mL, 2 µL + 
0.5 µL hanging drop, 
14 d 
 Nextal MbClassII, 
No.28 
0.1 M Trisodium citrate pH 5.5, 
0.1 M sodium chloride, 0.1 M 
lithium sulfate, 25 % PEG 
350 MME 
 
not to optimize 
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Protein Initial condition Optimized reservoir condition Droplet/Incubation 
SycD21-163K155S Nextal Cations No.45 1.85 M Lithium acetate,  
0.1 M Tris pH 8.4 
25 mg/mL,2 µL + 
0.5 µL, hanging 
drop, 14 d 
 Nextal MbClassII, 
No.28 
0.1 M Trisodium citrate pH 5.5, 
0.1 M sodium chloride,  
0.1 M lithium sulfate,  
25 % PEG 400 
29-47mg/mL,  
1 µL + 0.5 µL, 13 d, 
not to optimize 
 (hand-made PEG 
screen) 
45 % PEG 400, 0.1 M Tris pH 8.2 47 mg/mL, sitting 
drop, 0.2 µL + 
0.1 µL, 4 d, 
not to optimize 
SycD21-163 meth Nextal SM4 No.61 0.1 M Trisodium citrate,  
10-20 % 2-propanol,  
20-23 % PEG 4000, pH adjusted to 
~7.8 
14.3 mg/mL, 0.5 µL 
+ 0.25 µL sitting 
drop, 4 - 21 d 
SycD21-163methS94E/Y95E Emerald Biostructures 
Synergy Precipitant P1 
No. 38 
 
& No. 47 
Original bulk screen solutions 
40 % PEG 400, 5 % PEG 3350,  
0.1 M sodium acetate pH 5.5 
25 % PEG 3350, 5 % PEG400 
0.1 M sodium acetate pH 5.5 
15.3 mg/mL, 0.2 µL 
+0.1 µL, 6 d 
SycD21-163A61E/L65E meth 
SycD21-163L65Emeth 
Emerald Biostructures 
Synergy Precipitant P1 
No.45 
0.1 M Tris pH 8.5, 30 PEG 1500, 
8 % 2-methyl-2,4-pentanediol 
~12.6-13.8 mg/mL, 
1 µL + 0.5 µL, 
hanging drop, 7 d, 
not to optimize 
SycD21-163A61E/L65E Optimization of Nextal 
SM4 No.61  
0.1 M Trisodium citrate 
15 % 2-propanol, 
23 % PEG 4000 
15.4 mg/mL, 0.5 µL 
+ 0.25 µL, sitting 
drop, 14 d 
 
Crystals were subjected to quick-soaks (10 - 60 sec) in cryo-protection solutions (summarized 
in Table 5-18) to protect crystals from ice formation and radiation damage, and flash-frozen in 
liquid nitrogen. 
 
Table 5-18. Cryo-protection used. Cryo-protection solution were freshly prepared based on the crystallization 
condition supplemented with cryo-protectant, potentially with increased precipitant concentration. 
Protein Cryo-protectant Adjusted precipitant concentration 
SycT 19-26 % Glycerol 22 % PEG 4000 
SeMet SycT1-122 (crystal form 1) 19 % Glycerol - 
SeMet SycT1-122 (crystal form 2) 23 % Glycerol - 
SycD21-163 25 % Glycerol 2.1 M Potassium acetate 
 26 % Glucose 2.1 M Potassium acetate 
SycD21-163 K155S 25 % Glycerol 2.0 M Lithium acetate 
 26 % Glucose 2.0 M Lithium acetate 
 - 2.0 M Lithium acetate 
SycD21-163 meth 20 % Glycerol - 
SycD21-163 meth S94E/Y95E - (directly from well) - 
 10 % Glycerol 27 % PEG 3350 
SycD21-163 A61E/L65E  23 % Glycerol 23.4 % PEG 4000 
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Crystals were mounted on the goniometer head using cryo-tongues or nitrogen-filled vials, 
and maintained at 100 K via a nitrogen cryo-stream device. Diffraction images were further 
collected at room temperature (MicroMounts & Room Temperature Mounting System, 
MiTeGen) to confirm the diffraction potential of crystals poorly diffracting after flash-
freezing.  
 
5.14.2 Crystal engineering 
Heavy atom derivatization 
Heavy-atom derivatized crystals were prepared by quick and medium soaks (seconds to 
several minutes) in either near-molar concentrations of halides (potassium/sodium bromide or 
chloride) (Dauter et al., 2000) or in 10 mM heavy metal solutions (Sun and Radaev, 2002) of 
thimerosal (C6H9HgO2SNa), ethylmercurylphosphate (C2H7HgO4P), potassium tetracyano-
platinate (K2Pt(CN4)·xH2O), potassium tetrachloroplatinate (II) (K2PtCl4) or 
osmium(III)chloride hydrate (OsCl3·xH2O) containing appropriate cryo-protectants. Crystals 
treated with heavy metals were back-soaked (1 min) in 1 mM heavy atom solution with cryo-
protectant. Crystals were finally flash-frozen in liquid nitrogen. Xenon pressure derivatization 
(Panjikar and Tucker, 2002) was carried out with the help of S. Panjikar (EMBL Ham-
burg/DESY). The crystals, prior soaked in cryo-protection solution, were pressurized with 
xenon gas (room temperature, 4 MPa,1 min), the pressure was gradually released (20 s) and 
the crystals were flash-frozen in liquid nitrogen. 
 
Dehydration 
To improve the diffraction potential by homogenizing the packing and shrinking the unit cell 
in SycD21-163 and SycD21-163 K155S crystals different approaches were used. First, cover slides 
were simply transferred to even more concentrated reservoir wells. As second technique, 
introduced by Björn Klink (HZI, Braunschweig), three ~200 nL droplets of reservoir solutions 
already containing the cryo-protectant as well as high concentrations of precipitants (see 
Table 5-19) were pipetted around the rim of a crystals-containing reservoir drop followed by 
15-30 min of equilibration. These steps were repeated until the doubled drop volume and the 
final concentration were achieved. To monitor the progress, crystals were flash-frozen after 
3/6/9 addition cycles or over night equilibration and the diffraction pattern was analyzed. 
Controlled dehydration/hydration (Free mounting system, Proteros/Rigaku (Kiefersauer et al., 
2000)) by running gradients of relative humidity in combination with on-line X-ray measure-
ments (Bruker; MAR345 detector) was applied as a third technique.  
 
Table 5-19. Solutions used in the second, droplet dehydration technique. 
No. Dehydration solution Applied to 
1 2.8 M Potassium acetate, 0.1 M Tris pH 8.2, 20 % glycerol SycD21-163  
2 3.6 M Potassium acetate, 0.1 M Tris pH 8.2 SycD21-163 
3 2.4 M Potassium acetate, 0.1 M Tris pH 8.2, 30 % polyethylene glycol 400 SycD21-163 
4 4.5 M Lithium acetate, 0.1 M Tris pH 8.4  SycD21-163 K155S 
5 4.45 M Lithium acetate, 0.1 M Tris pH 8.4 + 1 % trehalose SycD21-163 K155S 
6 4.42 M Lithium acetate, 0.1 M Tris pH 8.4 + 1.6 % trehalose SycD21-163 K155S 
7 3.5 M Lithium acetate, 0.1 M Tris pH 8.2 + 20 % glycerol SycD21-163 K155S 
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5.14.3 Data collection and processing 
Data were collected using synchrotron radiation and MAR CCD and ADCS CCD detectors 
(Marresearch, Germany and Area Detector Systems Corporation, USA) (see Table 5-20). 
After fluorescence scanning, a multiple-wavelength anomalous dispersion (MAD) experiment 
was carried out for selenomethionine-labeled SycT1-122 at the peak, inflection and high remote 
energies of the selenium K-edge. Wavelengths used in data collection are listed in Table 5-20. 
Data of native SycT, SycD21-163 and SycD21-163 meth Xe were processed and scaled with 
DENZO/ SCALEPACK (Otwinowski, 1997), data of SeMet SycT1-122 crystal form 1 and 2 as 
well as SycD21-163 meth and mutants were processed with XDS and scaled with XSCALE 
(Kabsch, 1993). The CCP4 program suite (Collaborative Computational Project, 1994) 
provided further tools to manipulate reflection data and proceed in structure solution. 
 
Table 5-20. Synchrotron beamlines used for data collection. 
Protein crystals Synchrotron light source Beamline Wavelength [Å] 
SycT DESY / EMBL-Hamburg  BW6 1.05 
SycT1-122 crystal form 1 - Peak BESSY / Berlin BL14.1 0.9795 
SycT1-122 crystal form 2 - Peak BESSY / Berlin BL14.1 0.97957 
                                      - Inflection point BESSY / Berlin BL14.1 0.97976 
                                      - High energy remote Cryo-protection BL14.1 0.91165 
SycD21-163 DESY / EMBL-Hamburg X12 1.27815 
SycD21-163 meth DESY / EMBL-Hamburg 
ESRF / Grenoble 
X12 
ID23-1 
1.27815 
0.97925 
SycD21-163 meth Xe DESY / EMBL-Hamburg X12 1.5 
SycD21-163 meth S94E/Y95E  ESRF / Grenoble ID14-1 0.934 
SycD21-163 A61E/L65E(V64M) BESSY / Berlin BL14.1 0.91841 
 
5.14.4 Anomalous dispersion in structure solution 
The presence of a heavy atom (element with high atomic number) in the crystal lattice allows 
the de novo phase determination of the diffraction data. Anomalous scattering (also disper-
sion) occurs when the energy of the incident X-ray photon is close to the absorption 
edge/transition energy required to promote an electron to an unoccupied higher orbital or to 
eject it completely from an atom. The absorption of incident energy by the crystal results in a 
reduced intensity of the coherent scattering and a slight change in the phase of the scattered 
X-ray beams. This is expressed by the atomic scattering factor f of the heavy atom comprising 
now the normal scattering component 0f and a non-negligible wavelength-dependent real 
(dispersive, f’) and an imaginary (absorption, f’’) correction term for the anomalous scatter-
ing. The experimental determination of the actual shape of the absorption curve via 
fluorescence energy scan of the heavy atom-labeled crystal provides the precise values for f’’ 
and of its derivative f’. As the absorption term f’’ is always 90° advance in phase, the 
resonant/anomalous scattering causes a slight deviation from Friedel’s Law (Friedel, 1913). 
Friedel pairs Fhkl and F-h-k-l (short F+ and F-) are Bragg reflections related by inversion through 
the origin exhibiting the same magnitude of the structure factor intensity but opposite phase 
angles at normal scattering using wavelengths far from the absorption edge. In anomalous 
scattering, Friedel mates no longer have equal structure factor amplitudes (Bijvoet, 1954): 
Fhkl≠ F-h-k-l and their phase angles are no longer complementary. Near the absorption 
110   MATERIALS AND METHODS 
 
 
edge energy (“peak” wavelength), the imaginary anomalous component f’’, which is propor-
tional to the atomic absorption coefficient of the heavy atom, shows its largest value. The 
dispersive part f’ of the anomalous signal shows its minimum at the inflection point of the 
scan. The structure factors of the derivative at these wavelengths differ significantly in their 
amplitudes compared to the native data (or the equivalent data of a derivative collected at a 
remote energy). The advantage of such a multiple-wavelength anomalous dispersion (MAD) 
experiment is the resolution of the phase ambiguity and the (almost) perfect isomorphism of 
the collected datasets as they are collected from a single crystal. Non-isomorphism (changes 
of unit cell parameters or protein orientation in the unit cell) interferes with the phasing 
success. It has been shown that even a single wavelength is sufficient to obtain good phase 
estimates and to solve novel structures (single-wavelength anomalous dispersion (SAD) 
(Dauter et al., 2002). In SAD, the phase ambiguity is broken by density modification proto-
cols. The correct enantiomorph (handedness) of the anomalous scatterer substructure is 
thereby revealed by comparison of the electron-density maps treated by density modification. 
The incorrect enantiomorph contains no image of the macromolecule, whereas the correct 
map features clear solvent boundary and a macromolecular-like density histogram. 
The positions of the anomalously scattering heavy atoms in the unit cell can be deduced from 
an anomalous difference Patterson map (Patterson function introduced by Patterson, 1935), 
which is calculated using only the coefficients ∆F2 derived from the anomalous structure 
factor amplitude differences of the Friedel pairs (and their symmetry mates) ∆F=F+ - F-, 
also called Bijvoet amplitude differences. Significant non-origin peaks in the three-
dimensional Patterson map correspond to interatomic vectors between anomalously scattering 
atoms only that are related by crystallographic symmetry and are found in two-dimensional 
slices of the map (called Harker sections, Harker, 1936). From the Harker peaks (u,v,w), the 
coordinates of the heavy atoms (x,y,z) in the unit cell can be calculated. The normal scattering 
structure factor amplitude and phase, together with f’’ and its derivative f’, allows the 
estimation of the phases of the anomalous structure factors FA for the anomalous scatterer 
substructure. This allows a first approximation of the phase angles for the native protein 
structure factors FT. 
 
5.14.5 Structure determination 
Five out of six selenium atoms in the hexagonal packing of SycT1-122 crystal form 2 could be 
located by heavy-atom search, phasing and solvent flattening programs SHELXD (Uson and 
Sheldrick, 1999) and SHELXE (Sheldrick, 2002) that were run using the graphical user 
interface HKL2MAP (Pape and Schneider, 2004). SHELXE phases for crystal form 2 
provided interpretable electron density and were used to trace an initial model using the same 
anomalous dataset (see section 5.14.6). The structure for the orthorhombic (crystal form 1) 
data set was solved by molecular replacement using the refined structural model of crystal 
form 2 as search model in the program PHASER (Storoni et al., 2004). The native structure 
was solved using both refined SycT1-122 structural models of crystal form 2 and 1 as search 
ensemble for molecular replacement in PHASER.  
The structure of SycD21-163 meth could be solved by MR in the program PHASER searching 
with a mixed model of the TPR domain of a synthetic repeat protein (PDB accession code 
2FO7), obtained by application of the Fold & Function Assignment System (FFAS) algorithm 
to the SycD sequence (Rychlewski et al., 2000) (see Bioinformatics section 5.13). The correct 
MR solution became evident only after placing the second monomer. The completed and 
refined model for SycD21-163 meth (see section 5.14.6) was successfully used as MR search 
model to solve the structure of the xenon derivative and the mutants A61E/L65E and 
S94E/Y95E, but still failed to phase the tetragonal SycD21-163 crystal form. 
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5.14.6 Model building and structure refinement 
ARP/wARP (Lamzin and Wilson, 1993) was used to build first models into the initial electron 
densities of SeMet SycT1-122 crystal form 2 (80 % complete) and SycD21-163 meth (68 % 
complete). The initial models were refined by rigid body refinement and simulated annealing 
using the programs CNS (native SycT) (Brunger et al., 1998) and the PHENIX program tools 
(SycD21-163) (Adams et al., 2002). The obtained partial models of SycT were improved and 
completed by several cycles of manual building in the program O (Jones et al., 1991), models 
of SycD were improved in COOT (Emsley and Cowtan, 2004), followed by restrained (SycD) 
or TLS restrained refinement (SycT, SycD mutants), respectively, with REFMAC5 
(Murshudov, 1997) or PHENIX (SycD mutants). Structural models were validated using 
WHATIF (Vriend, 1990) and MOLPROBITY (Davis et al., 2004). 
 
5.14.7 Structural analysis and visualization 
Structures were analyzed regarding structural homology using a DALI (Holm, 1993) search 
and aligned with LSQKAB (Kabsch, 1976). Pairwise and multiple sequence alignments 
assigned with secondary structure elements were visualized with ESPript (Gouet et al., 1999). 
Sequence conservation was calculated in ProtSkin (http://www.mcgnmr.ca/ProtSkin/). Protein 
interfaces and quaternary structures were identified using AREAIMOL (SycT) (Lee and 
Richards, 1971), PISA (Krissinel and Henrick, 2007), the protein-protein interaction server 
(http://www.biochem.ucl.ac.uk/bsm/PP/server/) (Jones, 1998) and ProMate (Neuvirth et al., 
2004). Cavity volumes were calculated with VOIDOO (Kleywegt, 1994). Ribbon diagrams 
and surfaces were produced with PyMOL (DeLano, 2002) and Swiss-PDB Viewer (Guex and 
Peitsch, 1997), secondary structure assignment was calculated using STRIDE (Heinig and 
Frishman, 2004). 
 
5.15 Experiments in vivo 
The in vivo expression and secretion experiments with Yersinia enterocolitica were kindly 
carried out by Dr. Isabel Sorg (Biozentrum of the University of Basel, Switzerland) as part of 
a collaboration. The aim of the experiments was to assay the phenotype of the full-length 
monomeric SycD A61E/L65E (see Results section 2II.1.5) mutant regarding yop expression 
and secretion in comparison to wild-type SycD. 
 
SycD wild-type and mutant A61E/L65E sequences were cloned into the NcoI/EcoRI sites of 
pBADmycHisA (silent mutation of the internal sycD NcoI site) giving plasmids pISO156 and 
pISO157. Induction of the yop regulon was described by Cornelis et al., 1987. The bacteria 
were cultivated in permissive (Brain-heart infusion, BHI, supplemented with 20 mM sodium 
oxalate (-Ca2+)) or non-permissive conditions (BHI supplemented with 5 mM calcium 
chloride (+Ca2+)) (Cornelis et al., 1987; Marenne et al., 2003). Expression of the different 
genes cloned downstream from the pBAD promoter was routinely induced by adding 0.2 % 
L-arabinose to the culture just before the shift to 37 °C, and again 2 h later. The carbon source 
was glycerol (4 mg/ml). Total cell and supernatant fractions were separated by centrifugation 
at 20’800xg for 10 min at 4 °C. The cell pellet was taken as total cell fraction. Proteins in the 
supernatant were precipitated using trichloroacetic acid 10 % (w/v) final for 1 h at 4 °C.  
Secreted proteins were analyzed on Coomassie-stained 12 % SDS-PAGE. In each case 
proteins secreted by 3x108 bacteria were loaded per lane. For detection of proteins by 
immunoblotting, 1.6x108 bacteria (total cell fraction) and supernatants from 2.5x107 bacteria 
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(supernatant fraction) were loaded per lane. Immunoblotting was carried out using polyclonal 
rat-antibodies directed against YopB (MIPA98; 1:300), YopD (MIPA96; 1:300) and YopE 
(MIPA94; 1:10’000) or polyclonal rabbit-antibodies directed against SycD (MIPA35; 
1:1000). Detection was performed with the respective secondary antibodies conjugated to 
horseradish peroxidase (1:5000; Dako) before development with supersignal chemilumines-
cent substrate (Pierce). 
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Appendix 
A)  Nucleotide and amino acid sequences 
syopT (synthetic yopT gene, E. coli codon-usage optimized, GENEART No. 042691) 
   1 ATGGATAGCA TCCACGGCCA TTATCATATT CAGCTGAGCA ACTATAGCGC GGGTGAAAAC 
  61 TTGCAGAGCG CGACCCTGAC CGAAGGTGTT ATTGGTGCGC ATCGCGTGAA AGTTGAAACC 
 121 GCGCTGAGCC ATAGCAACCG TCAGAAAAAA CTGAGCGCGA CCATCAAACA TAATCAGAGC 
 181 AGCCGTAGCA TGCTGGATCG TAAACTGACC AGCGATGGCA AAGCGAATCA GCGTAGCAGC 
 241 TTTACCTTCA GCATGATCAT GTACCGCATG ATCCATTTTG TTCTGAGCAC CCGTGTTCCG 
 301 GCGGTTCGTG AAAGCGTTGC GAACTATGGC GGCAACATCA ACTTTAAATT CGCGCAGACG 
 361 AAAGGTGCGT TTCTGCACCA GATCATCAAA CACAGCGATA CCGCGAGCGG TGTTTGTGAA 
 421 GCGCTGTGCG CGCATTGGAT TTGGAGCCAT GCGCAGGGTC AGAGCCTGTT CGATCAGCTG 
 481 TATGTGGGCG GTCGTAAAGG CAAATTCCAG ATCGATACCC TGTACAGCAT TAAACAGCTG 
 541 CAGATCGATG GTTGTAAAGC GGATGTGGAT CAGGATGAAG TTACCCTGGA TTGGTTTAAA 
 601 AAAAAAGGCA TCAGCGAACG CATGATTGAA CGTCATTGTC TGCTGCGTCC GGTTGATGTT 
 661 ACCGGCACCA CCGAAAGCGA AGGTCCGGAT CAGCTGCTGA ATGCGATTCT GGATACCCAC 
 721 GGCATTGGCT ACGGCTATAA AAAAATCTAC CTGAGCGGTC AGATGAGCGC GCATGCGATT 
 781 GCGGCGTATG TGAACGAAAA AAGCGGCGTG ACCTTTTTTG ATCCGAACTT CGGCGAATTT 
 841 CACTTCAGCG ATAAAGAAAA ATTTCGCAAA TGGTTTACCA ACAGCTTCTG GGAAAACAGC 
 901 ATGTATCATT ATCCGCTGGG TGTGGGTCAG CGTTTTAGCG TGCTGACCTT CGATAGCAAA 
 961 GAAGTG 
SycT - amino acid sequence (GenBank entry AAD16809) 
   1 MQTTFTELMQ QLFLKLGLNH QVNENDVYTF EVDGHIQVLI ACYHQQWVQL FSELGADLPT 
  61 NDNLFGEHWP AHVQGRLDGK SILWSQQSLV GLDIDEMQAW LERFIDDIEQ RKEPQNTKFQ 
 121 PNSTSPILFI 
YopT - amino acid sequence (GenBank entry AAD16808, catalytic triad in bold) 
   1 MDSIHGHYHI QLSNYSAGEN LQSATLTEGV IGAHRVKVET ALSHSNRQKK LSATIKHNQS 
  61 SRSMLDRKLT SDGKANQRSS FTFSMIMYRM IHFVLSTRVP AVRESVANYG GNINFKFAQT 
 121 KGAFLHQIIK HSDTASGVCE ALCAHWIWSH AQGQSLFDQL YVGGRKGKFQ IDTLYSIKQL 
 181 QIDGCKADVD QDEVTLDWFK KKGISERMIE RHCLLRPVDV TGTTESEGPD QLLNAILDTH 
 241 GIGYGYKKIY LSGQMSAHAI AAYVNEKSGV TFFDPNFGEF HFSDKEKFRK WFTNSFWENS 
 301 MYHYPLGVGQ RFSVLTFDSK EV 
SycD - amino acid sequence (GenBank entry AAD16814) 
   1 MQQETTDTQE YQLAMESFLK GGGTIAMLNE ISSDTLEQLY SLAFNQYQSG KYEDAHKVFQ 
  61 ALCVLDHYDS RFFLGLGACR QAMGQYDLAI HSYSYGAVMD IKEPRFPFHA AECLLQKGEL 
 121 AEAESGLFLA QELIANKPEF KELSTRVSSM LEAIKLKKEM KHECVDNP 
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B)  Gene expression results for different YopT constructs and conditions 
 
Table B1. YopT expression constructs tested.  
ANo. Expression vector YopT construct Expression 
condition 
YopT 
expression 
Soluble 
1 pETM-30-IRES_sycT_yopTS13A YopTS13A GST-SycT + - 
2 pETM-30-IRES_sycT_∆13yopT YopT14-322 GST-SycT + + 
2 pETM-30-IRES_sycT_∆22yopT YopT23-322 GST-SycT ++ + 
2, 6 pETM-30-IRES_sycT_∆22yopT C139S YopT23-322C139S GST-SycT ++ + 
2 pETM-30-IRES_sycT_∆49yopT YopT50-322 GST-SycT +++ + 
2, 6 pETM-30-IRES_sycT_∆49yopT C139S YopT50-322C139S GST-SycT +++ + 
2 pETM-30-IRES_sycT_∆50yopT YopT51-322 GST-SycT +++ + 
2, 6 pETM-30-IRES_sycT_∆49yopTC139S YopT51-322C139S GST-SycT +++ + 
3 pETM-11_yopT His6-YopT AI - n.d. 
3 pETM-30_yopT GST-YopT AI + n.d. 
3 pETM-41_yopT MBP-YopT AI - n.d. 
3 pETM-60_yopT NusA-YopT AI - n.d. 
3, 4 pETM-11_yopT75-318 His6-YopT75-318 AI ++ -  
3, 4 pETM-30_yopT75-318 GST-YopT75-318 AI + - 
5 pETM-11_syopT His6-sYopT - ++ - 
5 pETM-30_syopT GST-sYopT - + - 
5 pET-28c+_syopT 6His sYopT-His6 - - - 
5 pET-28c+_syopT sYopT  - ++ - 
6 pETM-30-IRES_sycT_yopTC139S YopTS13A GST-SycT +++ + 
6 pETM-30_yopTC139S GST-YopTC139S - + n.d. 
7 pGEX-2TGL_syopT GST-GL-sYopT also TG1 + - 
8 pETM-30_yopT GST-YopT 10 °C, AEx. - n.d. 
8 pETM-30_yopT75-318 GST-YopT75-318 10 °C, AEx. - n.d. 
8 pET28c+_syopT sYopT 10 °C, AEx. - n.d. 
ANo., Approach, according to the classification in the Results section 2I.1.1, Table 2I-1; AI: Auto-inducing 
medium; GL: Glycine linker; TG1, E. coli expression host; AEx., ArcticExpress, E. coli expression host, 
psychrophilic due to chaperonin genes cpn10/cpn60 from Oleispira antarctica. YopT expression: from (+++) 
good to (-) not detected; Soluble: (+), yes, (-), no, (n.d.), not determined. 
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